Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 9.0E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Bladder Wall 4.9E-09 2.5E-08 8.6E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Bone Surface 1.6E-08 1.3E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Brain 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Breast 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 GI-Tract Oesophagus 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 St Wall 5.2E-09 2.6E-08 8.6E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 SI Wall 5.5E-09 2.6E-08 8.6E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 ULI Wall 7.7E-09 2.9E-08 9.1E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 LLI Wall 8.0E-09 3.7E-08 1.0E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Colon 7.8E-09 3.3E-08 9.5E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Kidneys 1.1E-07 1.1E-06 3.8E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 Liver 5.9E-08 5.5E-07 2.0E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Muscle 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Ovaries 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Pancreas 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Red Marrow 2.5E-08 2.2E-07 8.0E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Respiratory Tract ET Airways 1.1E-08 3.4E-08 9.5E-08 2.0E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Lungs 6.3E-08 8.3E-08 1.4E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Skin 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Spleen 9.6E-08 9.1E-07 3.3E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 Testes 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Thymus 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Thyroid 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Uterus 4.9E-09 2.5E-08 8.5E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Remainder 5.8E-08 5.4E-07 2.0E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Effective dose 2.0E-08 1.1E-07 3.7E-07 8.5E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 1.2E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Bladder Wall 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Bone Surface 2.2E-08 1.8E-07 6.5E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Brain 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Breast 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 GI-Tract Oesophagus 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 St Wall 6.9E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 SI Wall 7.2E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 ULI Wall 8.9E-09 3.8E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 LLI Wall 9.2E-09 4.4E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Colon 9.0E-09 4.1E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Kidneys 1.5E-07 1.4E-06 5.2E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Liver 8.0E-08 7.4E-07 2.7E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 Muscle 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Ovaries 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Pancreas 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Red Marrow 3.4E-08 3.0E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Respiratory Tract ET Airways 1.1E-08 4.1E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Lungs 1.5E-07 1.8E-07 2.6E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Skin 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Spleen 1.3E-07 1.2E-06 4.5E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Testes 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Thymus 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Thyroid 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Uterus 6.7E-09 3.5E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Remainder 7.9E-08 7.4E-07 2.7E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 Effective dose 3.5E-08 1.6E-07 5.1E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 1.7E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Bladder Wall 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Bone Surface 3.1E-08 2.6E-07 9.3E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Brain 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Breast 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 GI-Tract Oesophagus 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 St Wall 9.6E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 SI Wall 9.7E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 ULI Wall 1.1E-08 5.1E-08 1.7E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 LLI Wall 1.1E-08 5.5E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Colon 1.1E-08 5.3E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Kidneys 2.2E-07 2.0E-06 7.4E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Liver 1.1E-07 1.1E-06 3.8E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 Muscle 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Ovaries 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Pancreas 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Red Marrow 4.8E-08 4.2E-07 1.5E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Respiratory Tract ET Airways 1.2E-08 5.2E-08 1.7E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Lungs 2.0E-07 2.4E-07 3.5E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 Skin 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Spleen 1.9E-07 1.8E-06 6.4E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Testes 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Thymus 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Thyroid 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Uterus 9.5E-09 4.9E-08 1.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Remainder 1.1E-07 1.0E-06 3.8E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 Effective dose 4.7E-08 2.2E-07 7.2E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 1.8E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Bladder Wall 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Bone Surface 3.3E-08 2.7E-07 9.7E-07 2.2E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Brain 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Breast 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 GI-Tract Oesophagus 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 St Wall 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 SI Wall 1.0E-08 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 ULI Wall 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 LLI Wall 1.0E-08 5.5E-08 1.8E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Colon 1.0E-08 5.3E-08 1.8E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Kidneys 2.3E-07 2.1E-06 7.7E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Liver 1.2E-07 1.1E-06 4.0E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 Muscle 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Ovaries 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Pancreas 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Red Marrow 5.1E-08 4.4E-07 1.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Respiratory Tract ET Airways 1.1E-08 5.2E-08 1.7E-07 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Lungs 1.1E-07 1.6E-07 2.8E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 Skin 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Spleen 1.9E-07 1.8E-06 6.6E-06 1.5E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Testes 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Thymus 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Thyroid 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Uterus 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Remainder 1.2E-07 1.1E-06 4.0E-06 9.2E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 Effective dose 3.8E-08 2.2E-07 7.4E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 9.9E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Bladder Wall 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Bone Surface 1.8E-08 1.5E-07 5.3E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Brain 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Breast 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 GI-Tract Oesophagus 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 St Wall 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 SI Wall 5.5E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 ULI Wall 5.7E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 LLI Wall 5.7E-09 3.0E-08 9.9E-08 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Colon 5.7E-09 2.9E-08 9.7E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Kidneys 1.2E-07 1.2E-06 4.2E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 Liver 6.5E-08 6.0E-07 2.2E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 Muscle 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Ovaries 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Pancreas 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Red Marrow 2.8E-08 2.4E-07 8.8E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Respiratory Tract ET Airways 5.9E-09 2.9E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Lungs 5.4E-08 7.7E-08 1.4E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Skin 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Spleen 1.1E-07 1.0E-06 3.6E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 Testes 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Thymus 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Thyroid 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Uterus 5.4E-09 2.8E-08 9.4E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Remainder 6.5E-08 6.0E-07 2.2E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 Effective dose 2.0E-08 1.2E-07 4.1E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 5.6E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bladder Wall 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bone Surface 1.0E-08 8.4E-08 3.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 Brain 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Breast 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 GI-Tract Oesophagus 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 St Wall 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 SI Wall 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 ULI Wall 3.4E-09 1.7E-08 5.5E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 LLI Wall 3.4E-09 1.8E-08 5.7E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Colon 3.4E-09 1.7E-08 5.6E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Kidneys 7.0E-08 6.6E-07 2.4E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 Liver 3.7E-08 3.4E-07 1.2E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 Muscle 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Ovaries 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Pancreas 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Red Marrow 1.6E-08 1.4E-07 5.0E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Respiratory Tract ET Airways 3.7E-09 1.7E-08 5.4E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Lungs 2.7E-08 4.0E-08 7.7E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Skin 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Spleen 6.0E-08 5.7E-07 2.1E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 Testes 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thymus 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thyroid 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Uterus 3.1E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Remainder 3.7E-08 3.4E-07 1.2E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 Effective dose 1.1E-08 6.7E-08 2.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 6.4E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bladder Wall 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bone Surface 1.2E-08 9.6E-08 3.4E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 Brain 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Breast 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 GI-Tract Oesophagus 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 St Wall 3.6E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 SI Wall 3.8E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 ULI Wall 4.7E-09 2.0E-08 6.4E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 LLI Wall 4.8E-09 2.3E-08 6.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 4.8E-09 2.1E-08 6.6E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Kidneys 8.0E-08 7.6E-07 2.7E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 Liver 4.2E-08 3.9E-07 1.4E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Muscle 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Ovaries 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Pancreas 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Red Marrow 1.8E-08 1.6E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Respiratory Tract ET Airways 5.7E-09 2.1E-08 6.4E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Lungs 2.2E-08 3.6E-08 7.9E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Skin 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Spleen 6.9E-08 6.5E-07 2.4E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 Testes 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thymus 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thyroid 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Uterus 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Remainder 4.2E-08 3.9E-07 1.4E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Effective dose 1.2E-08 7.5E-08 2.6E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 8.1E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Bladder Wall 4.5E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Bone Surface 1.5E-08 1.2E-07 4.4E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Brain 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Breast 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 GI-Tract Oesophagus 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 St Wall 4.7E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 SI Wall 4.9E-09 2.4E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 ULI Wall 6.6E-09 2.6E-08 8.2E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 LLI Wall 6.9E-09 3.2E-08 9.0E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Colon 6.8E-09 2.9E-08 8.5E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Kidneys 1.0E-07 9.6E-07 3.5E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 Liver 5.3E-08 5.0E-07 1.8E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Muscle 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Ovaries 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Pancreas 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Red Marrow 2.3E-08 2.0E-07 7.2E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Respiratory Tract ET Airways 8.5E-09 2.9E-08 8.4E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Lungs 2.5E-08 4.4E-08 9.8E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Skin 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Spleen 8.7E-08 8.3E-07 3.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Testes 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Thymus 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Thyroid 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Uterus 4.4E-09 2.3E-08 7.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Remainder 5.3E-08 4.9E-07 1.8E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Effective dose 1.4E-08 9.6E-08 3.3E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 7.9E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bladder Wall 4.3E-09 2.2E-08 7.6E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bone Surface 1.4E-08 1.2E-07 4.2E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 Brain 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Breast 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 GI-Tract Oesophagus 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 St Wall 4.6E-09 2.3E-08 7.6E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 SI Wall 4.8E-09 2.3E-08 7.6E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 6.7E-09 2.6E-08 8.0E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 LLI Wall 7.0E-09 3.2E-08 8.8E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Colon 6.9E-09 2.9E-08 8.3E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Kidneys 9.8E-08 9.3E-07 3.4E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 Liver 5.2E-08 4.8E-07 1.8E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Muscle 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Ovaries 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Pancreas 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Red Marrow 2.2E-08 1.9E-07 7.0E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Respiratory Tract ET Airways 8.9E-09 2.9E-08 8.2E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Lungs 2.3E-08 4.1E-08 9.4E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Skin 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Spleen 8.5E-08 8.0E-07 2.9E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 Testes 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thymus 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thyroid 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Uterus 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Remainder 5.1E-08 4.8E-07 1.7E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Effective dose 1.4E-08 9.3E-08 3.2E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 6.7E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bladder Wall 3.7E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bone Surface 1.2E-08 1.0E-07 3.6E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 Brain 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Breast 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 GI-Tract Oesophagus 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 St Wall 3.9E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 SI Wall 4.2E-09 2.0E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 ULI Wall 6.0E-09 2.2E-08 6.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 LLI Wall 6.3E-09 2.9E-08 7.6E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Colon 6.2E-09 2.5E-08 7.1E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Kidneys 8.3E-08 7.9E-07 2.9E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 Liver 4.4E-08 4.1E-07 1.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 Muscle 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Ovaries 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Pancreas 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Red Marrow 1.9E-08 1.6E-07 5.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Respiratory Tract ET Airways 8.4E-09 2.6E-08 7.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Lungs 1.6E-08 3.1E-08 7.6E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Skin 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Spleen 7.1E-08 6.8E-07 2.5E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 Testes 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thymus 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thyroid 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Uterus 3.6E-09 1.9E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Remainder 4.3E-08 4.1E-07 1.5E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Effective dose 1.1E-08 7.8E-08 2.7E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 7.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Bladder Wall 1.0E-09 5.8E-09 2.1E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Bone Surface 3.2E-09 3.0E-08 1.2E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Brain 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Breast 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 GI-Tract Oesophagus 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 St Wall 1.6E-09 6.4E-09 2.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 SI Wall 2.3E-09 7.1E-09 2.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 ULI Wall 6.7E-09 1.4E-08 2.9E-08 5.9E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 LLI Wall 7.3E-09 2.9E-08 4.5E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 Colon 7.0E-09 2.0E-08 3.6E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 Kidneys 2.1E-08 2.4E-07 9.2E-07 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Liver 1.1E-08 1.2E-07 4.8E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Muscle 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Ovaries 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Pancreas 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Red Marrow 4.9E-09 5.0E-08 1.9E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Respiratory Tract ET Airways 9.5E-08 6.2E-07 2.3E-06 8.0E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 Lungs 3.5E-06 1.9E-05 5.2E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 Skin 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Spleen 1.8E-08 2.1E-07 7.9E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Testes 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Thymus 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Thyroid 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Uterus 1.0E-09 5.8E-09 2.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 Remainder 1.4E-09 9.7E-09 3.5E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 Effective dose 4.3E-07 2.2E-06 6.3E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.8E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Bladder Wall 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Bone Surface 3.6E-09 3.5E-08 1.4E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Brain 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Breast 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 GI-Tract Oesophagus 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 St Wall 1.7E-09 7.3E-09 2.6E-08 6.9E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 SI Wall 2.3E-09 8.1E-09 2.7E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 ULI Wall 6.3E-09 1.5E-08 3.4E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 LLI Wall 6.7E-09 3.0E-08 5.1E-08 9.8E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Colon 6.5E-09 2.1E-08 4.2E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Kidneys 2.4E-08 2.8E-07 1.1E-06 3.1E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Liver 1.3E-08 1.4E-07 5.8E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Muscle 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Ovaries 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Pancreas 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Red Marrow 5.5E-09 5.8E-08 2.3E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Respiratory Tract ET Airways 7.6E-08 4.9E-07 1.8E-06 6.4E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Lungs 9.3E-06 4.6E-05 1.3E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 Skin 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Spleen 2.1E-08 2.4E-07 9.7E-07 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Testes 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Thymus 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Thyroid 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Uterus 1.1E-09 6.8E-09 2.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Remainder 1.5E-09 1.1E-08 4.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Effective dose 1.1E-06 5.6E-06 1.5E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.4E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bladder Wall 1.2E-09 7.6E-09 3.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bone Surface 4.0E-09 4.0E-08 1.8E-07 6.9E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 Brain 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Breast 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 GI-Tract Oesophagus 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 St Wall 1.6E-09 8.0E-09 3.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 SI Wall 2.0E-09 8.6E-09 3.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 ULI Wall 4.4E-09 1.3E-08 3.9E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 LLI Wall 4.5E-09 2.4E-08 5.3E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 4.5E-09 1.8E-08 4.5E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Kidneys 2.7E-08 3.1E-07 1.4E-06 5.5E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 Liver 1.4E-08 1.6E-07 7.3E-07 2.8E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 Muscle 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Ovaries 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Pancreas 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Red Marrow 6.1E-09 6.5E-08 2.9E-07 1.1E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Respiratory Tract ET Airways 3.8E-08 2.5E-07 9.4E-07 3.3E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Lungs 1.2E-05 5.9E-05 1.6E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 Skin 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Spleen 2.3E-08 2.7E-07 1.2E-06 4.7E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 Testes 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thymus 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thyroid 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Uterus 1.2E-09 7.6E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Remainder 1.7E-09 1.2E-08 5.3E-08 2.0E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Effective dose 1.5E-06 7.1E-06 2.0E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.4E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bladder Wall 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bone Surface 3.7E-09 3.6E-08 1.7E-07 8.6E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Brain 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Breast 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 GI-Tract Oesophagus 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 St Wall 1.3E-09 7.1E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 SI Wall 1.5E-09 7.4E-09 3.2E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 ULI Wall 2.6E-09 9.9E-09 3.5E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 LLI Wall 2.5E-09 1.5E-08 4.4E-08 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Colon 2.5E-09 1.2E-08 3.9E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Kidneys 2.5E-08 2.8E-07 1.4E-06 6.9E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 Liver 1.3E-08 1.5E-07 7.1E-07 3.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Muscle 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Ovaries 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Pancreas 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Red Marrow 5.7E-09 5.9E-08 2.9E-07 1.4E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Respiratory Tract ET Airways 1.6E-08 1.0E-07 4.0E-07 1.4E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Lungs 7.0E-06 3.3E-05 9.3E-05 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 Skin 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Spleen 2.2E-08 2.4E-07 1.2E-06 5.9E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Testes 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thymus 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thyroid 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Uterus 1.1E-09 6.9E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Remainder 1.5E-09 1.1E-08 5.1E-08 2.5E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Effective dose 8.4E-07 4.0E-06 1.1E-05 1.7E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 6.9E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Bladder Wall 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Bone Surface 2.0E-09 1.9E-08 9.4E-08 4.8E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 Brain 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Breast 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 GI-Tract Oesophagus 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 St Wall 6.9E-10 3.8E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 SI Wall 7.8E-10 3.9E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 ULI Wall 1.3E-09 5.1E-09 1.9E-08 8.9E-08 9.1E-08 9.1E-08 9.1E-08 9.1E-08 9.1E-08 9.1E-08 LLI Wall 1.3E-09 7.7E-09 2.3E-08 9.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Colon 1.3E-09 6.2E-09 2.1E-08 9.2E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 Kidneys 1.4E-08 1.5E-07 7.5E-07 3.9E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Liver 7.2E-09 7.9E-08 3.9E-07 2.0E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Muscle 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Ovaries 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Pancreas 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Red Marrow 3.1E-09 3.2E-08 1.6E-07 8.0E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 Respiratory Tract ET Airways 7.5E-09 4.8E-08 1.8E-07 6.7E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 Lungs 3.3E-06 1.6E-05 4.4E-05 6.8E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 Skin 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Spleen 1.2E-08 1.3E-07 6.5E-07 3.3E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Testes 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Thymus 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Thyroid 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Uterus 6.1E-10 3.7E-09 1.7E-08 8.5E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Remainder 8.2E-10 6.0E-09 2.8E-08 1.4E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Effective dose 4.0E-07 1.9E-06 5.4E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.4E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Bladder Wall 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Bone Surface 1.2E-09 1.2E-08 5.5E-08 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Brain 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Breast 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 GI-Tract Oesophagus 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 St Wall 4.6E-10 2.4E-09 1.0E-08 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 SI Wall 5.6E-10 2.5E-09 1.0E-08 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 ULI Wall 1.1E-09 3.5E-09 1.2E-08 4.9E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 LLI Wall 1.2E-09 5.9E-09 1.5E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Colon 1.2E-09 4.6E-09 1.3E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Kidneys 8.4E-09 9.3E-08 4.4E-07 2.1E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Liver 4.4E-09 4.8E-08 2.3E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Muscle 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Ovaries 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Pancreas 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Red Marrow 1.9E-09 1.9E-08 9.2E-08 4.4E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Respiratory Tract ET Airways 1.1E-08 7.4E-08 2.8E-07 9.8E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Lungs 1.6E-06 7.8E-06 2.2E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 Skin 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Spleen 7.3E-09 8.0E-08 3.8E-07 1.8E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Testes 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Thymus 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Thyroid 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Uterus 3.8E-10 2.3E-09 9.9E-09 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Remainder 5.1E-10 3.7E-09 1.7E-08 7.9E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Effective dose 1.9E-07 9.4E-07 2.6E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.6E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bladder Wall 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bone Surface 1.8E-09 1.7E-08 7.2E-08 2.7E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Brain 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Breast 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 GI-Tract Oesophagus 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 St Wall 8.1E-10 3.5E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 SI Wall 1.1E-09 3.9E-09 1.3E-08 4.9E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 ULI Wall 2.9E-09 6.7E-09 1.7E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 LLI Wall 3.2E-09 1.3E-08 2.4E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 Colon 3.0E-09 9.4E-09 2.0E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Kidneys 1.2E-08 1.4E-07 5.8E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Liver 6.5E-09 7.1E-08 3.0E-07 1.1E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Muscle 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Ovaries 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Pancreas 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Red Marrow 2.8E-09 2.8E-08 1.2E-07 4.5E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Respiratory Tract ET Airways 4.0E-08 2.6E-07 9.9E-07 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 Lungs 1.2E-06 5.9E-06 1.7E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Skin 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Spleen 1.1E-08 1.2E-07 5.0E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Testes 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thymus 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thyroid 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Uterus 5.7E-10 3.3E-09 1.3E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Remainder 7.8E-10 5.4E-09 2.2E-08 8.2E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 Effective dose 1.4E-07 7.1E-07 2.0E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Bladder Wall 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Bone Surface 2.6E-09 2.5E-08 9.9E-08 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Brain 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Breast 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 GI-Tract Oesophagus 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 St Wall 1.3E-09 5.2E-09 1.8E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 SI Wall 1.8E-09 5.8E-09 1.9E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 ULI Wall 5.1E-09 1.1E-08 2.4E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 LLI Wall 5.6E-09 2.2E-08 3.6E-08 7.6E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 Colon 5.3E-09 1.6E-08 2.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Kidneys 1.8E-08 2.0E-07 7.9E-07 2.5E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Liver 9.5E-09 1.0E-07 4.1E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Muscle 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Ovaries 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Pancreas 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Red Marrow 4.1E-09 4.1E-08 1.6E-07 5.2E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 Respiratory Tract ET Airways 7.4E-08 4.8E-07 1.8E-06 6.3E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 Lungs 1.2E-06 5.8E-06 1.6E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Skin 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Spleen 1.5E-08 1.7E-07 6.8E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Testes 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Thymus 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Thyroid 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Uterus 8.4E-10 4.8E-09 1.8E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Remainder 1.1E-09 8.0E-09 3.0E-08 9.6E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Effective dose 1.4E-07 7.1E-07 2.0E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.0E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Bladder Wall 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Bone Surface 2.7E-09 2.6E-08 1.0E-07 2.9E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Brain 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Breast 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 GI-Tract Oesophagus 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 St Wall 1.3E-09 5.4E-09 1.8E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 SI Wall 1.9E-09 6.0E-09 1.9E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 ULI Wall 5.6E-09 1.1E-08 2.5E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 LLI Wall 6.1E-09 2.4E-08 3.8E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 Colon 5.8E-09 1.7E-08 3.0E-08 6.5E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 Kidneys 1.8E-08 2.0E-07 8.0E-07 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Liver 9.7E-09 1.1E-07 4.1E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Muscle 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Ovaries 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Pancreas 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Red Marrow 4.2E-09 4.3E-08 1.6E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Respiratory Tract ET Airways 8.1E-08 5.3E-07 2.0E-06 6.9E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 Lungs 9.7E-07 4.6E-06 1.3E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Skin 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Spleen 1.6E-08 1.8E-07 6.9E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Testes 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Thymus 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Thyroid 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Uterus 8.6E-10 4.9E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Remainder 1.2E-09 8.2E-09 3.1E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 Effective dose 1.2E-07 5.7E-07 1.6E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.0E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Bladder Wall 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Bone Surface 2.5E-09 2.3E-08 8.8E-08 2.3E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Brain 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Breast 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 GI-Tract Oesophagus 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 St Wall 1.2E-09 4.9E-09 1.6E-08 4.1E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 SI Wall 1.8E-09 5.5E-09 1.7E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 ULI Wall 5.4E-09 1.1E-08 2.2E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 LLI Wall 5.9E-09 2.3E-08 3.5E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 Colon 5.6E-09 1.6E-08 2.8E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Kidneys 1.7E-08 1.8E-07 7.0E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Liver 8.8E-09 9.6E-08 3.6E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Muscle 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Ovaries 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Pancreas 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Red Marrow 3.8E-09 3.9E-08 1.5E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Respiratory Tract ET Airways 8.0E-08 5.2E-07 2.0E-06 6.8E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Lungs 5.6E-07 2.5E-06 6.8E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Skin 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Spleen 1.4E-08 1.6E-07 6.1E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Testes 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Thymus 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Thyroid 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Uterus 7.8E-10 4.5E-09 1.6E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Remainder 1.1E-09 7.5E-09 2.7E-08 7.2E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Effective dose 6.9E-08 3.1E-07 8.6E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 9.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Bladder Wall 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Bone Surface 1.8E-10 2.0E-09 7.6E-09 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Brain 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Breast 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 GI-Tract Oesophagus 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 St Wall 6.6E-10 1.0E-09 2.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 SI Wall 1.5E-09 1.9E-09 2.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 ULI Wall 6.6E-09 9.6E-09 1.1E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 LLI Wall 7.2E-09 2.7E-08 2.9E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 Colon 6.9E-09 1.7E-08 1.9E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 Kidneys 1.2E-09 1.6E-08 6.0E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Liver 6.5E-10 8.1E-09 3.1E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 Muscle 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Ovaries 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Pancreas 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Red Marrow 2.8E-10 3.3E-09 1.2E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 Respiratory Tract ET Airways 1.0E-07 6.9E-07 2.7E-06 1.5E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Lungs 3.9E-06 2.1E-05 6.1E-05 9.5E-05 9.5E-05 9.5E-05 9.5E-05 9.5E-05 9.5E-05 9.5E-05 Skin 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Spleen 1.1E-09 1.3E-08 5.2E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Testes 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Thymus 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Thyroid 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Uterus 6.1E-11 3.8E-10 1.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 3.3E-09 Remainder 1.6E-10 9.8E-10 3.6E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 Effective dose 4.7E-07 2.5E-06 7.3E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 2.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Bladder Wall 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Bone Surface 1.7E-10 2.0E-09 8.1E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Brain 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Breast 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 GI-Tract Oesophagus 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 St Wall 6.3E-10 1.0E-09 2.1E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 SI Wall 1.5E-09 1.9E-09 3.1E-09 5.8E-09 5.8E-09 5.8E-09 5.8E-09 5.8E-09 5.8E-09 5.8E-09 ULI Wall 6.0E-09 9.6E-09 1.2E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 LLI Wall 6.4E-09 2.7E-08 3.1E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Colon 6.2E-09 1.7E-08 2.0E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 Kidneys 1.1E-09 1.6E-08 6.5E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Liver 6.0E-10 8.2E-09 3.3E-08 9.4E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Muscle 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Ovaries 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Pancreas 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Red Marrow 2.6E-10 3.3E-09 1.3E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 Respiratory Tract ET Airways 8.3E-08 5.5E-07 2.2E-06 1.2E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Lungs 1.0E-05 5.2E-05 1.5E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 Skin 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Spleen 9.8E-10 1.4E-08 5.6E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Testes 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Thymus 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Thyroid 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Uterus 5.7E-11 3.8E-10 1.4E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Remainder 1.4E-10 9.1E-10 3.5E-09 1.2E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Effective dose 1.2E-06 6.2E-06 1.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.0E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Bladder Wall 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Bone Surface 1.2E-10 1.6E-09 7.3E-09 3.0E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 Brain 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Breast 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 GI-Tract Oesophagus 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 St Wall 4.3E-10 7.7E-10 1.9E-09 6.0E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 SI Wall 9.6E-10 1.4E-09 2.7E-09 7.0E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 ULI Wall 3.7E-09 7.1E-09 9.8E-09 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 LLI Wall 3.7E-09 2.0E-08 2.6E-08 3.5E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Colon 3.7E-09 1.3E-08 1.7E-08 2.4E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 Kidneys 7.9E-10 1.3E-08 5.8E-08 2.4E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Liver 4.2E-10 6.5E-09 3.0E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Muscle 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Ovaries 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Pancreas 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Red Marrow 1.8E-10 2.6E-09 1.2E-08 5.0E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Respiratory Tract ET Airways 4.1E-08 2.7E-07 1.1E-06 5.8E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Lungs 1.4E-05 6.6E-05 1.9E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 Skin 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Spleen 6.9E-10 1.1E-08 5.0E-08 2.1E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Testes 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Thymus 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Thyroid 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Uterus 4.1E-11 3.1E-10 1.3E-09 5.3E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 5.6E-09 Remainder 9.1E-11 6.5E-10 2.7E-09 1.2E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Effective dose 1.6E-06 8.0E-06 2.3E-05 3.6E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.9E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Bladder Wall 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Bone Surface 7.2E-11 9.7E-10 5.2E-09 3.3E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Brain 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Breast 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 GI-Tract Oesophagus 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 St Wall 2.0E-10 4.2E-10 1.3E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 SI Wall 4.5E-10 7.7E-10 1.8E-09 6.9E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 ULI Wall 1.7E-09 3.7E-09 6.0E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 LLI Wall 1.6E-09 1.0E-08 1.5E-08 2.7E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 Colon 1.7E-09 6.4E-09 1.0E-08 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Kidneys 4.8E-10 7.6E-09 4.1E-08 2.6E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Liver 2.6E-10 3.9E-09 2.1E-08 1.4E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Muscle 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Ovaries 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Pancreas 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Red Marrow 1.1E-10 1.6E-09 8.6E-09 5.4E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 Respiratory Tract ET Airways 1.7E-08 1.1E-07 4.4E-07 2.3E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Lungs 7.7E-06 3.8E-05 1.1E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 Skin 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Spleen 4.2E-10 6.6E-09 3.6E-08 2.3E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Testes 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Thymus 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Thyroid 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Uterus 2.4E-11 1.9E-10 9.3E-10 5.7E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 Remainder 4.8E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Effective dose 9.3E-07 4.5E-06 1.3E-05 2.2E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 9.3E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Bladder Wall 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Bone Surface 3.6E-11 4.8E-10 2.7E-09 1.8E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Brain 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Breast 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 GI-Tract Oesophagus 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 St Wall 9.6E-11 2.1E-10 6.5E-10 3.4E-09 3.7E-09 3.7E-09 3.7E-09 3.7E-09 3.7E-09 3.7E-09 SI Wall 2.1E-10 3.7E-10 8.9E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 ULI Wall 7.7E-10 1.7E-09 3.0E-09 6.9E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 LLI Wall 7.5E-10 4.7E-09 7.6E-09 1.4E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 Colon 7.6E-10 3.0E-09 5.0E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Kidneys 2.4E-10 3.8E-09 2.1E-08 1.4E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Liver 1.3E-10 2.0E-09 1.1E-08 7.5E-08 8.3E-08 8.3E-08 8.3E-08 8.3E-08 8.3E-08 8.3E-08 Muscle 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Ovaries 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Pancreas 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Red Marrow 5.5E-11 7.9E-10 4.4E-09 3.0E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Respiratory Tract ET Airways 7.6E-09 5.0E-08 2.0E-07 1.1E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Lungs 3.7E-06 1.8E-05 5.2E-05 9.1E-05 9.3E-05 9.3E-05 9.3E-05 9.3E-05 9.3E-05 9.3E-05 Skin 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Spleen 2.1E-10 3.3E-09 1.8E-08 1.2E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Testes 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Thymus 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Thyroid 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Uterus 1.2E-11 9.3E-11 4.8E-10 3.2E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 3.5E-09 Remainder 2.3E-11 1.8E-10 9.0E-10 5.8E-09 6.5E-09 6.5E-09 6.5E-09 6.5E-09 6.5E-09 6.5E-09 Effective dose 4.4E-07 2.1E-06 6.2E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 4.6E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Bladder Wall 1.1E-11 7.4E-11 3.4E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Bone Surface 3.2E-11 3.8E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Brain 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Breast 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 GI-Tract Oesophagus 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 St Wall 9.6E-11 1.7E-10 4.6E-10 2.0E-09 2.2E-09 2.2E-09 2.2E-09 2.2E-09 2.2E-09 2.2E-09 SI Wall 2.2E-10 3.2E-10 6.5E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 ULI Wall 8.8E-10 1.5E-09 2.2E-09 4.4E-09 4.6E-09 4.6E-09 4.6E-09 4.6E-09 4.6E-09 4.6E-09 LLI Wall 9.2E-10 4.3E-09 5.8E-09 9.3E-09 9.6E-09 9.6E-09 9.6E-09 9.6E-09 9.6E-09 9.6E-09 Colon 8.9E-10 2.7E-09 3.8E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Kidneys 2.1E-10 3.0E-09 1.5E-08 8.4E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 Liver 1.1E-10 1.6E-09 7.7E-09 4.3E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Muscle 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Ovaries 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Pancreas 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Red Marrow 4.9E-11 6.3E-10 3.1E-09 1.7E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Respiratory Tract ET Airways 1.2E-08 8.1E-08 3.2E-07 1.7E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Lungs 1.8E-06 8.8E-06 2.6E-05 4.5E-05 4.6E-05 4.6E-05 4.6E-05 4.6E-05 4.6E-05 4.6E-05 Skin 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Spleen 1.8E-10 2.6E-09 1.3E-08 7.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Testes 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Thymus 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Thyroid 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Uterus 1.1E-11 7.4E-11 3.3E-10 1.8E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 2.0E-09 Remainder 2.4E-11 1.6E-10 7.2E-10 3.9E-09 4.3E-09 4.3E-09 4.3E-09 4.3E-09 4.3E-09 4.3E-09 Effective dose 2.1E-07 1.1E-06 3.1E-06 5.5E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Bladder Wall 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Bone Surface 8.1E-11 8.8E-10 3.6E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 Brain 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Breast 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 GI-Tract Oesophagus 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 St Wall 2.8E-10 4.3E-10 9.2E-10 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 SI Wall 6.4E-10 8.1E-10 1.3E-09 3.1E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 ULI Wall 2.7E-09 4.0E-09 4.8E-09 7.0E-09 7.2E-09 7.2E-09 7.2E-09 7.2E-09 7.2E-09 7.2E-09 LLI Wall 3.0E-09 1.1E-08 1.3E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 Colon 2.9E-09 7.2E-09 8.3E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Kidneys 5.4E-10 6.9E-09 2.9E-08 1.0E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Liver 2.9E-10 3.6E-09 1.5E-08 5.4E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Muscle 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Ovaries 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Pancreas 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Red Marrow 1.2E-10 1.4E-09 5.9E-09 2.2E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Respiratory Tract ET Airways 4.4E-08 2.9E-07 1.2E-06 6.2E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 Lungs 1.3E-06 6.6E-06 1.9E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Skin 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Spleen 4.7E-10 6.0E-09 2.5E-08 9.0E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 Testes 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Thymus 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Thyroid 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Uterus 2.7E-11 1.7E-10 6.4E-10 2.3E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 2.4E-09 Remainder 6.9E-11 4.3E-10 1.6E-09 6.9E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 Effective dose 1.6E-07 8.0E-07 2.3E-06 4.2E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.4E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Bladder Wall 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Bone Surface 1.4E-10 1.5E-09 5.8E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Brain 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Breast 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 GI-Tract Oesophagus 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 St Wall 5.0E-10 7.5E-10 1.5E-09 3.5E-09 3.7E-09 3.7E-09 3.7E-09 3.7E-09 3.7E-09 3.7E-09 SI Wall 1.2E-09 1.4E-09 2.2E-09 4.3E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 ULI Wall 5.0E-09 7.1E-09 8.2E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 LLI Wall 5.4E-09 2.0E-08 2.2E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 Colon 5.2E-09 1.3E-08 1.4E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Kidneys 9.4E-10 1.2E-08 4.7E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Liver 5.0E-10 6.1E-09 2.4E-08 7.2E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 Muscle 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Ovaries 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Pancreas 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Red Marrow 2.1E-10 2.5E-09 9.6E-09 2.9E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 Respiratory Tract ET Airways 8.1E-08 5.4E-07 2.1E-06 1.1E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Lungs 1.3E-06 6.5E-06 1.9E-05 3.3E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 Skin 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Spleen 8.1E-10 1.0E-08 4.0E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Testes 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Thymus 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Thyroid 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Uterus 4.7E-11 2.9E-10 1.0E-09 3.0E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 Remainder 1.2E-10 7.5E-10 2.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Effective dose 1.6E-07 7.8E-07 2.3E-06 4.0E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 2.7E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Bladder Wall 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Bone Surface 1.5E-10 1.6E-09 6.2E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Brain 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Breast 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 GI-Tract Oesophagus 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 St Wall 5.4E-10 8.1E-10 1.6E-09 3.5E-09 3.6E-09 3.6E-09 3.6E-09 3.6E-09 3.6E-09 3.6E-09 SI Wall 1.3E-09 1.5E-09 2.4E-09 4.3E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 ULI Wall 5.5E-09 7.8E-09 8.8E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 LLI Wall 6.0E-09 2.2E-08 2.4E-08 2.6E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Colon 5.7E-09 1.4E-08 1.5E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Kidneys 1.0E-09 1.3E-08 5.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Liver 5.4E-10 6.6E-09 2.6E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Muscle 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Ovaries 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Pancreas 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Red Marrow 2.3E-10 2.7E-09 1.0E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 Respiratory Tract ET Airways 8.9E-08 5.9E-07 2.4E-06 1.3E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Lungs 1.1E-06 5.2E-06 1.5E-05 2.6E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Skin 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Spleen 8.8E-10 1.1E-08 4.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Testes 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Thymus 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Thyroid 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Uterus 5.1E-11 3.1E-10 1.1E-09 3.0E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 3.1E-09 Remainder 1.3E-10 8.1E-10 3.0E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Effective dose 1.3E-07 6.3E-07 1.8E-06 3.1E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Po-210, adult member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type S, f1 = 0.01 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Bladder Wall 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Bone Surface 1.5E-10 1.6E-09 5.9E-09 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 Brain 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Breast 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 GI-Tract Oesophagus 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 St Wall 5.3E-10 7.8E-10 1.5E-09 3.1E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 SI Wall 1.2E-09 1.5E-09 2.3E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 ULI Wall 5.4E-09 7.6E-09 8.4E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 LLI Wall 5.9E-09 2.1E-08 2.3E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 Colon 5.6E-09 1.4E-08 1.5E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 Kidneys 9.8E-10 1.2E-08 4.7E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Liver 5.2E-10 6.4E-09 2.4E-08 6.2E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Muscle 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Ovaries 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Pancreas 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Red Marrow 2.3E-10 2.6E-09 9.7E-09 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 Respiratory Tract ET Airways 8.8E-08 5.9E-07 2.3E-06 1.2E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Lungs 6.2E-07 2.8E-06 7.9E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Skin 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Spleen 8.5E-10 1.1E-08 4.0E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Testes 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Thymus 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Thyroid 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Uterus 4.9E-11 3.0E-10 1.0E-09 2.6E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 2.7E-09 Remainder 1.3E-10 7.9E-10 2.9E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Effective dose 7.5E-08 3.4E-07 9.6E-07 1.6E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Po-210, adult member of the public Ingestion: f1 = 0.5 Highest committed equivalent dose coefficient: Kidneys, 1.3E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Bladder Wall 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Bone Surface 2.0E-08 1.9E-07 6.8E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Brain 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Breast 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 GI-Tract Oesophagus 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 St Wall 7.6E-09 3.7E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 SI Wall 7.9E-09 3.7E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 ULI Wall 1.4E-08 4.5E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 LLI Wall 1.5E-08 6.4E-08 1.5E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Colon 1.4E-08 5.3E-08 1.4E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Kidneys 1.3E-07 1.5E-06 5.4E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Liver 7.1E-08 7.7E-07 2.8E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 Muscle 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Ovaries 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Pancreas 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Red Marrow 3.1E-08 3.1E-07 1.1E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Respiratory Tract ET Airways 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Lungs 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Skin 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Spleen 1.2E-07 1.3E-06 4.7E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Testes 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Thymus 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Thyroid 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Uterus 6.4E-09 3.6E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Remainder 7.1E-08 7.6E-07 2.8E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Effective dose 1.7E-08 1.4E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 7.9E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Bladder Wall 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Bone Surface 4.2E-07 3.9E-06 1.3E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Brain 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Breast 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 GI-Tract Oesophagus 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 St Wall 5.9E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 SI Wall 6.2E-08 3.0E-07 9.6E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 ULI Wall 8.6E-08 3.3E-07 1.0E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 LLI Wall 8.9E-08 4.1E-07 1.1E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Colon 8.7E-08 3.7E-07 1.0E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Kidneys 8.7E-07 8.3E-06 2.9E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 Liver 5.3E-07 5.0E-06 1.8E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 Muscle 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Ovaries 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Pancreas 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Red Marrow 4.2E-07 3.8E-06 1.3E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 Respiratory Tract ET Airways 1.0E-07 3.6E-07 1.0E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Lungs 1.9E-07 4.3E-07 1.1E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Skin 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Spleen 1.1E-06 1.0E-05 3.7E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 Testes 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Thymus 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Thyroid 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Uterus 5.5E-08 2.9E-07 9.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Remainder 5.7E-07 5.4E-06 1.9E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 Effective dose 1.7E-07 1.3E-06 4.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 1.0E-04 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Bladder Wall 7.3E-08 3.8E-07 1.3E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Bone Surface 5.5E-07 5.1E-06 1.8E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 Brain 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Breast 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 GI-Tract Oesophagus 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 St Wall 7.6E-08 3.8E-07 1.3E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 SI Wall 7.9E-08 3.9E-07 1.3E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 ULI Wall 9.9E-08 4.2E-07 1.3E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 LLI Wall 1.0E-07 4.9E-07 1.4E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 Colon 1.0E-07 4.5E-07 1.3E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Kidneys 1.2E-06 1.1E-05 3.9E-05 8.3E-05 8.3E-05 8.3E-05 8.3E-05 8.3E-05 8.3E-05 8.3E-05 Liver 7.1E-07 6.6E-06 2.3E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Muscle 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Ovaries 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Pancreas 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Red Marrow 5.5E-07 5.0E-06 1.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 Respiratory Tract ET Airways 1.1E-07 4.4E-07 1.3E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Lungs 5.2E-07 8.3E-07 1.7E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 Skin 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Spleen 1.4E-06 1.4E-05 4.8E-05 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 Testes 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Thymus 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Thyroid 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Uterus 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Remainder 7.6E-07 7.1E-06 2.5E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 Effective dose 2.6E-07 1.7E-06 5.7E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 1.4E-04 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Bladder Wall 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Bone Surface 7.7E-07 7.0E-06 2.4E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Brain 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Breast 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 GI-Tract Oesophagus 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 St Wall 1.0E-07 5.3E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 SI Wall 1.0E-07 5.3E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 ULI Wall 1.1E-07 5.5E-07 1.8E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 LLI Wall 1.2E-07 5.9E-07 1.8E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Colon 1.2E-07 5.7E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Kidneys 1.6E-06 1.5E-05 5.3E-05 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 Liver 9.8E-07 9.0E-06 3.2E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 Muscle 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Ovaries 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Pancreas 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Red Marrow 7.6E-07 6.9E-06 2.4E-05 5.2E-05 5.2E-05 5.2E-05 5.2E-05 5.2E-05 5.2E-05 5.2E-05 Respiratory Tract ET Airways 1.2E-07 5.5E-07 1.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Lungs 1.0E-06 1.4E-06 2.6E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 Skin 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Spleen 2.0E-06 1.9E-05 6.6E-05 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 Testes 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Thymus 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Thyroid 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Uterus 1.0E-07 5.2E-07 1.7E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Remainder 1.1E-06 9.7E-06 3.4E-05 7.4E-05 7.4E-05 7.4E-05 7.4E-05 7.4E-05 7.4E-05 7.4E-05 Effective dose 3.9E-07 2.4E-06 7.9E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 1.5E-04 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Bladder Wall 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Bone Surface 8.0E-07 7.2E-06 2.5E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 Brain 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Breast 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 GI-Tract Oesophagus 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 St Wall 1.1E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 SI Wall 1.1E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 ULI Wall 1.1E-07 5.6E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 LLI Wall 1.1E-07 5.8E-07 1.9E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Colon 1.1E-07 5.7E-07 1.8E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Kidneys 1.7E-06 1.6E-05 5.5E-05 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 Liver 1.0E-06 9.3E-06 3.3E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 Muscle 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Ovaries 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Pancreas 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Red Marrow 7.9E-07 7.2E-06 2.5E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 Respiratory Tract ET Airways 1.1E-07 5.5E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Lungs 7.2E-07 1.2E-06 2.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 Skin 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Spleen 2.1E-06 1.9E-05 6.8E-05 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 Testes 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Thymus 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Thyroid 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Uterus 1.0E-07 5.4E-07 1.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Remainder 1.1E-06 1.0E-05 3.5E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 Effective dose 3.6E-07 2.4E-06 8.1E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 9.8E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Bladder Wall 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Bone Surface 5.3E-07 4.8E-06 1.7E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Brain 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Breast 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 GI-Tract Oesophagus 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 St Wall 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 SI Wall 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 ULI Wall 7.2E-08 3.7E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 LLI Wall 7.3E-08 3.8E-07 1.2E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Colon 7.3E-08 3.7E-07 1.2E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Kidneys 1.1E-06 1.0E-05 3.7E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 Liver 6.8E-07 6.2E-06 2.2E-05 4.8E-05 4.8E-05 4.8E-05 4.8E-05 4.8E-05 4.8E-05 4.8E-05 Muscle 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Ovaries 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Pancreas 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Red Marrow 5.3E-07 4.8E-06 1.7E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 Respiratory Tract ET Airways 7.3E-08 3.7E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Lungs 3.7E-07 6.7E-07 1.5E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Skin 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Spleen 1.4E-06 1.3E-05 4.6E-05 9.8E-05 9.8E-05 9.8E-05 9.8E-05 9.8E-05 9.8E-05 9.8E-05 Testes 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Thymus 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Thyroid 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Uterus 7.0E-08 3.6E-07 1.2E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Remainder 7.3E-07 6.7E-06 2.4E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Effective dose 2.3E-07 1.6E-06 5.4E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 6.1E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Bladder Wall 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Bone Surface 3.3E-07 3.0E-06 1.0E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Brain 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Breast 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 GI-Tract Oesophagus 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 St Wall 4.4E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 SI Wall 4.5E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 ULI Wall 4.9E-08 2.4E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 LLI Wall 5.0E-08 2.5E-07 7.9E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Colon 5.0E-08 2.4E-07 7.7E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Kidneys 6.9E-07 6.5E-06 2.3E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 Liver 4.2E-07 3.9E-06 1.4E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 Muscle 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Ovaries 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Pancreas 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Red Marrow 3.3E-07 3.0E-06 1.0E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Respiratory Tract ET Airways 5.1E-08 2.4E-07 7.5E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Lungs 1.9E-07 3.7E-07 8.9E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Skin 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Spleen 8.5E-07 8.1E-06 2.8E-05 6.1E-05 6.1E-05 6.1E-05 6.1E-05 6.1E-05 6.1E-05 6.1E-05 Testes 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Thymus 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Thyroid 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Uterus 4.3E-08 2.3E-07 7.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Remainder 4.5E-07 4.2E-06 1.5E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 Effective dose 1.4E-07 9.8E-07 3.4E-06 7.2E-06 7.2E-06 7.2E-06 7.2E-06 7.2E-06 7.2E-06 7.2E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 6.3E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Bladder Wall 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Bone Surface 3.4E-07 3.1E-06 1.1E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Brain 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Breast 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 GI-Tract Oesophagus 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 St Wall 4.7E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 SI Wall 4.8E-08 2.4E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 ULI Wall 6.3E-08 2.6E-07 8.0E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 LLI Wall 6.5E-08 3.1E-07 8.6E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Colon 6.3E-08 2.8E-07 8.2E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Kidneys 7.0E-07 6.6E-06 2.3E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Liver 4.3E-07 4.0E-06 1.4E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Muscle 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Ovaries 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Pancreas 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Red Marrow 3.3E-07 3.1E-06 1.1E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Respiratory Tract ET Airways 6.6E-08 2.6E-07 7.9E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Lungs 1.1E-07 3.0E-07 8.3E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Skin 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Spleen 8.7E-07 8.3E-06 2.9E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 Testes 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Thymus 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Thyroid 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Uterus 4.4E-08 2.3E-07 7.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Remainder 4.6E-07 4.3E-06 1.5E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 Effective dose 1.3E-07 1.0E-06 3.5E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 7.1E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Bladder Wall 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Bone Surface 3.7E-07 3.5E-06 1.2E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Brain 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Breast 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 GI-Tract Oesophagus 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 St Wall 5.3E-08 2.6E-07 8.6E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 SI Wall 5.6E-08 2.7E-07 8.6E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 ULI Wall 7.7E-08 3.0E-07 9.0E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 LLI Wall 8.0E-08 3.7E-07 9.9E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Colon 7.9E-08 3.3E-07 9.4E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Kidneys 7.8E-07 7.5E-06 2.6E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 Liver 4.8E-07 4.5E-06 1.6E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Muscle 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Ovaries 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Pancreas 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Red Marrow 3.7E-07 3.4E-06 1.2E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Respiratory Tract ET Airways 8.5E-08 3.1E-07 9.0E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Lungs 9.1E-08 3.0E-07 8.9E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Skin 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Spleen 9.7E-07 9.3E-06 3.3E-05 7.1E-05 7.1E-05 7.1E-05 7.1E-05 7.1E-05 7.1E-05 7.1E-05 Testes 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Thymus 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Thyroid 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Uterus 5.0E-08 2.6E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Remainder 5.1E-07 4.8E-06 1.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 Effective dose 1.5E-07 1.1E-06 3.9E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 6.8E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Bladder Wall 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Bone Surface 3.6E-07 3.3E-06 1.2E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Brain 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Breast 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 GI-Tract Oesophagus 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 St Wall 5.1E-08 2.5E-07 8.2E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 SI Wall 5.3E-08 2.5E-07 8.2E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 ULI Wall 7.6E-08 2.9E-07 8.6E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 LLI Wall 7.9E-08 3.6E-07 9.6E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Colon 7.7E-08 3.2E-07 9.0E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Kidneys 7.4E-07 7.1E-06 2.5E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 Liver 4.6E-07 4.3E-06 1.5E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 Muscle 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Ovaries 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Pancreas 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Red Marrow 3.6E-07 3.3E-06 1.2E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Respiratory Tract ET Airways 8.5E-08 3.0E-07 8.7E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Lungs 7.8E-08 2.8E-07 8.5E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Skin 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Spleen 9.2E-07 8.9E-06 3.1E-05 6.8E-05 6.8E-05 6.8E-05 6.8E-05 6.8E-05 6.8E-05 6.8E-05 Testes 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Thymus 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Thyroid 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Uterus 4.7E-08 2.5E-07 8.1E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Remainder 4.9E-07 4.6E-06 1.6E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Effective dose 1.4E-07 1.1E-06 3.7E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type F, f1 = 0.2 Highest committed equivalent dose coefficient: Spleen, 5.8E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Bladder Wall 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Bone Surface 3.1E-07 2.8E-06 9.9E-06 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Brain 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Breast 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 GI-Tract Oesophagus 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 St Wall 4.4E-08 2.2E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 SI Wall 4.6E-08 2.2E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 ULI Wall 6.7E-08 2.5E-07 7.4E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 LLI Wall 7.0E-08 3.2E-07 8.3E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Colon 6.8E-08 2.8E-07 7.8E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Kidneys 6.4E-07 6.1E-06 2.2E-05 4.7E-05 4.7E-05 4.7E-05 4.7E-05 4.7E-05 4.7E-05 4.7E-05 Liver 3.9E-07 3.7E-06 1.3E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Muscle 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Ovaries 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Pancreas 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Red Marrow 3.0E-07 2.8E-06 9.9E-06 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Respiratory Tract ET Airways 7.7E-08 2.7E-07 7.5E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Lungs 5.8E-08 2.3E-07 7.2E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Skin 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Spleen 7.9E-07 7.6E-06 2.7E-05 5.8E-05 5.8E-05 5.8E-05 5.8E-05 5.8E-05 5.8E-05 5.8E-05 Testes 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Thymus 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Thyroid 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Uterus 4.1E-08 2.1E-07 7.0E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Remainder 4.2E-07 3.9E-06 1.4E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 Effective dose 1.2E-07 9.2E-07 3.2E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: Lungs, 1.8E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Bladder Wall 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Bone Surface 1.2E-07 1.4E-06 4.9E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Brain 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Breast 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 GI-Tract Oesophagus 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 St Wall 2.5E-08 1.1E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 SI Wall 3.1E-08 1.2E-07 3.6E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 ULI Wall 7.9E-08 1.9E-07 4.4E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 LLI Wall 8.5E-08 3.4E-07 6.0E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Colon 8.2E-08 2.5E-07 5.1E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Kidneys 2.6E-07 2.9E-06 1.1E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Liver 1.6E-07 1.7E-06 6.4E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Muscle 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Ovaries 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Pancreas 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Red Marrow 1.2E-07 1.3E-06 4.9E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Respiratory Tract ET Airways 7.1E-07 4.6E-06 1.7E-05 5.2E-05 5.2E-05 5.2E-05 5.2E-05 5.2E-05 5.2E-05 5.2E-05 Lungs 8.0E-06 4.6E-05 1.3E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 Skin 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Spleen 3.2E-07 3.6E-06 1.3E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 Testes 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Thymus 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Thyroid 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Uterus 1.8E-08 1.0E-07 3.5E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Remainder 2.3E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Effective dose 1.0E-06 5.9E-06 1.7E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: Lungs, 5.7E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Bladder Wall 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Bone Surface 1.3E-07 1.5E-06 5.7E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Brain 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Breast 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 GI-Tract Oesophagus 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 St Wall 2.6E-08 1.2E-07 4.1E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 SI Wall 3.2E-08 1.3E-07 4.1E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 ULI Wall 7.8E-08 2.0E-07 5.0E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 LLI Wall 8.2E-08 3.5E-07 6.7E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Colon 7.9E-08 2.6E-07 5.7E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Kidneys 2.8E-07 3.2E-06 1.2E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 Liver 1.7E-07 1.9E-06 7.4E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Muscle 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Ovaries 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Pancreas 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Red Marrow 1.3E-07 1.5E-06 5.7E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Respiratory Tract ET Airways 5.9E-07 3.8E-06 1.4E-05 4.3E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 Lungs 2.7E-05 1.4E-04 4.0E-04 5.7E-04 5.7E-04 5.7E-04 5.7E-04 5.7E-04 5.7E-04 5.7E-04 Skin 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Spleen 3.4E-07 4.0E-06 1.5E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 Testes 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Thymus 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Thyroid 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Uterus 1.9E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Remainder 2.4E-08 1.7E-07 6.4E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Effective dose 3.3E-06 1.8E-05 5.0E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: Lungs, 1.1E-03 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Bladder Wall 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Bone Surface 1.3E-07 1.6E-06 6.4E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Brain 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Breast 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 GI-Tract Oesophagus 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 St Wall 2.4E-08 1.2E-07 4.6E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 SI Wall 2.9E-08 1.3E-07 4.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 ULI Wall 6.1E-08 1.9E-07 5.5E-07 1.3E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 LLI Wall 6.1E-08 3.2E-07 7.1E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Colon 6.1E-08 2.5E-07 6.2E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Kidneys 2.7E-07 3.4E-06 1.4E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 Liver 1.7E-07 2.0E-06 8.4E-06 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Muscle 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Ovaries 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Pancreas 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Red Marrow 1.3E-07 1.6E-06 6.4E-06 1.7E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Respiratory Tract ET Airways 3.2E-07 2.1E-06 7.6E-06 2.3E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Lungs 5.8E-05 2.9E-04 7.8E-04 1.1E-03 1.1E-03 1.1E-03 1.1E-03 1.1E-03 1.1E-03 1.1E-03 Skin 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Spleen 3.3E-07 4.2E-06 1.7E-05 4.8E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 Testes 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Thymus 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Thyroid 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Uterus 1.8E-08 1.2E-07 4.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Remainder 2.4E-08 1.8E-07 7.1E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Effective dose 7.0E-06 3.5E-05 9.5E-05 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: Lungs, 8.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Bladder Wall 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Bone Surface 1.0E-07 1.2E-06 5.5E-06 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Brain 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Breast 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 GI-Tract Oesophagus 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 St Wall 1.7E-08 9.7E-08 4.0E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 SI Wall 2.0E-08 1.0E-07 4.0E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 ULI Wall 3.4E-08 1.3E-07 4.5E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 LLI Wall 3.4E-08 2.1E-07 5.5E-07 1.6E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Colon 3.4E-08 1.7E-07 4.9E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Kidneys 2.2E-07 2.6E-06 1.2E-05 4.4E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 Liver 1.3E-07 1.6E-06 7.2E-06 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Muscle 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Ovaries 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Pancreas 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Red Marrow 1.0E-07 1.2E-06 5.5E-06 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Respiratory Tract ET Airways 1.3E-07 8.5E-07 3.2E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Lungs 4.0E-05 2.0E-04 5.4E-04 8.2E-04 8.2E-04 8.2E-04 8.2E-04 8.2E-04 8.2E-04 8.2E-04 Skin 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Spleen 2.7E-07 3.3E-06 1.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 Testes 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Thymus 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Thyroid 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Uterus 1.5E-08 9.4E-08 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Remainder 1.9E-08 1.4E-07 6.2E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Effective dose 4.9E-06 2.4E-05 6.7E-05 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: Lungs, 4.4E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Bladder Wall 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Bone Surface 6.5E-08 7.5E-07 3.5E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Brain 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Breast 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 GI-Tract Oesophagus 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 St Wall 1.0E-08 5.9E-08 2.5E-07 9.7E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 SI Wall 1.1E-08 6.0E-08 2.5E-07 9.7E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 ULI Wall 1.8E-08 7.7E-08 2.8E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 LLI Wall 1.8E-08 1.1E-07 3.3E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Colon 1.8E-08 9.2E-08 3.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Kidneys 1.4E-07 1.6E-06 7.5E-06 3.0E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Liver 8.3E-08 9.6E-07 4.5E-06 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Muscle 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Ovaries 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Pancreas 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Red Marrow 6.5E-08 7.4E-07 3.5E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Respiratory Tract ET Airways 6.2E-08 4.0E-07 1.5E-06 4.9E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 Lungs 2.0E-05 1.0E-04 2.8E-04 4.4E-04 4.4E-04 4.4E-04 4.4E-04 4.4E-04 4.4E-04 4.4E-04 Skin 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Spleen 1.7E-07 2.0E-06 9.4E-06 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 Testes 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Thymus 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Thyroid 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Uterus 8.9E-09 5.7E-08 2.5E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Remainder 1.1E-08 8.7E-08 3.9E-07 1.5E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Effective dose 2.5E-06 1.2E-05 3.4E-05 5.6E-05 5.6E-05 5.6E-05 5.6E-05 5.6E-05 5.6E-05 5.6E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: Lungs, 2.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Bladder Wall 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Bone Surface 5.1E-08 5.7E-07 2.4E-06 8.4E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 Brain 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Breast 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 GI-Tract Oesophagus 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 St Wall 8.7E-09 4.5E-08 1.8E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 SI Wall 1.0E-08 4.7E-08 1.8E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 ULI Wall 2.0E-08 6.5E-08 2.0E-07 6.5E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 LLI Wall 2.1E-08 1.0E-07 2.5E-07 7.2E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 Colon 2.1E-08 8.1E-08 2.2E-07 6.8E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Kidneys 1.1E-07 1.2E-06 5.3E-06 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Liver 6.5E-08 7.3E-07 3.2E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Muscle 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Ovaries 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Pancreas 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Red Marrow 5.1E-08 5.6E-07 2.4E-06 8.6E-06 8.7E-06 8.7E-06 8.7E-06 8.7E-06 8.7E-06 8.7E-06 Respiratory Tract ET Airways 1.4E-07 8.9E-07 3.3E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Lungs 1.0E-05 4.9E-05 1.4E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 Skin 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Spleen 1.3E-07 1.5E-06 6.7E-06 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Testes 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Thymus 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Thyroid 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Uterus 7.0E-09 4.3E-08 1.7E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Remainder 9.0E-09 6.6E-08 2.7E-07 9.7E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Effective dose 1.2E-06 6.1E-06 1.7E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: Lungs, 1.1E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Bladder Wall 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Bone Surface 8.2E-08 8.9E-07 3.4E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 Brain 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Breast 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 GI-Tract Oesophagus 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 St Wall 1.6E-08 7.1E-08 2.4E-07 6.4E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 SI Wall 1.9E-08 7.5E-08 2.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 ULI Wall 4.7E-08 1.2E-07 2.9E-07 7.0E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 LLI Wall 5.0E-08 2.1E-07 3.9E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 Colon 4.8E-08 1.5E-07 3.4E-07 7.5E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Kidneys 1.7E-07 1.9E-06 7.3E-06 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Liver 1.0E-07 1.1E-06 4.4E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Muscle 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Ovaries 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Pancreas 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Red Marrow 8.1E-08 8.8E-07 3.4E-06 9.0E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 Respiratory Tract ET Airways 4.2E-07 2.7E-06 1.0E-05 3.1E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 Lungs 4.5E-06 2.3E-05 6.5E-05 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 Skin 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Spleen 2.1E-07 2.4E-06 9.2E-06 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Testes 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Thymus 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Thyroid 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Uterus 1.1E-08 6.7E-08 2.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Remainder 1.5E-08 1.0E-07 3.8E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Effective dose 5.7E-07 3.0E-06 8.7E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: Lungs, 5.9E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Bladder Wall 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Bone Surface 1.1E-07 1.2E-06 4.3E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Brain 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Breast 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 GI-Tract Oesophagus 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 St Wall 2.2E-08 9.5E-08 3.1E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 SI Wall 2.7E-08 1.0E-07 3.2E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 ULI Wall 6.9E-08 1.6E-07 3.8E-07 8.0E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 LLI Wall 7.4E-08 2.9E-07 5.2E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 Colon 7.1E-08 2.2E-07 4.4E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 Kidneys 2.3E-07 2.5E-06 9.4E-06 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Liver 1.4E-07 1.5E-06 5.6E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Muscle 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Ovaries 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Pancreas 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Red Marrow 1.1E-07 1.2E-06 4.3E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Respiratory Tract ET Airways 6.4E-07 4.1E-06 1.5E-05 4.7E-05 4.8E-05 4.8E-05 4.8E-05 4.8E-05 4.8E-05 4.8E-05 Lungs 2.5E-06 1.3E-05 3.6E-05 5.9E-05 5.9E-05 5.9E-05 5.9E-05 5.9E-05 5.9E-05 5.9E-05 Skin 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Spleen 2.8E-07 3.2E-06 1.2E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Testes 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Thymus 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Thyroid 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Uterus 1.5E-08 8.9E-08 3.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Remainder 2.0E-08 1.4E-07 4.9E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Effective dose 3.4E-07 1.8E-06 5.4E-06 9.6E-06 9.7E-06 9.7E-06 9.7E-06 9.7E-06 9.7E-06 9.7E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: ET Airways, 4.9E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Bladder Wall 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Bone Surface 1.1E-07 1.2E-06 4.3E-06 9.6E-06 9.6E-06 9.6E-06 9.6E-06 9.6E-06 9.6E-06 9.6E-06 Brain 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Breast 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 GI-Tract Oesophagus 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 St Wall 2.2E-08 9.6E-08 3.1E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 SI Wall 2.7E-08 1.0E-07 3.1E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 ULI Wall 7.0E-08 1.6E-07 3.8E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 LLI Wall 7.5E-08 3.0E-07 5.2E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 Colon 7.2E-08 2.2E-07 4.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 Kidneys 2.3E-07 2.5E-06 9.3E-06 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Liver 1.4E-07 1.5E-06 5.6E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Muscle 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Ovaries 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Pancreas 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Red Marrow 1.1E-07 1.2E-06 4.3E-06 9.7E-06 9.8E-06 9.8E-06 9.8E-06 9.8E-06 9.8E-06 9.8E-06 Respiratory Tract ET Airways 6.6E-07 4.3E-06 1.6E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 Lungs 1.7E-06 8.7E-06 2.5E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 Skin 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Spleen 2.8E-07 3.2E-06 1.2E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Testes 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Thymus 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Thyroid 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Uterus 1.5E-08 8.9E-08 3.0E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Remainder 3.4E-07 2.2E-06 8.0E-06 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Effective dose 2.6E-07 1.5E-06 4.4E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type M, f1 = 0.2 Highest committed equivalent dose coefficient: ET Airways, 4.5E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Bladder Wall 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Bone Surface 9.8E-08 1.1E-06 3.8E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 Brain 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Breast 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 GI-Tract Oesophagus 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 St Wall 2.0E-08 8.6E-08 2.7E-07 5.9E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 SI Wall 2.5E-08 9.1E-08 2.8E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 ULI Wall 6.4E-08 1.5E-07 3.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 LLI Wall 6.9E-08 2.7E-07 4.7E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 Colon 6.6E-08 2.0E-07 4.0E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 Kidneys 2.0E-07 2.3E-06 8.3E-06 1.8E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Liver 1.3E-07 1.4E-06 5.0E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Muscle 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Ovaries 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Pancreas 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Red Marrow 9.8E-08 1.1E-06 3.8E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 Respiratory Tract ET Airways 6.1E-07 3.9E-06 1.4E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 Lungs 8.5E-07 4.0E-06 1.1E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Skin 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Spleen 2.5E-07 2.9E-06 1.0E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Testes 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Thymus 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Thyroid 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Uterus 1.4E-08 8.0E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Remainder 3.1E-07 2.0E-06 7.4E-06 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Effective dose 1.5E-07 8.6E-07 2.7E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: Lungs, 2.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Bladder Wall 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Bone Surface 9.1E-09 1.1E-07 4.0E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Brain 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Breast 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 GI-Tract Oesophagus 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 St Wall 9.0E-09 1.6E-08 3.6E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 SI Wall 1.9E-08 2.6E-08 4.6E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 ULI Wall 7.9E-08 1.1E-07 1.4E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 LLI Wall 8.4E-08 3.1E-07 3.4E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Colon 8.1E-08 2.0E-07 2.3E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Kidneys 1.9E-08 2.4E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Liver 1.2E-08 1.4E-07 5.3E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Muscle 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Ovaries 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Pancreas 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Red Marrow 9.1E-09 1.1E-07 4.0E-07 8.9E-07 8.9E-07 8.9E-07 8.9E-07 8.9E-07 8.9E-07 8.9E-07 Respiratory Tract ET Airways 7.6E-07 5.0E-06 1.9E-05 8.9E-05 9.6E-05 9.6E-05 9.6E-05 9.6E-05 9.6E-05 9.6E-05 Lungs 8.9E-06 5.2E-05 1.5E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 Skin 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Spleen 2.3E-08 2.9E-07 1.1E-06 2.4E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Testes 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Thymus 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Thyroid 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Uterus 1.4E-09 8.3E-09 2.8E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Remainder 2.4E-09 1.6E-08 5.5E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Effective dose 1.1E-06 6.3E-06 1.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: Lungs, 7.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Bladder Wall 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Bone Surface 8.8E-09 1.1E-07 4.3E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Brain 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Breast 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 GI-Tract Oesophagus 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 St Wall 8.9E-09 1.6E-08 3.9E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 SI Wall 1.8E-08 2.6E-08 5.0E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 ULI Wall 7.6E-08 1.2E-07 1.5E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 LLI Wall 7.9E-08 3.2E-07 3.7E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Colon 7.7E-08 2.0E-07 2.4E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Kidneys 1.8E-08 2.4E-07 9.3E-07 2.2E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Liver 1.1E-08 1.4E-07 5.6E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Muscle 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Ovaries 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Pancreas 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Red Marrow 8.7E-09 1.1E-07 4.3E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Respiratory Tract ET Airways 6.3E-07 4.2E-06 1.6E-05 7.3E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 Lungs 3.0E-05 1.6E-04 4.7E-04 7.2E-04 7.2E-04 7.2E-04 7.2E-04 7.2E-04 7.2E-04 7.2E-04 Skin 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Spleen 2.2E-08 3.0E-07 1.2E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Testes 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Thymus 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Thyroid 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Uterus 1.3E-09 8.5E-09 3.0E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 Remainder 2.3E-09 1.5E-08 5.7E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Effective dose 3.6E-06 2.0E-05 5.7E-05 8.7E-05 8.7E-05 8.7E-05 8.7E-05 8.7E-05 8.7E-05 8.7E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: Lungs, 1.4E-03 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Bladder Wall 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Bone Surface 6.3E-09 9.8E-08 4.1E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Brain 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Breast 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 GI-Tract Oesophagus 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 St Wall 7.0E-09 1.4E-08 3.7E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 SI Wall 1.4E-08 2.3E-08 4.8E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 ULI Wall 5.5E-08 1.0E-07 1.4E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 LLI Wall 5.3E-08 2.8E-07 3.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Colon 5.4E-08 1.8E-07 2.4E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Kidneys 1.3E-08 2.1E-07 9.0E-07 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Liver 8.0E-09 1.3E-07 5.4E-07 1.5E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Muscle 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Ovaries 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Pancreas 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Red Marrow 6.3E-09 9.7E-08 4.1E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Respiratory Tract ET Airways 3.3E-07 2.2E-06 8.5E-06 3.9E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 Lungs 6.4E-05 3.2E-04 9.2E-04 1.4E-03 1.4E-03 1.4E-03 1.4E-03 1.4E-03 1.4E-03 1.4E-03 Skin 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Spleen 1.6E-08 2.6E-07 1.1E-06 3.1E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Testes 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Thymus 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Thyroid 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Uterus 9.8E-10 7.4E-09 2.9E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Remainder 1.6E-09 1.3E-08 5.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Effective dose 7.7E-06 3.9E-05 1.1E-04 1.7E-04 1.7E-04 1.7E-04 1.7E-04 1.7E-04 1.7E-04 1.7E-04 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: Lungs, 1.1E-03 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Bladder Wall 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Bone Surface 3.3E-09 5.6E-08 2.7E-07 9.7E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Brain 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Breast 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 GI-Tract Oesophagus 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 St Wall 3.6E-09 8.2E-09 2.4E-08 7.7E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 SI Wall 7.1E-09 1.3E-08 3.1E-08 8.5E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 ULI Wall 2.6E-08 5.7E-08 9.0E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 LLI Wall 2.4E-08 1.5E-07 2.2E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Colon 2.5E-08 9.8E-08 1.5E-07 2.3E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Kidneys 6.9E-09 1.2E-07 5.8E-07 2.2E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Liver 4.2E-09 7.3E-08 3.5E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Muscle 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Ovaries 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Pancreas 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Red Marrow 3.3E-09 5.6E-08 2.7E-07 9.9E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Respiratory Tract ET Airways 1.3E-07 8.6E-07 3.3E-06 1.5E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Lungs 4.5E-05 2.2E-04 6.4E-04 1.1E-03 1.1E-03 1.1E-03 1.1E-03 1.1E-03 1.1E-03 1.1E-03 Skin 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Spleen 8.5E-09 1.5E-07 7.3E-07 2.8E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 Testes 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Thymus 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Thyroid 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Uterus 5.2E-10 4.3E-09 1.9E-08 7.1E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Remainder 8.2E-10 7.2E-09 3.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Effective dose 5.4E-06 2.7E-05 7.7E-05 1.3E-04 1.3E-04 1.3E-04 1.3E-04 1.3E-04 1.3E-04 1.3E-04 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: Lungs, 6.0E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Bladder Wall 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Bone Surface 1.7E-09 2.9E-08 1.5E-07 6.1E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 Brain 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Breast 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 GI-Tract Oesophagus 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 St Wall 1.7E-09 4.2E-09 1.3E-08 4.8E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 SI Wall 3.4E-09 6.6E-09 1.7E-08 5.3E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 ULI Wall 1.2E-08 2.8E-08 4.8E-08 9.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 LLI Wall 1.1E-08 7.4E-08 1.2E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Colon 1.2E-08 4.8E-08 7.7E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Kidneys 3.5E-09 6.3E-08 3.2E-07 1.4E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Liver 2.2E-09 3.8E-08 1.9E-07 8.6E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 Muscle 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Ovaries 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Pancreas 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Red Marrow 1.7E-09 2.9E-08 1.5E-07 6.3E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Respiratory Tract ET Airways 5.9E-08 3.9E-07 1.5E-06 6.9E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 Lungs 2.3E-05 1.1E-04 3.3E-04 5.9E-04 6.0E-04 6.0E-04 6.0E-04 6.0E-04 6.0E-04 6.0E-04 Skin 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Spleen 4.4E-09 7.8E-08 4.0E-07 1.7E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Testes 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Thymus 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Thyroid 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Uterus 2.6E-10 2.2E-09 1.0E-08 4.5E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Remainder 4.1E-10 3.7E-09 1.7E-08 7.5E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 Effective dose 2.7E-06 1.4E-05 4.0E-05 7.1E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: Lungs, 3.0E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Bladder Wall 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Bone Surface 2.2E-09 3.0E-08 1.3E-07 4.3E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Brain 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Breast 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 GI-Tract Oesophagus 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 St Wall 2.1E-09 4.3E-09 1.2E-08 3.5E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 SI Wall 4.3E-09 6.8E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 ULI Wall 1.7E-08 3.0E-08 4.3E-08 7.3E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 LLI Wall 1.8E-08 8.0E-08 1.0E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 1.7E-08 5.1E-08 6.9E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Kidneys 4.5E-09 6.4E-08 2.8E-07 9.9E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Liver 2.8E-09 3.9E-08 1.7E-07 6.1E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 Muscle 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Ovaries 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Pancreas 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Red Marrow 2.2E-09 3.0E-08 1.3E-07 4.4E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Respiratory Tract ET Airways 1.4E-07 9.6E-07 3.7E-06 1.7E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Lungs 1.1E-05 5.6E-05 1.6E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 Skin 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Spleen 5.5E-09 8.0E-08 3.5E-07 1.2E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Testes 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Thymus 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Thyroid 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Uterus 3.2E-10 2.3E-09 9.1E-09 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Remainder 5.5E-10 4.0E-09 1.6E-08 5.9E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 Effective dose 1.3E-06 6.7E-06 2.0E-05 3.6E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: Lungs, 1.5E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Bladder Wall 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Bone Surface 5.4E-09 6.5E-08 2.4E-07 6.0E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 Brain 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Breast 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 GI-Tract Oesophagus 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 St Wall 5.2E-09 9.5E-09 2.2E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 SI Wall 1.1E-08 1.5E-08 2.8E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 ULI Wall 4.6E-08 6.7E-08 8.3E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 LLI Wall 4.8E-08 1.8E-07 2.0E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Colon 4.7E-08 1.2E-07 1.4E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Kidneys 1.1E-08 1.4E-07 5.3E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Liver 6.8E-09 8.4E-08 3.2E-07 8.3E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 Muscle 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Ovaries 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Pancreas 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Red Marrow 5.3E-09 6.5E-08 2.4E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Respiratory Tract ET Airways 4.5E-07 3.0E-06 1.2E-05 5.3E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 Lungs 5.0E-06 2.6E-05 7.7E-05 1.4E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 Skin 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Spleen 1.4E-08 1.7E-07 6.6E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Testes 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Thymus 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Thyroid 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Uterus 7.9E-10 4.9E-09 1.7E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Remainder 1.4E-09 9.3E-09 3.4E-08 9.7E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Effective dose 6.1E-07 3.2E-06 9.3E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: ET Airways, 8.7E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Bladder Wall 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Bone Surface 7.9E-09 9.4E-08 3.4E-07 7.7E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 Brain 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Breast 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 GI-Tract Oesophagus 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 St Wall 7.7E-09 1.4E-08 3.1E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 SI Wall 1.6E-08 2.2E-08 3.9E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 ULI Wall 6.8E-08 9.8E-08 1.2E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 LLI Wall 7.3E-08 2.7E-07 2.9E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Colon 7.0E-08 1.7E-07 1.9E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Kidneys 1.6E-08 2.0E-07 7.5E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Liver 1.0E-08 1.2E-07 4.5E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Muscle 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Ovaries 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Pancreas 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Red Marrow 7.9E-09 9.4E-08 3.4E-07 7.8E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Respiratory Tract ET Airways 6.9E-07 4.6E-06 1.8E-05 8.1E-05 8.7E-05 8.7E-05 8.7E-05 8.7E-05 8.7E-05 8.7E-05 Lungs 2.8E-06 1.4E-05 4.2E-05 8.0E-05 8.2E-05 8.2E-05 8.2E-05 8.2E-05 8.2E-05 8.2E-05 Skin 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Spleen 2.0E-08 2.5E-07 9.3E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Testes 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Thymus 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Thyroid 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Uterus 1.2E-09 7.1E-09 2.4E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Remainder 3.5E-07 2.3E-06 8.9E-06 4.0E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 Effective dose 3.6E-07 1.9E-06 5.6E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: ET Airways, 9.0E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Bladder Wall 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Bone Surface 8.1E-09 9.6E-08 3.5E-07 7.6E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Brain 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Breast 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 GI-Tract Oesophagus 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 St Wall 7.9E-09 1.4E-08 3.1E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 SI Wall 1.6E-08 2.3E-08 4.0E-08 7.0E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 ULI Wall 7.0E-08 1.0E-07 1.2E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 LLI Wall 7.5E-08 2.7E-07 2.9E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Colon 7.2E-08 1.7E-07 1.9E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Kidneys 1.7E-08 2.1E-07 7.6E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Liver 1.0E-08 1.2E-07 4.6E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Muscle 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Ovaries 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Pancreas 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Red Marrow 8.1E-09 9.6E-08 3.5E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 Respiratory Tract ET Airways 7.1E-07 4.7E-06 1.8E-05 8.3E-05 9.0E-05 9.0E-05 9.0E-05 9.0E-05 9.0E-05 9.0E-05 Lungs 1.9E-06 9.7E-06 2.9E-05 5.3E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 Skin 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Spleen 2.1E-08 2.6E-07 9.5E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Testes 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Thymus 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Thyroid 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Uterus 1.2E-09 7.3E-09 2.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Remainder 3.6E-07 2.4E-06 9.1E-06 4.2E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 Effective dose 2.6E-07 1.3E-06 4.0E-06 8.7E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 Po-210, 3-month-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type S, f1 = 0.02 Highest committed equivalent dose coefficient: ET Airways, 8.3E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bladder Wall 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bone Surface 7.5E-09 8.8E-08 3.2E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 Brain 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Breast 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 GI-Tract Oesophagus 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 St Wall 7.3E-09 1.3E-08 2.9E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 SI Wall 1.5E-08 2.1E-08 3.6E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 ULI Wall 6.4E-08 9.2E-08 1.1E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 LLI Wall 6.9E-08 2.5E-07 2.7E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Colon 6.6E-08 1.6E-07 1.8E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Kidneys 1.5E-08 1.9E-07 6.9E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Liver 9.5E-09 1.1E-07 4.2E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 Muscle 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Ovaries 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Pancreas 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Red Marrow 7.4E-09 8.8E-08 3.2E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 6.9E-07 Respiratory Tract ET Airways 6.6E-07 4.4E-06 1.7E-05 7.7E-05 8.3E-05 8.3E-05 8.3E-05 8.3E-05 8.3E-05 8.3E-05 Lungs 9.3E-07 4.4E-06 1.3E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Skin 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Spleen 1.9E-08 2.4E-07 8.6E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Testes 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thymus 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thyroid 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Uterus 1.1E-09 6.7E-09 2.2E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Remainder 3.3E-07 2.2E-06 8.5E-06 3.8E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 Effective dose 1.4E-07 6.8E-07 2.1E-06 4.9E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 Po-210, 3-month-old member of the public Ingestion: f1 = 1.0 Highest committed equivalent dose coefficient: Spleen, 2.2E-04 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69y 9m Adrenals 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Bladder Wall 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Bone Surface 1.2E-06 1.1E-05 3.8E-05 8.0E-05 8.0E-05 8.0E-05 8.0E-05 8.0E-05 8.0E-05 8.0E-05 Brain 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Breast 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 GI-Tract Oesophagus 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 St Wall 1.7E-07 8.4E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 SI Wall 1.6E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 ULI Wall 1.6E-07 8.3E-07 2.7E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 LLI Wall 1.6E-07 8.5E-07 2.8E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 Colon 1.6E-07 8.4E-07 2.8E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 Kidneys 2.4E-06 2.3E-05 8.3E-05 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 Liver 1.5E-06 1.4E-05 5.0E-05 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 Muscle 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Ovaries 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Pancreas 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Red Marrow 1.2E-06 1.1E-05 3.8E-05 8.1E-05 8.1E-05 8.1E-05 8.1E-05 8.1E-05 8.1E-05 8.1E-05 Respiratory Tract ET Airways 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Lungs 1.6E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Skin 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Spleen 3.0E-06 2.9E-05 1.0E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 Testes 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Thymus 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Thyroid 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Uterus 1.5E-07 8.2E-07 2.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Remainder 1.6E-06 1.5E-05 5.4E-05 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 Effective dose 4.2E-07 3.5E-06 1.2E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 5.1E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Bladder Wall 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Bone Surface 2.1E-07 1.9E-06 6.8E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Brain 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Breast 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 GI-Tract Oesophagus 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 St Wall 3.5E-08 1.8E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 SI Wall 3.8E-08 1.8E-07 5.9E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 ULI Wall 5.5E-08 2.0E-07 6.2E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 LLI Wall 5.7E-08 2.6E-07 6.9E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Colon 5.6E-08 2.3E-07 6.5E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Kidneys 5.2E-07 4.9E-06 1.8E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 Liver 3.4E-07 3.2E-06 1.2E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Muscle 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Ovaries 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Pancreas 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Red Marrow 2.3E-07 2.1E-06 7.5E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Respiratory Tract ET Airways 6.4E-08 2.2E-07 6.3E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Lungs 1.6E-07 3.0E-07 7.1E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Skin 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Spleen 6.4E-07 6.1E-06 2.2E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Testes 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Thymus 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Thyroid 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Uterus 3.3E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Remainder 3.4E-07 3.2E-06 1.1E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Effective dose 1.1E-07 7.4E-07 2.6E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 6.9E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Bladder Wall 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Bone Surface 2.9E-07 2.6E-06 9.3E-06 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Brain 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Breast 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 GI-Tract Oesophagus 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 St Wall 4.7E-08 2.4E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 SI Wall 4.9E-08 2.4E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 ULI Wall 6.3E-08 2.6E-07 8.3E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 LLI Wall 6.5E-08 3.1E-07 8.9E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Colon 6.4E-08 2.8E-07 8.5E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Kidneys 7.1E-07 6.7E-06 2.4E-05 5.6E-05 5.6E-05 5.6E-05 5.6E-05 5.6E-05 5.6E-05 5.6E-05 Liver 4.7E-07 4.3E-06 1.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 Muscle 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Ovaries 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Pancreas 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Red Marrow 3.1E-07 2.8E-06 1.0E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Respiratory Tract ET Airways 6.9E-08 2.7E-07 8.2E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Lungs 4.5E-07 6.4E-07 1.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Skin 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Spleen 8.7E-07 8.2E-06 3.0E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 Testes 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Thymus 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Thyroid 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Uterus 4.5E-08 2.3E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Remainder 4.6E-07 4.3E-06 1.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 Effective dose 1.7E-07 1.0E-06 3.5E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 9.7E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Bladder Wall 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Bone Surface 4.0E-07 3.6E-06 1.3E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 Brain 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Breast 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 GI-Tract Oesophagus 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 St Wall 6.5E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 SI Wall 6.6E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 ULI Wall 7.4E-08 3.5E-07 1.1E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 LLI Wall 7.4E-08 3.8E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Colon 7.4E-08 3.6E-07 1.2E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Kidneys 1.0E-06 9.5E-06 3.4E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 7.9E-05 Liver 6.6E-07 6.1E-06 2.2E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Muscle 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Ovaries 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Pancreas 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Red Marrow 4.4E-07 4.0E-06 1.4E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 Respiratory Tract ET Airways 7.6E-08 3.5E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Lungs 7.7E-07 1.0E-06 1.8E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Skin 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Spleen 1.2E-06 1.2E-05 4.2E-05 9.7E-05 9.7E-05 9.7E-05 9.7E-05 9.7E-05 9.7E-05 9.7E-05 Testes 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Thymus 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Thyroid 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Uterus 6.4E-08 3.3E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Remainder 6.6E-07 6.0E-06 2.2E-05 5.0E-05 5.0E-05 5.0E-05 5.0E-05 5.0E-05 5.0E-05 5.0E-05 Effective dose 2.6E-07 1.5E-06 5.0E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 1.0E-04 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Bladder Wall 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Bone Surface 4.4E-07 3.9E-06 1.4E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 Brain 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Breast 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 GI-Tract Oesophagus 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 St Wall 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 SI Wall 7.0E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 ULI Wall 7.3E-08 3.7E-07 1.2E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 LLI Wall 7.3E-08 3.8E-07 1.3E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Colon 7.3E-08 3.7E-07 1.2E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Kidneys 1.1E-06 1.0E-05 3.7E-05 8.5E-05 8.5E-05 8.5E-05 8.5E-05 8.5E-05 8.5E-05 8.5E-05 Liver 7.2E-07 6.6E-06 2.4E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 Muscle 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Ovaries 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Pancreas 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Red Marrow 4.8E-07 4.3E-06 1.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 Respiratory Tract ET Airways 7.4E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Lungs 5.0E-07 7.9E-07 1.6E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 Skin 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Spleen 1.3E-06 1.3E-05 4.6E-05 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 Testes 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Thymus 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Thyroid 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Uterus 6.9E-08 3.6E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Remainder 7.1E-07 6.5E-06 2.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 Effective dose 2.4E-07 1.5E-06 5.4E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 6.8E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Bladder Wall 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Bone Surface 2.8E-07 2.5E-06 9.1E-06 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Brain 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Breast 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 GI-Tract Oesophagus 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 St Wall 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 SI Wall 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 ULI Wall 4.7E-08 2.4E-07 7.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 LLI Wall 4.7E-08 2.5E-07 8.2E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Colon 4.7E-08 2.4E-07 8.1E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Kidneys 7.1E-07 6.6E-06 2.4E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 Liver 4.7E-07 4.3E-06 1.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 Muscle 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Ovaries 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Pancreas 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Red Marrow 3.1E-07 2.8E-06 1.0E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Respiratory Tract ET Airways 4.7E-08 2.4E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Lungs 2.5E-07 4.4E-07 9.9E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Skin 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Spleen 8.7E-07 8.1E-06 3.0E-05 6.8E-05 6.8E-05 6.8E-05 6.8E-05 6.8E-05 6.8E-05 6.8E-05 Testes 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Thymus 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Thyroid 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Uterus 4.5E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Remainder 4.6E-07 4.2E-06 1.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Effective dose 1.5E-07 9.9E-07 3.5E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 4.1E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Bladder Wall 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Bone Surface 1.7E-07 1.5E-06 5.6E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Brain 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Breast 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 GI-Tract Oesophagus 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 St Wall 2.8E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 SI Wall 2.8E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 ULI Wall 3.2E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 LLI Wall 3.2E-08 1.6E-07 5.1E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Colon 3.2E-08 1.5E-07 5.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Kidneys 4.3E-07 4.0E-06 1.5E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 Liver 2.8E-07 2.6E-06 9.5E-06 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Muscle 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Ovaries 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Pancreas 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Red Marrow 1.9E-07 1.7E-06 6.2E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Respiratory Tract ET Airways 3.2E-08 1.5E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Lungs 1.3E-07 2.4E-07 5.8E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Skin 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Spleen 5.3E-07 5.0E-06 1.8E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 Testes 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Thymus 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Thyroid 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Uterus 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Remainder 2.8E-07 2.6E-06 9.4E-06 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Effective dose 8.6E-08 6.0E-07 2.1E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 4.2E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Bladder Wall 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Bone Surface 1.7E-07 1.5E-06 5.6E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Brain 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Breast 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 GI-Tract Oesophagus 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 St Wall 2.9E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 SI Wall 3.0E-08 1.5E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 ULI Wall 4.1E-08 1.6E-07 5.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 LLI Wall 4.2E-08 2.0E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Colon 4.1E-08 1.8E-07 5.2E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Kidneys 4.3E-07 4.1E-06 1.5E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 Liver 2.8E-07 2.6E-06 9.5E-06 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Muscle 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Ovaries 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Pancreas 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Red Marrow 1.9E-07 1.7E-06 6.2E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Respiratory Tract ET Airways 4.2E-08 1.6E-07 5.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Lungs 7.8E-08 1.9E-07 5.3E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Skin 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Spleen 5.3E-07 5.0E-06 1.8E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 4.2E-05 Testes 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Thymus 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Thyroid 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Uterus 2.7E-08 1.4E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Remainder 2.8E-07 2.6E-06 9.4E-06 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Effective dose 8.1E-08 6.0E-07 2.1E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 4.6E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Bladder Wall 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Bone Surface 1.9E-07 1.7E-06 6.1E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Brain 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Breast 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 GI-Tract Oesophagus 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 St Wall 3.2E-08 1.6E-07 5.3E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 SI Wall 3.4E-08 1.6E-07 5.3E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 ULI Wall 5.0E-08 1.8E-07 5.6E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 LLI Wall 5.1E-08 2.3E-07 6.2E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Colon 5.1E-08 2.1E-07 5.9E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Kidneys 4.7E-07 4.4E-06 1.6E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 Liver 3.1E-07 2.9E-06 1.0E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Muscle 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Ovaries 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Pancreas 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Red Marrow 2.1E-07 1.9E-06 6.8E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Respiratory Tract ET Airways 5.4E-08 1.9E-07 5.6E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Lungs 6.4E-08 1.9E-07 5.6E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Skin 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Spleen 5.8E-07 5.5E-06 2.0E-05 4.6E-05 4.6E-05 4.6E-05 4.6E-05 4.6E-05 4.6E-05 4.6E-05 Testes 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Thymus 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Thyroid 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Uterus 3.0E-08 1.6E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Remainder 3.1E-07 2.8E-06 1.0E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Effective dose 8.7E-08 6.6E-07 2.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 4.3E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Bladder Wall 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Bone Surface 1.8E-07 1.6E-06 5.8E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Brain 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Breast 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 GI-Tract Oesophagus 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 St Wall 3.0E-08 1.5E-07 5.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 SI Wall 3.3E-08 1.5E-07 5.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 ULI Wall 4.9E-08 1.8E-07 5.3E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 LLI Wall 5.0E-08 2.3E-07 5.9E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Colon 4.9E-08 2.0E-07 5.6E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Kidneys 4.4E-07 4.2E-06 1.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Liver 2.9E-07 2.7E-06 9.8E-06 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Muscle 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Ovaries 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Pancreas 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Red Marrow 1.9E-07 1.8E-06 6.4E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Respiratory Tract ET Airways 5.4E-08 1.8E-07 5.3E-07 1.1E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Lungs 5.4E-08 1.7E-07 5.2E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Skin 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Spleen 5.4E-07 5.2E-06 1.9E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 Testes 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Thymus 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Thyroid 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Uterus 2.8E-08 1.5E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Remainder 2.9E-07 2.7E-06 9.7E-06 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Effective dose 8.2E-08 6.2E-07 2.2E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 3.6E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Bladder Wall 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Bone Surface 1.5E-07 1.4E-06 4.9E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Brain 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Breast 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 GI-Tract Oesophagus 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 St Wall 2.6E-08 1.3E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 SI Wall 2.8E-08 1.3E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 ULI Wall 4.3E-08 1.5E-07 4.5E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 LLI Wall 4.4E-08 2.0E-07 5.1E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Colon 4.3E-08 1.7E-07 4.7E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Kidneys 3.7E-07 3.5E-06 1.3E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 Liver 2.5E-07 2.3E-06 8.3E-06 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Muscle 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Ovaries 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Pancreas 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Red Marrow 1.6E-07 1.5E-06 5.4E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Respiratory Tract ET Airways 4.9E-08 1.6E-07 4.5E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Lungs 3.9E-08 1.4E-07 4.3E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 Skin 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Spleen 4.6E-07 4.4E-06 1.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 Testes 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Thymus 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Thyroid 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Uterus 2.4E-08 1.2E-07 4.2E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Remainder 2.4E-07 2.3E-06 8.2E-06 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Effective dose 6.8E-08 5.2E-07 1.9E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.7E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Bladder Wall 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Bone Surface 4.2E-08 4.4E-07 1.7E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Brain 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Breast 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 GI-Tract Oesophagus 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 St Wall 1.1E-08 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 SI Wall 1.7E-08 5.0E-08 1.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 ULI Wall 5.1E-08 1.0E-07 2.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 LLI Wall 5.4E-08 2.1E-07 3.2E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 Colon 5.2E-08 1.5E-07 2.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Kidneys 1.0E-07 1.1E-06 4.4E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Liver 6.9E-08 7.4E-07 2.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 Muscle 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Ovaries 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Pancreas 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Red Marrow 4.6E-08 4.8E-07 1.8E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 Respiratory Tract ET Airways 4.7E-07 3.0E-06 1.1E-05 3.8E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 Lungs 7.6E-06 4.2E-05 1.2E-04 1.7E-04 1.7E-04 1.7E-04 1.7E-04 1.7E-04 1.7E-04 1.7E-04 Skin 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Spleen 1.3E-07 1.4E-06 5.4E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Testes 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Thymus 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Thyroid 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Uterus 7.1E-09 4.0E-08 1.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Remainder 9.2E-09 6.3E-08 2.3E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 Effective dose 9.3E-07 5.2E-06 1.5E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 5.1E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Bladder Wall 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Bone Surface 4.8E-08 5.1E-07 2.0E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 Brain 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Breast 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 GI-Tract Oesophagus 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 St Wall 1.2E-08 5.1E-08 1.8E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 SI Wall 1.7E-08 5.7E-08 1.8E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 ULI Wall 5.0E-08 1.1E-07 2.4E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 LLI Wall 5.1E-08 2.2E-07 3.7E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 Colon 5.0E-08 1.6E-07 3.0E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Kidneys 1.2E-07 1.3E-06 5.4E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Liver 7.9E-08 8.7E-07 3.5E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 Muscle 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Ovaries 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Pancreas 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Red Marrow 5.3E-08 5.7E-07 2.2E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 Respiratory Tract ET Airways 3.8E-07 2.5E-06 9.3E-06 3.1E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 Lungs 2.5E-05 1.3E-04 3.6E-04 5.1E-04 5.1E-04 5.1E-04 5.1E-04 5.1E-04 5.1E-04 5.1E-04 Skin 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Spleen 1.5E-07 1.7E-06 6.6E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Testes 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Thymus 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Thyroid 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Uterus 8.0E-09 4.7E-08 1.7E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Remainder 1.0E-08 7.3E-08 2.8E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Effective dose 3.0E-06 1.6E-05 4.4E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 6.3E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 8.9E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Bladder Wall 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Bone Surface 5.3E-08 5.9E-07 2.5E-06 8.4E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 Brain 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Breast 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 GI-Tract Oesophagus 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 St Wall 1.2E-08 5.8E-08 2.2E-07 7.1E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 SI Wall 1.6E-08 6.2E-08 2.3E-07 7.2E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 ULI Wall 3.7E-08 1.0E-07 2.8E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 LLI Wall 3.6E-08 1.9E-07 3.9E-07 9.3E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Colon 3.7E-08 1.4E-07 3.3E-07 8.5E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 8.6E-07 Kidneys 1.3E-07 1.5E-06 6.7E-06 2.2E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Liver 8.7E-08 9.9E-07 4.3E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Muscle 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Ovaries 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Pancreas 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Red Marrow 5.9E-08 6.5E-07 2.8E-06 9.3E-06 9.4E-06 9.4E-06 9.4E-06 9.4E-06 9.4E-06 9.4E-06 Respiratory Tract ET Airways 2.0E-07 1.3E-06 5.0E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Lungs 4.6E-05 2.2E-04 6.2E-04 8.9E-04 8.9E-04 8.9E-04 8.9E-04 8.9E-04 8.9E-04 8.9E-04 Skin 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Spleen 1.6E-07 1.9E-06 8.2E-06 2.7E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Testes 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Thymus 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Thyroid 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Uterus 8.9E-09 5.4E-08 2.2E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Remainder 1.1E-08 8.3E-08 3.4E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Effective dose 5.5E-06 2.7E-05 7.5E-05 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 6.1E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Bladder Wall 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Bone Surface 5.0E-08 5.3E-07 2.5E-06 1.1E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Brain 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Breast 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 GI-Tract Oesophagus 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 St Wall 9.5E-09 5.1E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 SI Wall 1.1E-08 5.4E-08 2.2E-07 9.7E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 9.9E-07 ULI Wall 2.1E-08 7.6E-08 2.6E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 LLI Wall 2.0E-08 1.2E-07 3.3E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Colon 2.0E-08 9.6E-08 2.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Kidneys 1.2E-07 1.4E-06 6.7E-06 3.0E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Liver 8.2E-08 9.0E-07 4.3E-06 1.9E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Muscle 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Ovaries 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Pancreas 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Red Marrow 5.5E-08 5.9E-07 2.8E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Respiratory Tract ET Airways 8.3E-08 5.4E-07 2.1E-06 7.1E-06 7.3E-06 7.3E-06 7.3E-06 7.3E-06 7.3E-06 7.3E-06 Lungs 2.9E-05 1.4E-04 3.9E-04 6.1E-04 6.1E-04 6.1E-04 6.1E-04 6.1E-04 6.1E-04 6.1E-04 Skin 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Spleen 1.5E-07 1.7E-06 8.2E-06 3.7E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 Testes 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Thymus 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Thyroid 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Uterus 8.1E-09 4.9E-08 2.2E-07 9.6E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Remainder 1.0E-08 7.5E-08 3.4E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Effective dose 3.5E-06 1.7E-05 4.8E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Bladder Wall 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Bone Surface 3.1E-08 3.3E-07 1.6E-06 7.8E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 7.9E-06 Brain 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Breast 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 GI-Tract Oesophagus 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 St Wall 5.7E-09 3.2E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 SI Wall 6.6E-09 3.3E-08 1.4E-07 6.6E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 ULI Wall 1.1E-08 4.4E-08 1.6E-07 7.0E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 LLI Wall 1.1E-08 6.6E-08 2.0E-07 7.6E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Colon 1.1E-08 5.3E-08 1.8E-07 7.2E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 Kidneys 7.8E-08 8.7E-07 4.3E-06 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Liver 5.1E-08 5.6E-07 2.7E-06 1.3E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Muscle 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Ovaries 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Pancreas 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Red Marrow 3.4E-08 3.7E-07 1.8E-06 8.7E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 Respiratory Tract ET Airways 4.0E-08 2.6E-07 1.0E-06 3.5E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Lungs 1.4E-05 6.9E-05 2.0E-04 3.2E-04 3.2E-04 3.2E-04 3.2E-04 3.2E-04 3.2E-04 3.2E-04 Skin 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Spleen 9.6E-08 1.1E-06 5.2E-06 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Testes 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Thymus 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Thyroid 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Uterus 5.1E-09 3.1E-08 1.4E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Remainder 6.5E-09 4.7E-08 2.2E-07 1.0E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Effective dose 1.7E-06 8.4E-06 2.4E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.6E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Bladder Wall 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Bone Surface 2.2E-08 2.3E-07 1.1E-06 4.6E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 Brain 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Breast 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 GI-Tract Oesophagus 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 St Wall 4.4E-09 2.2E-08 9.2E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 SI Wall 5.7E-09 2.4E-08 9.3E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 ULI Wall 1.3E-08 3.6E-08 1.1E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 LLI Wall 1.3E-08 6.3E-08 1.4E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Colon 1.3E-08 4.8E-08 1.2E-07 4.4E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Kidneys 5.4E-08 6.0E-07 2.8E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Liver 3.6E-08 3.9E-07 1.8E-06 7.9E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 Muscle 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Ovaries 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Pancreas 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Red Marrow 2.4E-08 2.5E-07 1.2E-06 5.1E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 Respiratory Tract ET Airways 9.2E-08 6.0E-07 2.3E-06 7.7E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 Lungs 6.8E-06 3.4E-05 9.6E-05 1.6E-04 1.6E-04 1.6E-04 1.6E-04 1.6E-04 1.6E-04 1.6E-04 Skin 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Spleen 6.7E-08 7.4E-07 3.4E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Testes 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Thymus 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Thyroid 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Uterus 3.6E-09 2.1E-08 9.0E-08 3.9E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Remainder 4.6E-09 3.2E-08 1.4E-07 6.2E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 Effective dose 8.3E-07 4.1E-06 1.2E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 8.1E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Bladder Wall 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Bone Surface 3.0E-08 3.1E-07 1.2E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Brain 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Breast 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 GI-Tract Oesophagus 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 St Wall 7.2E-09 3.1E-08 1.1E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 SI Wall 1.0E-08 3.4E-08 1.1E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 ULI Wall 3.1E-08 6.4E-08 1.4E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 LLI Wall 3.2E-08 1.3E-07 2.1E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Colon 3.1E-08 9.1E-08 1.7E-07 4.2E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Kidneys 7.3E-08 8.0E-07 3.3E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Liver 4.8E-08 5.2E-07 2.1E-06 7.0E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 Muscle 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Ovaries 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Pancreas 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Red Marrow 3.2E-08 3.4E-07 1.4E-06 4.5E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Respiratory Tract ET Airways 2.8E-07 1.8E-06 6.9E-06 2.3E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Lungs 3.3E-06 1.7E-05 4.8E-05 8.1E-05 8.1E-05 8.1E-05 8.1E-05 8.1E-05 8.1E-05 8.1E-05 Skin 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Spleen 9.0E-08 9.9E-07 4.0E-06 1.3E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Testes 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Thymus 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Thyroid 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Uterus 4.9E-09 2.8E-08 1.1E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Remainder 6.4E-09 4.4E-08 1.7E-07 5.5E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 Effective dose 4.1E-07 2.1E-06 6.2E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 4.9E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Bladder Wall 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Bone Surface 3.7E-08 3.9E-07 1.5E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Brain 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Breast 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 GI-Tract Oesophagus 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 St Wall 9.6E-09 3.9E-08 1.3E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 SI Wall 1.5E-08 4.4E-08 1.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 ULI Wall 4.4E-08 8.8E-08 1.8E-07 4.0E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 LLI Wall 4.7E-08 1.8E-07 2.8E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 Colon 4.6E-08 1.3E-07 2.2E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Kidneys 9.2E-08 1.0E-06 3.9E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Liver 6.1E-08 6.5E-07 2.5E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Muscle 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Ovaries 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Pancreas 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Red Marrow 4.1E-08 4.3E-07 1.6E-06 4.5E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Respiratory Tract ET Airways 4.3E-07 2.8E-06 1.0E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Lungs 2.0E-06 1.0E-05 3.0E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 Skin 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Spleen 1.1E-07 1.2E-06 4.8E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Testes 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Thymus 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Thyroid 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Uterus 6.2E-09 3.6E-08 1.3E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Remainder 8.2E-09 5.5E-08 2.0E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 Effective dose 2.6E-07 1.4E-06 4.0E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: ET Airways, 3.6E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Bladder Wall 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Bone Surface 3.7E-08 3.8E-07 1.4E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Brain 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Breast 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 GI-Tract Oesophagus 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 St Wall 9.6E-09 3.8E-08 1.3E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 SI Wall 1.5E-08 4.4E-08 1.3E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 ULI Wall 4.5E-08 8.8E-08 1.8E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 LLI Wall 4.8E-08 1.8E-07 2.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Colon 4.7E-08 1.3E-07 2.2E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 Kidneys 9.1E-08 9.9E-07 3.8E-06 9.8E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 Liver 6.0E-08 6.4E-07 2.4E-06 6.3E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 Muscle 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Ovaries 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Pancreas 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Red Marrow 4.0E-08 4.2E-07 1.6E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Respiratory Tract ET Airways 4.4E-07 2.9E-06 1.1E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 Lungs 1.4E-06 7.2E-06 2.1E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 Skin 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Spleen 1.1E-07 1.2E-06 4.7E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Testes 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Thymus 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Thyroid 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Uterus 6.1E-09 3.5E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Remainder 2.2E-07 1.5E-06 5.5E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Effective dose 2.0E-07 1.1E-06 3.2E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: ET Airways, 3.4E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Bladder Wall 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Bone Surface 3.2E-08 3.4E-07 1.2E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 Brain 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Breast 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 GI-Tract Oesophagus 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 St Wall 8.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 SI Wall 1.3E-08 3.9E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 ULI Wall 4.2E-08 8.0E-08 1.6E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 LLI Wall 4.4E-08 1.7E-07 2.5E-07 4.0E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Colon 4.3E-08 1.2E-07 2.0E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Kidneys 8.0E-08 8.8E-07 3.3E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 Liver 5.3E-08 5.7E-07 2.1E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 Muscle 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Ovaries 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Pancreas 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Red Marrow 3.5E-08 3.7E-07 1.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Respiratory Tract ET Airways 4.1E-07 2.6E-06 9.9E-06 3.3E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 Lungs 7.1E-07 3.4E-06 9.6E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Skin 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Spleen 9.8E-08 1.1E-06 4.0E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 Testes 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Thymus 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Thyroid 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Uterus 5.4E-09 3.1E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Remainder 2.1E-07 1.3E-06 5.0E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Effective dose 1.1E-07 5.8E-07 1.8E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 2.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Bladder Wall 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Bone Surface 2.5E-09 2.9E-08 1.1E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Brain 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Breast 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 GI-Tract Oesophagus 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 St Wall 4.6E-09 6.9E-09 1.4E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 SI Wall 1.2E-08 1.4E-08 2.1E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 ULI Wall 5.1E-08 7.3E-08 8.2E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 LLI Wall 5.4E-08 2.0E-07 2.1E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Colon 5.2E-08 1.3E-07 1.4E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Kidneys 6.1E-09 7.6E-08 2.9E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Liver 4.0E-09 4.9E-08 1.9E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Muscle 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Ovaries 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Pancreas 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Red Marrow 2.7E-09 3.2E-08 1.2E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Respiratory Tract ET Airways 5.1E-07 3.4E-06 1.3E-05 6.7E-05 7.3E-05 7.3E-05 7.3E-05 7.3E-05 7.3E-05 7.3E-05 Lungs 8.4E-06 4.8E-05 1.4E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 Skin 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Spleen 7.4E-09 9.4E-08 3.6E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 Testes 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Thymus 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Thyroid 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Uterus 4.4E-10 2.7E-09 9.5E-09 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Remainder 9.5E-10 5.7E-09 2.1E-08 6.4E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 Effective dose 1.0E-06 5.8E-06 1.7E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 6.5E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Bladder Wall 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Bone Surface 2.4E-09 3.0E-08 1.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Brain 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Breast 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 GI-Tract Oesophagus 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 St Wall 4.5E-09 7.1E-09 1.5E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 SI Wall 1.1E-08 1.4E-08 2.3E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 ULI Wall 4.8E-08 7.4E-08 8.8E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 LLI Wall 4.9E-08 2.0E-07 2.3E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Colon 4.9E-08 1.3E-07 1.5E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Kidneys 5.9E-09 7.8E-08 3.2E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 Liver 3.9E-09 5.1E-08 2.0E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Muscle 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Ovaries 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Pancreas 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Red Marrow 2.6E-09 3.3E-08 1.3E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Respiratory Tract ET Airways 4.2E-07 2.8E-06 1.1E-05 5.5E-05 6.0E-05 6.0E-05 6.0E-05 6.0E-05 6.0E-05 6.0E-05 Lungs 2.8E-05 1.4E-04 4.2E-04 6.5E-04 6.5E-04 6.5E-04 6.5E-04 6.5E-04 6.5E-04 6.5E-04 Skin 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Spleen 7.2E-09 9.6E-08 3.9E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Testes 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Thymus 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Thyroid 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Uterus 4.2E-10 2.8E-09 1.0E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Remainder 8.9E-10 5.5E-09 2.1E-08 6.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Effective dose 3.3E-06 1.7E-05 5.1E-05 7.8E-05 7.8E-05 7.8E-05 7.8E-05 7.8E-05 7.8E-05 7.8E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.1E-03 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Bladder Wall 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Bone Surface 1.8E-09 2.6E-08 1.2E-07 4.0E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Brain 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Breast 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 GI-Tract Oesophagus 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 St Wall 3.4E-09 6.0E-09 1.4E-08 3.9E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 SI Wall 8.3E-09 1.2E-08 2.2E-08 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 ULI Wall 3.3E-08 6.2E-08 8.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 LLI Wall 3.2E-08 1.7E-07 2.1E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Colon 3.2E-08 1.1E-07 1.4E-07 1.8E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Kidneys 4.3E-09 6.8E-08 3.1E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Liver 2.9E-09 4.4E-08 2.0E-07 6.8E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 Muscle 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Ovaries 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Pancreas 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Red Marrow 1.9E-09 2.9E-08 1.3E-07 4.4E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Respiratory Tract ET Airways 2.1E-07 1.4E-06 5.7E-06 2.8E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Lungs 5.1E-05 2.5E-04 7.2E-04 1.1E-03 1.1E-03 1.1E-03 1.1E-03 1.1E-03 1.1E-03 1.1E-03 Skin 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Spleen 5.3E-09 8.3E-08 3.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Testes 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Thymus 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Thyroid 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Uterus 3.2E-10 2.4E-09 1.0E-08 3.4E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Remainder 6.2E-10 4.4E-09 1.8E-08 6.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Effective dose 6.1E-06 3.0E-05 8.7E-05 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 1.4E-04 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 8.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Bladder Wall 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Bone Surface 1.0E-09 1.6E-08 8.3E-08 4.4E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Brain 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Breast 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 GI-Tract Oesophagus 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 St Wall 1.7E-09 3.4E-09 9.7E-09 4.1E-08 4.3E-08 4.3E-08 4.3E-08 4.3E-08 4.3E-08 4.3E-08 SI Wall 4.0E-09 6.6E-09 1.4E-08 4.7E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 ULI Wall 1.5E-08 3.3E-08 5.0E-08 9.7E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 LLI Wall 1.4E-08 8.6E-08 1.3E-07 2.0E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Colon 1.5E-08 5.6E-08 8.4E-08 1.4E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Kidneys 2.6E-09 4.1E-08 2.2E-07 1.2E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Liver 1.7E-09 2.7E-08 1.4E-07 7.6E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 Muscle 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Ovaries 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Pancreas 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Red Marrow 1.1E-09 1.7E-08 9.1E-08 4.9E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 Respiratory Tract ET Airways 8.4E-08 5.5E-07 2.2E-06 1.1E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Lungs 3.2E-05 1.6E-04 4.6E-04 8.1E-04 8.2E-04 8.2E-04 8.2E-04 8.2E-04 8.2E-04 8.2E-04 Skin 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Spleen 3.1E-09 5.1E-08 2.7E-07 1.4E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Testes 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Thymus 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Thyroid 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Uterus 1.9E-10 1.5E-09 7.1E-09 3.7E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 Remainder 3.3E-10 2.5E-09 1.2E-08 6.4E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Effective dose 3.8E-06 1.9E-05 5.5E-05 9.7E-05 9.9E-05 9.9E-05 9.9E-05 9.9E-05 9.9E-05 9.9E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 4.4E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Bladder Wall 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Bone Surface 5.7E-10 8.5E-09 4.7E-08 2.9E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Brain 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Breast 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 GI-Tract Oesophagus 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 St Wall 8.0E-10 1.7E-09 5.4E-09 2.6E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 SI Wall 1.9E-09 3.3E-09 7.8E-09 3.0E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 ULI Wall 7.0E-09 1.6E-08 2.7E-08 5.8E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 LLI Wall 6.5E-09 4.2E-08 6.7E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Colon 6.8E-09 2.7E-08 4.4E-08 8.4E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Kidneys 1.4E-09 2.2E-08 1.2E-07 7.7E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 Liver 9.3E-10 1.4E-08 8.0E-08 5.0E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Muscle 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Ovaries 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Pancreas 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Red Marrow 6.2E-10 9.3E-09 5.2E-08 3.2E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Respiratory Tract ET Airways 3.9E-08 2.6E-07 1.0E-06 5.2E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 Lungs 1.6E-05 7.8E-05 2.3E-04 4.3E-04 4.4E-04 4.4E-04 4.4E-04 4.4E-04 4.4E-04 4.4E-04 Skin 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Spleen 1.7E-09 2.7E-08 1.5E-07 9.5E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Testes 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Thymus 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Thyroid 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Uterus 1.0E-10 7.9E-10 4.0E-09 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Remainder 1.7E-10 1.3E-09 6.8E-09 4.1E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Effective dose 1.9E-06 9.4E-06 2.8E-05 5.2E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 2.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Bladder Wall 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Bone Surface 6.4E-10 8.3E-09 3.9E-08 1.9E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Brain 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Breast 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 GI-Tract Oesophagus 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 St Wall 1.0E-09 1.8E-09 4.6E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 SI Wall 2.6E-09 3.6E-09 6.8E-09 2.0E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 ULI Wall 1.1E-08 1.8E-08 2.5E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 LLI Wall 1.1E-08 4.9E-08 6.3E-08 9.1E-08 9.3E-08 9.3E-08 9.3E-08 9.3E-08 9.3E-08 9.3E-08 Colon 1.1E-08 3.1E-08 4.1E-08 6.4E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Kidneys 1.6E-09 2.2E-08 1.0E-07 5.0E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 Liver 1.0E-09 1.4E-08 6.6E-08 3.2E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Muscle 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Ovaries 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Pancreas 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Red Marrow 7.0E-10 9.2E-09 4.3E-08 2.1E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Respiratory Tract ET Airways 9.8E-08 6.5E-07 2.6E-06 1.3E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Lungs 7.6E-06 3.8E-05 1.1E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 Skin 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Spleen 1.9E-09 2.7E-08 1.3E-07 6.1E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Testes 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Thymus 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Thyroid 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Uterus 1.1E-10 7.7E-10 3.3E-09 1.6E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Remainder 2.2E-10 1.5E-09 6.4E-09 3.0E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Effective dose 9.1E-07 4.6E-06 1.4E-05 2.6E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.1E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Bladder Wall 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Bone Surface 1.5E-09 1.8E-08 6.9E-08 2.1E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Brain 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Breast 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 GI-Tract Oesophagus 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 St Wall 2.7E-09 4.1E-09 8.5E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 SI Wall 6.7E-09 8.3E-09 1.3E-08 2.5E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 ULI Wall 3.0E-08 4.2E-08 4.9E-08 6.4E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 LLI Wall 3.1E-08 1.2E-07 1.3E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 3.0E-08 7.4E-08 8.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Kidneys 3.7E-09 4.6E-08 1.8E-07 5.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Liver 2.4E-09 3.0E-08 1.2E-07 3.6E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Muscle 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Ovaries 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Pancreas 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Red Marrow 1.6E-09 1.9E-08 7.7E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Respiratory Tract ET Airways 3.1E-07 2.0E-06 8.1E-06 4.1E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 Lungs 3.6E-06 1.9E-05 5.7E-05 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 Skin 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Spleen 4.5E-09 5.7E-08 2.2E-07 7.0E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 7.2E-07 Testes 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Thymus 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Thyroid 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Uterus 2.6E-10 1.6E-09 5.9E-09 1.8E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 Remainder 5.6E-10 3.4E-09 1.3E-08 4.6E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 Effective dose 4.4E-07 2.3E-06 6.9E-06 1.3E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 6.9E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Bladder Wall 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Bone Surface 2.2E-09 2.5E-08 9.5E-08 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Brain 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Breast 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 GI-Tract Oesophagus 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 St Wall 3.9E-09 5.9E-09 1.2E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 SI Wall 1.0E-08 1.2E-08 1.8E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 ULI Wall 4.4E-08 6.2E-08 6.9E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 LLI Wall 4.7E-08 1.7E-07 1.8E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Colon 4.5E-08 1.1E-07 1.2E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Kidneys 5.3E-09 6.6E-08 2.5E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Liver 3.5E-09 4.2E-08 1.6E-07 4.2E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Muscle 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Ovaries 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Pancreas 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Red Marrow 2.4E-09 2.8E-08 1.1E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Respiratory Tract ET Airways 4.6E-07 3.1E-06 1.2E-05 6.2E-05 6.7E-05 6.7E-05 6.7E-05 6.7E-05 6.7E-05 6.7E-05 Lungs 2.2E-06 1.2E-05 3.5E-05 6.7E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 Skin 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Spleen 6.5E-09 8.1E-08 3.1E-07 8.1E-07 8.3E-07 8.3E-07 8.3E-07 8.3E-07 8.3E-07 8.3E-07 Testes 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Thymus 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Thyroid 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Uterus 3.8E-10 2.3E-09 8.1E-09 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Remainder 8.3E-10 5.0E-09 1.8E-08 5.9E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 6.2E-08 Effective dose 2.7E-07 1.4E-06 4.2E-06 8.1E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: ET Airways, 6.9E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Bladder Wall 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Bone Surface 2.2E-09 2.6E-08 9.6E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Brain 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Breast 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 GI-Tract Oesophagus 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 St Wall 4.0E-09 6.0E-09 1.2E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 SI Wall 1.0E-08 1.2E-08 1.8E-08 3.0E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 ULI Wall 4.5E-08 6.3E-08 7.0E-08 8.3E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 8.4E-08 LLI Wall 4.8E-08 1.7E-07 1.8E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Colon 4.6E-08 1.1E-07 1.2E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Kidneys 5.4E-09 6.7E-08 2.5E-07 6.3E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Liver 3.6E-09 4.3E-08 1.6E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Muscle 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Ovaries 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Pancreas 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Red Marrow 2.4E-09 2.8E-08 1.1E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Respiratory Tract ET Airways 4.8E-07 3.2E-06 1.3E-05 6.3E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 6.9E-05 Lungs 1.6E-06 8.1E-06 2.4E-05 4.6E-05 4.7E-05 4.7E-05 4.7E-05 4.7E-05 4.7E-05 4.7E-05 Skin 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Spleen 6.6E-09 8.2E-08 3.1E-07 7.8E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Testes 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Thymus 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Thyroid 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Uterus 3.9E-10 2.3E-09 8.2E-09 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Remainder 2.4E-07 1.6E-06 6.3E-06 3.2E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Effective dose 2.1E-07 1.1E-06 3.3E-06 7.1E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 Po-210, 1-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: ET Airways, 6.4E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Bladder Wall 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Bone Surface 2.0E-09 2.3E-08 8.7E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Brain 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Breast 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 GI-Tract Oesophagus 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 St Wall 3.7E-09 5.5E-09 1.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 SI Wall 9.4E-09 1.1E-08 1.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 ULI Wall 4.2E-08 5.8E-08 6.4E-08 7.4E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 LLI Wall 4.4E-08 1.6E-07 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Colon 4.3E-08 1.0E-07 1.1E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Kidneys 5.0E-09 6.1E-08 2.3E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 Liver 3.3E-09 3.9E-08 1.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Muscle 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Ovaries 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Pancreas 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Red Marrow 2.2E-09 2.6E-08 9.6E-08 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Respiratory Tract ET Airways 4.4E-07 2.9E-06 1.2E-05 5.9E-05 6.4E-05 6.4E-05 6.4E-05 6.4E-05 6.4E-05 6.4E-05 Lungs 7.8E-07 3.8E-06 1.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Skin 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Spleen 6.1E-09 7.5E-08 2.8E-07 6.7E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 Testes 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Thymus 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Thyroid 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Uterus 3.5E-10 2.1E-09 7.4E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Remainder 2.2E-07 1.5E-06 5.8E-06 2.9E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 Effective dose 1.1E-07 5.5E-07 1.7E-06 4.0E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Po-210, 1-year-old member of the public Ingestion: f1 = 0.5 Highest committed equivalent dose coefficient: Spleen, 7.6E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 69 years Adrenals 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Bladder Wall 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Bone Surface 2.7E-07 2.8E-06 1.0E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Brain 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Breast 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 GI-Tract Oesophagus 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 St Wall 5.4E-08 2.6E-07 8.8E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 SI Wall 5.7E-08 2.7E-07 8.8E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 ULI Wall 1.0E-07 3.3E-07 9.5E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 LLI Wall 1.1E-07 4.6E-07 1.1E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Colon 1.1E-07 3.9E-07 1.0E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Kidneys 6.7E-07 7.3E-06 2.7E-05 6.2E-05 6.2E-05 6.2E-05 6.2E-05 6.2E-05 6.2E-05 6.2E-05 Liver 4.4E-07 4.7E-06 1.7E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 Muscle 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Ovaries 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Pancreas 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Red Marrow 3.0E-07 3.1E-06 1.1E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Respiratory Tract ET Airways 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Lungs 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Skin 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Spleen 8.2E-07 9.0E-06 3.3E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 Testes 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Thymus 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Thyroid 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Uterus 4.6E-08 2.6E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Remainder 4.4E-07 4.7E-06 1.7E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 Effective dose 1.3E-07 1.1E-06 3.9E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 2.7E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Bladder Wall 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 Bone Surface 8.1E-08 7.2E-07 2.6E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 Brain 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Breast 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 GI-Tract Oesophagus 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 St Wall 1.7E-08 8.6E-08 2.9E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 SI Wall 1.9E-08 8.8E-08 2.9E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 ULI Wall 2.7E-08 1.0E-07 3.1E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 LLI Wall 2.8E-08 1.3E-07 3.4E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 7.3E-07 Colon 2.8E-08 1.1E-07 3.2E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 Kidneys 2.8E-07 2.7E-06 9.8E-06 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Liver 1.7E-07 1.6E-06 5.8E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Muscle 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Ovaries 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Pancreas 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Red Marrow 1.1E-07 9.8E-07 3.6E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 Respiratory Tract ET Airways 3.2E-08 1.1E-07 3.1E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 Lungs 1.1E-07 1.7E-07 3.8E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 Skin 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Spleen 3.4E-07 3.2E-06 1.2E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Testes 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Thymus 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Thyroid 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Uterus 1.6E-08 8.6E-08 2.9E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Remainder 1.8E-07 1.7E-06 6.1E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Effective dose 5.6E-08 3.7E-07 1.3E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 3.7E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Bladder Wall 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Bone Surface 1.1E-07 9.6E-07 3.5E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 Brain 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Breast 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 GI-Tract Oesophagus 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 St Wall 2.3E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 SI Wall 2.4E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 ULI Wall 3.1E-08 1.3E-07 4.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 LLI Wall 3.2E-08 1.5E-07 4.4E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 9.6E-07 Colon 3.1E-08 1.4E-07 4.2E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 9.3E-07 Kidneys 3.8E-07 3.6E-06 1.3E-05 3.0E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Liver 2.3E-07 2.2E-06 7.8E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Muscle 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Ovaries 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Pancreas 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Red Marrow 1.5E-07 1.3E-06 4.8E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Respiratory Tract ET Airways 3.4E-08 1.3E-07 4.1E-07 9.0E-07 9.0E-07 9.0E-07 9.0E-07 9.0E-07 9.0E-07 9.0E-07 Lungs 2.9E-07 3.8E-07 6.5E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Skin 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Spleen 4.6E-07 4.3E-06 1.6E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 Testes 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Thymus 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Thyroid 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Uterus 2.2E-08 1.2E-07 3.9E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Remainder 2.4E-07 2.3E-06 8.2E-06 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Effective dose 9.2E-08 5.1E-07 1.7E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 5.1E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Bladder Wall 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Bone Surface 1.6E-07 1.4E-06 4.9E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Brain 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Breast 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 GI-Tract Oesophagus 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 St Wall 3.2E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 SI Wall 3.2E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 ULI Wall 3.6E-08 1.7E-07 5.6E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 LLI Wall 3.6E-08 1.8E-07 5.9E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Colon 3.6E-08 1.8E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Kidneys 5.4E-07 5.1E-06 1.9E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 Liver 3.3E-07 3.0E-06 1.1E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Muscle 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Ovaries 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Pancreas 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Red Marrow 2.1E-07 1.9E-06 6.7E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Respiratory Tract ET Airways 3.7E-08 1.7E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Lungs 4.5E-07 5.8E-07 9.6E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Skin 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Spleen 6.5E-07 6.1E-06 2.2E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Testes 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Thymus 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Thyroid 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Uterus 3.1E-08 1.6E-07 5.5E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Remainder 3.4E-07 3.2E-06 1.1E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Effective dose 1.3E-07 7.2E-07 2.5E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 5.4E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Bladder Wall 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Bone Surface 1.6E-07 1.4E-06 5.2E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Brain 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Breast 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 GI-Tract Oesophagus 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 St Wall 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 SI Wall 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 ULI Wall 3.5E-08 1.8E-07 5.9E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 LLI Wall 3.5E-08 1.8E-07 6.1E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Colon 3.5E-08 1.8E-07 6.0E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Kidneys 5.7E-07 5.4E-06 1.9E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 4.5E-05 Liver 3.5E-07 3.2E-06 1.2E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Muscle 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Ovaries 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Pancreas 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Red Marrow 2.2E-07 2.0E-06 7.1E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Respiratory Tract ET Airways 3.5E-08 1.7E-07 5.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Lungs 2.8E-07 4.2E-07 8.3E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Skin 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Spleen 6.8E-07 6.4E-06 2.3E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 Testes 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Thymus 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Thyroid 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Uterus 3.3E-08 1.7E-07 5.7E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Remainder 3.6E-07 3.3E-06 1.2E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Effective dose 1.2E-07 7.4E-07 2.6E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 3.2E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Bladder Wall 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Bone Surface 9.5E-08 8.3E-07 3.0E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 Brain 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Breast 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 GI-Tract Oesophagus 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 St Wall 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 SI Wall 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 ULI Wall 2.0E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 LLI Wall 2.0E-08 1.1E-07 3.5E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 Colon 2.0E-08 1.0E-07 3.5E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 Kidneys 3.3E-07 3.1E-06 1.1E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 2.6E-05 Liver 2.0E-07 1.9E-06 6.7E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Muscle 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Ovaries 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Pancreas 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Red Marrow 1.3E-07 1.1E-06 4.1E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 Respiratory Tract ET Airways 2.0E-08 1.0E-07 3.4E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Lungs 1.4E-07 2.2E-07 4.5E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Skin 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Spleen 4.0E-07 3.7E-06 1.4E-05 3.1E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 Testes 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Thymus 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Thyroid 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Uterus 1.9E-08 9.9E-08 3.3E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 7.6E-07 Remainder 2.1E-07 1.9E-06 7.0E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Effective dose 6.6E-08 4.3E-07 1.5E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 1.8E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Bladder Wall 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Bone Surface 5.5E-08 4.8E-07 1.7E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Brain 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Breast 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 GI-Tract Oesophagus 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 St Wall 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 SI Wall 1.2E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 ULI Wall 1.3E-08 6.1E-08 2.0E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 LLI Wall 1.3E-08 6.6E-08 2.1E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Colon 1.3E-08 6.3E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Kidneys 1.9E-07 1.8E-06 6.6E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Liver 1.2E-07 1.1E-06 3.9E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 Muscle 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Ovaries 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Pancreas 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Red Marrow 7.4E-08 6.6E-07 2.4E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 Respiratory Tract ET Airways 1.3E-08 6.1E-08 2.0E-07 4.4E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Lungs 6.9E-08 1.2E-07 2.5E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 Skin 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Spleen 2.3E-07 2.2E-06 7.9E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Testes 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Thymus 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Thyroid 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Uterus 1.1E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Remainder 1.2E-07 1.1E-06 4.1E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 Effective dose 3.7E-08 2.5E-07 8.6E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 2.0E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Bladder Wall 1.2E-08 6.4E-08 2.2E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Bone Surface 6.1E-08 5.3E-07 1.9E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 Brain 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Breast 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 GI-Tract Oesophagus 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 St Wall 1.3E-08 6.4E-08 2.2E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 SI Wall 1.3E-08 6.5E-08 2.2E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 ULI Wall 1.8E-08 7.2E-08 2.3E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 LLI Wall 1.8E-08 8.6E-08 2.4E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 Colon 1.8E-08 7.8E-08 2.3E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 Kidneys 2.1E-07 2.0E-06 7.3E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Liver 1.3E-07 1.2E-06 4.3E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Muscle 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Ovaries 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Pancreas 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Red Marrow 8.1E-08 7.3E-07 2.7E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Respiratory Tract ET Airways 1.8E-08 7.3E-08 2.2E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 Lungs 4.6E-08 9.7E-08 2.5E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 Skin 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Spleen 2.5E-07 2.4E-06 8.8E-06 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Testes 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Thymus 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Thyroid 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Uterus 1.2E-08 6.4E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Remainder 1.3E-07 1.2E-06 4.5E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Effective dose 3.8E-08 2.7E-07 9.5E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 2.5E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Bladder Wall 1.5E-08 7.8E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Bone Surface 7.4E-08 6.5E-07 2.3E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 Brain 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Breast 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 GI-Tract Oesophagus 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 St Wall 1.6E-08 7.8E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 SI Wall 1.7E-08 7.9E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 ULI Wall 2.4E-08 9.1E-08 2.8E-07 6.1E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 LLI Wall 2.5E-08 1.1E-07 3.1E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 Colon 2.4E-08 1.0E-07 2.9E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 Kidneys 2.6E-07 2.4E-06 8.8E-06 2.0E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Liver 1.6E-07 1.4E-06 5.3E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Muscle 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Ovaries 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Pancreas 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Red Marrow 9.8E-08 8.9E-07 3.2E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 Respiratory Tract ET Airways 2.6E-08 9.3E-08 2.8E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 Lungs 4.3E-08 1.1E-07 2.9E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 6.2E-07 Skin 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Spleen 3.1E-07 2.9E-06 1.1E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Testes 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Thymus 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Thyroid 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Uterus 1.5E-08 7.7E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Remainder 1.6E-07 1.5E-06 5.5E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Effective dose 4.5E-08 3.3E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 2.4E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Bladder Wall 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Bone Surface 7.1E-08 6.2E-07 2.3E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 Brain 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Breast 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 GI-Tract Oesophagus 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 St Wall 1.5E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 SI Wall 1.6E-08 7.7E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 ULI Wall 2.4E-08 8.8E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 LLI Wall 2.5E-08 1.1E-07 3.0E-07 6.3E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Colon 2.4E-08 9.9E-08 2.8E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 Kidneys 2.5E-07 2.3E-06 8.5E-06 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Liver 1.5E-07 1.4E-06 5.1E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Muscle 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Ovaries 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Pancreas 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Red Marrow 9.5E-08 8.5E-07 3.1E-06 7.2E-06 7.2E-06 7.2E-06 7.2E-06 7.2E-06 7.2E-06 7.2E-06 Respiratory Tract ET Airways 2.6E-08 9.2E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Lungs 3.8E-08 9.8E-08 2.7E-07 5.9E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 Skin 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Spleen 3.0E-07 2.8E-06 1.0E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Testes 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Thymus 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Thyroid 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Uterus 1.4E-08 7.5E-08 2.5E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Remainder 1.6E-07 1.5E-06 5.3E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Effective dose 4.3E-08 3.1E-07 1.1E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 2.0E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Bladder Wall 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Bone Surface 6.0E-08 5.3E-07 1.9E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 Brain 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Breast 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 GI-Tract Oesophagus 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 St Wall 1.3E-08 6.4E-08 2.1E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 SI Wall 1.4E-08 6.5E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 ULI Wall 2.1E-08 7.6E-08 2.3E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 LLI Wall 2.2E-08 1.0E-07 2.6E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Colon 2.2E-08 8.7E-08 2.4E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 Kidneys 2.1E-07 2.0E-06 7.2E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Liver 1.3E-07 1.2E-06 4.3E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Muscle 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Ovaries 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Pancreas 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Red Marrow 8.0E-08 7.3E-07 2.6E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Respiratory Tract ET Airways 2.4E-08 8.1E-08 2.3E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 Lungs 2.7E-08 7.8E-08 2.3E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 Skin 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Spleen 2.5E-07 2.4E-06 8.7E-06 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Testes 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Thymus 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Thyroid 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Uterus 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Remainder 1.3E-07 1.2E-06 4.5E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Effective dose 3.6E-08 2.7E-07 9.4E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bladder Wall 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bone Surface 1.6E-08 1.7E-07 6.3E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Brain 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Breast 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 GI-Tract Oesophagus 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 St Wall 5.4E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 SI Wall 8.3E-09 2.5E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 2.5E-08 5.0E-08 1.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 LLI Wall 2.7E-08 1.0E-07 1.6E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Colon 2.6E-08 7.4E-08 1.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Kidneys 5.6E-08 6.2E-07 2.4E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 Liver 3.4E-08 3.7E-07 1.4E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 Muscle 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Ovaries 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Pancreas 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Red Marrow 2.2E-08 2.3E-07 8.6E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Respiratory Tract ET Airways 2.3E-07 1.5E-06 5.6E-06 1.9E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Lungs 5.3E-06 2.9E-05 8.1E-05 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 Skin 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Spleen 6.7E-08 7.5E-07 2.8E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Testes 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thymus 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thyroid 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Uterus 3.5E-09 2.0E-08 7.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Remainder 4.7E-09 3.2E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Effective dose 6.4E-07 3.5E-06 1.0E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Bladder Wall 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Bone Surface 1.8E-08 1.9E-07 7.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Brain 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Breast 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 GI-Tract Oesophagus 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 St Wall 5.7E-09 2.5E-08 8.7E-08 2.2E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 SI Wall 8.5E-09 2.8E-08 9.1E-08 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 ULI Wall 2.4E-08 5.3E-08 1.2E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 LLI Wall 2.5E-08 1.1E-07 1.8E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Colon 2.5E-08 7.7E-08 1.5E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Kidneys 6.4E-08 7.2E-07 2.9E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 Liver 3.9E-08 4.3E-07 1.7E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Muscle 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Ovaries 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Pancreas 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Red Marrow 2.5E-08 2.6E-07 1.1E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Respiratory Tract ET Airways 1.9E-07 1.2E-06 4.6E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Lungs 1.6E-05 8.4E-05 2.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 Skin 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Spleen 7.6E-08 8.7E-07 3.5E-06 9.2E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 Testes 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Thymus 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Thyroid 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Uterus 3.9E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Remainder 5.2E-09 3.7E-08 1.4E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Effective dose 2.0E-06 1.0E-05 2.8E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 5.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Bladder Wall 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Bone Surface 2.0E-08 2.2E-07 9.5E-07 3.3E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Brain 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Breast 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 GI-Tract Oesophagus 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 St Wall 5.6E-09 2.8E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 SI Wall 7.5E-09 3.0E-08 1.1E-07 3.7E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 ULI Wall 1.8E-08 5.0E-08 1.4E-07 4.0E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 LLI Wall 1.7E-08 9.3E-08 1.9E-07 4.7E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Colon 1.7E-08 6.8E-08 1.6E-07 4.3E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Kidneys 7.1E-08 8.2E-07 3.6E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Liver 4.3E-08 4.9E-07 2.1E-06 7.5E-06 7.6E-06 7.6E-06 7.6E-06 7.6E-06 7.6E-06 7.6E-06 Muscle 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Ovaries 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Pancreas 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Red Marrow 2.7E-08 3.0E-07 1.3E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Respiratory Tract ET Airways 9.9E-08 6.4E-07 2.4E-06 8.4E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 Lungs 2.7E-05 1.3E-04 3.6E-04 5.3E-04 5.3E-04 5.3E-04 5.3E-04 5.3E-04 5.3E-04 5.3E-04 Skin 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Spleen 8.4E-08 9.8E-07 4.3E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Testes 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Thymus 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Thyroid 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Uterus 4.3E-09 2.6E-08 1.1E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Remainder 5.6E-09 4.1E-08 1.7E-07 6.0E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 Effective dose 3.3E-06 1.6E-05 4.4E-05 6.4E-05 6.5E-05 6.5E-05 6.5E-05 6.5E-05 6.5E-05 6.5E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.5E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Bladder Wall 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Bone Surface 1.9E-08 2.0E-07 9.3E-07 4.3E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 Brain 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Breast 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 GI-Tract Oesophagus 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 St Wall 4.5E-09 2.4E-08 1.1E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 SI Wall 5.4E-09 2.6E-08 1.1E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 ULI Wall 9.9E-09 3.6E-08 1.2E-07 5.1E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 LLI Wall 9.6E-09 5.8E-08 1.6E-07 5.6E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Colon 9.8E-09 4.6E-08 1.4E-07 5.3E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Kidneys 6.5E-08 7.3E-07 3.5E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Liver 4.0E-08 4.4E-07 2.1E-06 9.8E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Muscle 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Ovaries 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Pancreas 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Red Marrow 2.5E-08 2.7E-07 1.3E-06 6.0E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Respiratory Tract ET Airways 4.2E-08 2.7E-07 1.0E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Lungs 1.7E-05 8.1E-05 2.2E-04 3.5E-04 3.5E-04 3.5E-04 3.5E-04 3.5E-04 3.5E-04 3.5E-04 Skin 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Spleen 7.8E-08 8.8E-07 4.2E-06 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Testes 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Thymus 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Thyroid 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Uterus 3.9E-09 2.4E-08 1.0E-07 4.8E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Remainder 5.1E-09 3.7E-08 1.7E-07 7.8E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 Effective dose 2.0E-06 9.8E-06 2.7E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.8E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Bladder Wall 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Bone Surface 1.1E-08 1.1E-07 5.3E-07 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Brain 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Breast 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 GI-Tract Oesophagus 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 St Wall 2.5E-09 1.4E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 SI Wall 2.9E-09 1.4E-08 6.1E-08 2.9E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 ULI Wall 5.0E-09 1.9E-08 6.9E-08 3.0E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 LLI Wall 4.9E-09 3.0E-08 8.6E-08 3.3E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Colon 4.9E-09 2.4E-08 7.6E-08 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Kidneys 3.7E-08 4.1E-07 2.0E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Liver 2.3E-08 2.5E-07 1.2E-06 5.9E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Muscle 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Ovaries 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Pancreas 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Red Marrow 1.4E-08 1.5E-07 7.3E-07 3.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Respiratory Tract ET Airways 2.0E-08 1.3E-07 4.9E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Lungs 8.1E-06 3.9E-05 1.1E-04 1.7E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 1.8E-04 Skin 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Spleen 4.4E-08 5.0E-07 2.4E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Testes 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Thymus 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Thyroid 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Uterus 2.2E-09 1.3E-08 6.0E-08 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Remainder 2.9E-09 2.1E-08 9.7E-08 4.7E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Effective dose 9.8E-07 4.8E-06 1.3E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 8.6E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bladder Wall 1.4E-09 8.6E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bone Surface 6.9E-09 7.1E-08 3.3E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Brain 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Breast 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 GI-Tract Oesophagus 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 St Wall 1.8E-09 8.9E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 SI Wall 2.2E-09 9.5E-09 3.8E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 5.0E-09 1.4E-08 4.4E-08 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 LLI Wall 5.1E-09 2.5E-08 5.8E-08 1.9E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Colon 5.0E-09 1.9E-08 5.0E-08 1.8E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Kidneys 2.4E-08 2.7E-07 1.2E-06 5.7E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 Liver 1.5E-08 1.6E-07 7.4E-07 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Muscle 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Ovaries 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Pancreas 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Red Marrow 9.2E-09 9.7E-08 4.5E-07 2.0E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Respiratory Tract ET Airways 3.4E-08 2.2E-07 8.4E-07 2.9E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 Lungs 3.9E-06 1.9E-05 5.4E-05 8.5E-05 8.6E-05 8.6E-05 8.6E-05 8.6E-05 8.6E-05 8.6E-05 Skin 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Spleen 2.9E-08 3.2E-07 1.5E-06 6.8E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 Testes 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thymus 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thyroid 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Uterus 1.4E-09 8.5E-09 3.7E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Remainder 1.9E-09 1.4E-08 6.0E-08 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Effective dose 4.7E-07 2.3E-06 6.6E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 5.1E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Bladder Wall 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Bone Surface 1.0E-08 1.0E-07 4.2E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Brain 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Breast 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 GI-Tract Oesophagus 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 St Wall 3.0E-09 1.3E-08 4.8E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 SI Wall 4.4E-09 1.5E-08 4.9E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 1.3E-08 2.7E-08 6.3E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 LLI Wall 1.3E-08 5.4E-08 9.2E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Colon 1.3E-08 3.8E-08 7.6E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Kidneys 3.5E-08 3.8E-07 1.6E-06 5.6E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Liver 2.1E-08 2.3E-07 9.4E-07 3.3E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Muscle 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Ovaries 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Pancreas 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Red Marrow 1.3E-08 1.4E-07 5.8E-07 2.0E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Respiratory Tract ET Airways 1.1E-07 7.5E-07 2.8E-06 9.7E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 Lungs 2.2E-06 1.1E-05 3.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Skin 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Spleen 4.2E-08 4.6E-07 1.9E-06 6.7E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 Testes 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Thymus 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Thyroid 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Uterus 2.1E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Remainder 2.8E-09 2.0E-08 7.7E-08 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Effective dose 2.6E-07 1.4E-06 3.9E-06 6.6E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.9E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Bladder Wall 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Bone Surface 1.4E-08 1.4E-07 5.5E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Brain 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Breast 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 GI-Tract Oesophagus 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 St Wall 4.5E-09 1.9E-08 6.3E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 SI Wall 6.8E-09 2.1E-08 6.5E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 ULI Wall 2.1E-08 4.1E-08 8.7E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 LLI Wall 2.2E-08 8.5E-08 1.3E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Colon 2.1E-08 6.0E-08 1.1E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Kidneys 4.8E-08 5.3E-07 2.1E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 Liver 2.9E-08 3.2E-07 1.2E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Muscle 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Ovaries 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Pancreas 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Red Marrow 1.9E-08 1.9E-07 7.6E-07 2.2E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Respiratory Tract ET Airways 1.9E-07 1.3E-06 4.8E-06 1.6E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Lungs 1.7E-06 8.4E-06 2.4E-05 3.8E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 Skin 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Spleen 5.8E-08 6.4E-07 2.5E-06 7.4E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 Testes 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Thymus 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Thyroid 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Uterus 3.0E-09 1.7E-08 6.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Remainder 4.0E-09 2.7E-08 1.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Effective dose 2.1E-07 1.1E-06 3.1E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 5.2E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.8E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bladder Wall 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bone Surface 1.4E-08 1.4E-07 5.5E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Brain 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Breast 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 GI-Tract Oesophagus 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 St Wall 4.6E-09 1.9E-08 6.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 SI Wall 7.1E-09 2.1E-08 6.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 2.2E-08 4.3E-08 8.7E-08 1.9E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 LLI Wall 2.3E-08 8.9E-08 1.4E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Colon 2.2E-08 6.3E-08 1.1E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Kidneys 4.9E-08 5.4E-07 2.1E-06 5.7E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 5.8E-06 Liver 3.0E-08 3.2E-07 1.2E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Muscle 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Ovaries 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Pancreas 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Red Marrow 1.9E-08 2.0E-07 7.5E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Respiratory Tract ET Airways 2.1E-07 1.4E-06 5.1E-06 1.7E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Lungs 1.3E-06 6.3E-06 1.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Skin 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Spleen 5.8E-08 6.4E-07 2.5E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 Testes 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thymus 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thyroid 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Uterus 3.0E-09 1.7E-08 6.1E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Remainder 4.0E-09 2.8E-08 1.0E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Effective dose 1.6E-07 8.1E-07 2.3E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: ET Airways, 1.7E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Bladder Wall 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Bone Surface 1.3E-08 1.3E-07 4.8E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Brain 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Breast 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 GI-Tract Oesophagus 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 St Wall 4.2E-09 1.7E-08 5.5E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 SI Wall 6.6E-09 1.9E-08 5.7E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 ULI Wall 2.0E-08 3.9E-08 7.8E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 LLI Wall 2.2E-08 8.3E-08 1.2E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Colon 2.1E-08 5.8E-08 9.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Kidneys 4.4E-08 4.8E-07 1.8E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Liver 2.7E-08 2.9E-07 1.1E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Muscle 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Ovaries 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Pancreas 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Red Marrow 1.7E-08 1.8E-07 6.6E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Respiratory Tract ET Airways 2.0E-07 1.3E-06 4.9E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Lungs 7.0E-07 3.2E-06 8.8E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Skin 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Spleen 5.2E-08 5.8E-07 2.2E-06 5.5E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 Testes 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Thymus 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Thyroid 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Uterus 2.7E-09 1.5E-08 5.3E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Remainder 1.0E-07 6.6E-07 2.5E-06 8.4E-06 8.6E-06 8.6E-06 8.6E-06 8.6E-06 8.6E-06 8.6E-06 Effective dose 9.6E-08 4.6E-07 1.4E-06 2.5E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.5E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Bladder Wall 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Bone Surface 9.5E-10 1.1E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Brain 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Breast 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 GI-Tract Oesophagus 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 St Wall 2.2E-09 3.3E-09 6.7E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 SI Wall 5.8E-09 7.0E-09 1.1E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 ULI Wall 2.5E-08 3.6E-08 4.1E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 LLI Wall 2.7E-08 9.9E-08 1.1E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Colon 2.6E-08 6.3E-08 6.9E-08 7.7E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 Kidneys 3.3E-09 4.1E-08 1.6E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Liver 2.0E-09 2.5E-08 9.4E-08 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Muscle 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Ovaries 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Pancreas 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Red Marrow 1.3E-09 1.5E-08 5.7E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Respiratory Tract ET Airways 2.5E-07 1.7E-06 6.6E-06 3.5E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 3.8E-05 Lungs 5.9E-06 3.3E-05 9.6E-05 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 Skin 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Spleen 3.9E-09 4.9E-08 1.9E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Testes 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Thymus 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Thyroid 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Uterus 2.1E-10 1.3E-09 4.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Remainder 4.9E-10 2.9E-09 1.1E-08 3.4E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Effective dose 7.1E-07 3.9E-06 1.2E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 4.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Bladder Wall 2.1E-10 1.4E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Bone Surface 9.1E-10 1.1E-08 4.5E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Brain 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Breast 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 GI-Tract Oesophagus 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 St Wall 2.1E-09 3.4E-09 7.3E-09 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 SI Wall 5.6E-09 7.1E-09 1.1E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 ULI Wall 2.3E-08 3.6E-08 4.3E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 LLI Wall 2.4E-08 1.0E-07 1.1E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Colon 2.4E-08 6.4E-08 7.4E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Kidneys 3.1E-09 4.2E-08 1.7E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Liver 1.9E-09 2.5E-08 1.0E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Muscle 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Ovaries 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Pancreas 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Red Marrow 1.2E-09 1.5E-08 6.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Respiratory Tract ET Airways 2.1E-07 1.4E-06 5.4E-06 2.8E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Lungs 1.8E-05 9.4E-05 2.7E-04 4.2E-04 4.2E-04 4.2E-04 4.2E-04 4.2E-04 4.2E-04 4.2E-04 Skin 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Spleen 3.7E-09 5.0E-08 2.0E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 Testes 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Thymus 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Thyroid 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Uterus 2.1E-10 1.3E-09 5.0E-09 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Remainder 4.5E-10 2.8E-09 1.1E-08 3.4E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Effective dose 2.2E-06 1.1E-05 3.3E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 6.8E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Bladder Wall 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Bone Surface 6.6E-10 9.4E-09 4.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Brain 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Breast 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 GI-Tract Oesophagus 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 St Wall 1.6E-09 2.8E-09 6.7E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 SI Wall 3.9E-09 5.8E-09 1.0E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 ULI Wall 1.6E-08 2.9E-08 3.9E-08 5.7E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 LLI Wall 1.5E-08 7.9E-08 1.0E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Colon 1.5E-08 5.1E-08 6.6E-08 8.9E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 Kidneys 2.2E-09 3.5E-08 1.6E-07 5.9E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 Liver 1.4E-09 2.1E-08 9.5E-08 3.5E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Muscle 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Ovaries 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Pancreas 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Red Marrow 8.7E-10 1.3E-08 5.8E-08 2.1E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Respiratory Tract ET Airways 1.1E-07 7.0E-07 2.8E-06 1.4E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Lungs 3.0E-05 1.5E-04 4.3E-04 6.8E-04 6.8E-04 6.8E-04 6.8E-04 6.8E-04 6.8E-04 6.8E-04 Skin 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Spleen 2.7E-09 4.2E-08 1.9E-07 7.1E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 Testes 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Thymus 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Thyroid 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Uterus 1.5E-10 1.1E-09 4.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Remainder 3.1E-10 2.2E-09 9.0E-09 3.4E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Effective dose 3.6E-06 1.8E-05 5.1E-05 8.1E-05 8.2E-05 8.2E-05 8.2E-05 8.2E-05 8.2E-05 8.2E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 4.7E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Bladder Wall 8.8E-11 6.9E-10 3.4E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Bone Surface 3.9E-10 5.7E-09 3.0E-08 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Brain 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Breast 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 GI-Tract Oesophagus 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 St Wall 7.6E-10 1.6E-09 4.6E-09 2.0E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 SI Wall 1.9E-09 3.1E-09 6.7E-09 2.3E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 ULI Wall 7.1E-09 1.5E-08 2.4E-08 4.7E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 LLI Wall 6.7E-09 4.1E-08 6.1E-08 9.9E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Colon 6.9E-09 2.6E-08 4.0E-08 6.9E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 Kidneys 1.3E-09 2.1E-08 1.1E-07 6.4E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 7.0E-07 Liver 8.1E-10 1.3E-08 6.7E-08 3.8E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Muscle 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Ovaries 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Pancreas 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Red Marrow 5.2E-10 7.8E-09 4.1E-08 2.3E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Respiratory Tract ET Airways 4.2E-08 2.8E-07 1.1E-06 5.8E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 Lungs 1.9E-05 9.1E-05 2.6E-04 4.6E-04 4.7E-04 4.7E-04 4.7E-04 4.7E-04 4.7E-04 4.7E-04 Skin 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Spleen 1.6E-09 2.6E-08 1.4E-07 7.7E-07 8.3E-07 8.3E-07 8.3E-07 8.3E-07 8.3E-07 8.3E-07 Testes 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Thymus 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Thyroid 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Uterus 8.8E-11 6.9E-10 3.3E-09 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Remainder 1.6E-10 1.3E-09 6.0E-09 3.3E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 3.6E-08 Effective dose 2.2E-06 1.1E-05 3.2E-05 5.5E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 5.7E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 2.4E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Bladder Wall 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Bone Surface 2.0E-10 2.9E-09 1.6E-08 9.9E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Brain 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Breast 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 GI-Tract Oesophagus 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 St Wall 3.6E-10 7.8E-10 2.4E-09 1.2E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 SI Wall 8.9E-10 1.5E-09 3.5E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 ULI Wall 3.3E-09 7.4E-09 1.2E-08 2.6E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 LLI Wall 3.1E-09 2.0E-08 3.1E-08 5.3E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Colon 3.2E-09 1.3E-08 2.0E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Kidneys 6.9E-10 1.1E-08 6.0E-08 3.8E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Liver 4.2E-10 6.5E-09 3.6E-08 2.2E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Muscle 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Ovaries 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Pancreas 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Red Marrow 2.7E-10 4.0E-09 2.2E-08 1.4E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Respiratory Tract ET Airways 1.9E-08 1.3E-07 5.1E-07 2.7E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 Lungs 9.0E-06 4.4E-05 1.3E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 2.4E-04 Skin 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Spleen 8.2E-10 1.3E-08 7.2E-08 4.5E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Testes 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Thymus 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Thyroid 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Uterus 4.5E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Remainder 8.1E-11 6.3E-10 3.1E-09 1.9E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Effective dose 1.1E-06 5.3E-06 1.6E-05 2.8E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 2.9E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Bladder Wall 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Bone Surface 1.9E-10 2.5E-09 1.2E-08 6.0E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Brain 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Breast 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 GI-Tract Oesophagus 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 St Wall 3.9E-10 7.0E-10 1.8E-09 7.2E-09 7.7E-09 7.7E-09 7.7E-09 7.7E-09 7.7E-09 7.7E-09 SI Wall 9.9E-10 1.4E-09 2.7E-09 8.3E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 ULI Wall 4.1E-09 7.0E-09 9.7E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 LLI Wall 4.2E-09 1.9E-08 2.5E-08 3.7E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 Colon 4.1E-09 1.2E-08 1.6E-08 2.6E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Kidneys 6.6E-10 9.3E-09 4.5E-08 2.3E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Liver 4.1E-10 5.6E-09 2.7E-08 1.4E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Muscle 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Ovaries 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Pancreas 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Red Marrow 2.6E-10 3.4E-09 1.6E-08 8.2E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 Respiratory Tract ET Airways 3.6E-08 2.4E-07 9.5E-07 5.0E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 Lungs 4.3E-06 2.1E-05 6.3E-05 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 1.2E-04 Skin 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Spleen 7.9E-10 1.1E-08 5.4E-08 2.7E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Testes 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Thymus 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Thyroid 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Uterus 4.3E-11 3.0E-10 1.3E-09 6.6E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 7.1E-09 Remainder 8.9E-11 6.0E-10 2.6E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 Effective dose 5.2E-07 2.6E-06 7.6E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 7.2E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Bladder Wall 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Bone Surface 4.8E-10 5.6E-09 2.2E-08 7.4E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 Brain 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Breast 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 GI-Tract Oesophagus 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 St Wall 1.1E-09 1.7E-09 3.5E-09 9.3E-09 9.6E-09 9.6E-09 9.6E-09 9.6E-09 9.6E-09 9.6E-09 SI Wall 2.8E-09 3.4E-09 5.4E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 ULI Wall 1.2E-08 1.8E-08 2.0E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 LLI Wall 1.3E-08 4.8E-08 5.3E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Colon 1.2E-08 3.1E-08 3.5E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Kidneys 1.7E-09 2.1E-08 8.4E-08 2.8E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Liver 1.0E-09 1.2E-08 5.0E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Muscle 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Ovaries 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Pancreas 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Red Marrow 6.4E-10 7.6E-09 3.1E-08 1.0E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Respiratory Tract ET Airways 1.2E-07 8.3E-07 3.3E-06 1.7E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Lungs 2.4E-06 1.2E-05 3.7E-05 7.0E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 7.2E-05 Skin 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Spleen 2.0E-09 2.5E-08 1.0E-07 3.4E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Testes 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Thymus 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Thyroid 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Uterus 1.1E-10 6.7E-10 2.5E-09 8.1E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 8.5E-09 Remainder 2.4E-10 1.5E-09 5.6E-09 2.1E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 Effective dose 2.9E-07 1.5E-06 4.4E-06 8.4E-06 8.6E-06 8.6E-06 8.6E-06 8.6E-06 8.6E-06 8.6E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 5.4E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Bladder Wall 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Bone Surface 7.8E-10 8.9E-09 3.4E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Brain 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Breast 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 GI-Tract Oesophagus 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 St Wall 1.8E-09 2.7E-09 5.5E-09 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 SI Wall 4.6E-09 5.6E-09 8.5E-09 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 ULI Wall 2.0E-08 2.9E-08 3.2E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 LLI Wall 2.2E-08 7.9E-08 8.4E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Colon 2.1E-08 5.0E-08 5.5E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Kidneys 2.7E-09 3.3E-08 1.3E-07 3.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Liver 1.6E-09 2.0E-08 7.6E-08 2.1E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Muscle 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Ovaries 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Pancreas 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Red Marrow 1.0E-09 1.2E-08 4.7E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Respiratory Tract ET Airways 2.1E-07 1.4E-06 5.6E-06 2.9E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 Lungs 1.9E-06 9.4E-06 2.8E-05 5.2E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 5.4E-05 Skin 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Spleen 3.2E-09 4.0E-08 1.5E-07 4.3E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Testes 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Thymus 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Thyroid 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Uterus 1.7E-10 1.1E-09 3.8E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Remainder 4.0E-10 2.4E-09 8.7E-09 3.0E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 Effective dose 2.3E-07 1.1E-06 3.4E-06 6.3E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.9E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Bladder Wall 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Bone Surface 8.2E-10 9.3E-09 3.5E-08 9.3E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 Brain 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Breast 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 GI-Tract Oesophagus 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 St Wall 1.9E-09 2.8E-09 5.7E-09 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 SI Wall 4.9E-09 5.9E-09 8.8E-09 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 ULI Wall 2.2E-08 3.0E-08 3.4E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 LLI Wall 2.3E-08 8.4E-08 8.9E-08 9.7E-08 9.8E-08 9.8E-08 9.8E-08 9.8E-08 9.8E-08 9.8E-08 Colon 2.2E-08 5.3E-08 5.7E-08 6.5E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 Kidneys 2.8E-09 3.5E-08 1.3E-07 3.5E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Liver 1.7E-09 2.1E-08 7.9E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Muscle 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Ovaries 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Pancreas 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Red Marrow 1.1E-09 1.3E-08 4.9E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Respiratory Tract ET Airways 2.3E-07 1.5E-06 6.0E-06 3.1E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Lungs 1.4E-06 7.1E-06 2.1E-05 3.8E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 Skin 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Spleen 3.4E-09 4.2E-08 1.6E-07 4.2E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Testes 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Thymus 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Thyroid 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Uterus 1.8E-10 1.1E-09 3.9E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 Remainder 4.2E-10 2.5E-09 9.1E-09 3.1E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 Effective dose 1.8E-07 8.6E-07 2.5E-06 4.7E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 Po-210, 5-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: ET Airways, 3.3E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Bladder Wall 1.7E-10 1.0E-09 3.6E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Bone Surface 7.7E-10 8.7E-09 3.3E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Brain 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Breast 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 GI-Tract Oesophagus 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 St Wall 1.8E-09 2.7E-09 5.3E-09 1.0E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 SI Wall 4.7E-09 5.6E-09 8.2E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 ULI Wall 2.0E-08 2.9E-08 3.2E-08 3.7E-08 3.7E-08 3.7E-08 3.7E-08 3.7E-08 3.7E-08 3.7E-08 LLI Wall 2.2E-08 7.9E-08 8.3E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 Colon 2.1E-08 5.0E-08 5.4E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 Kidneys 2.7E-09 3.3E-08 1.2E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Liver 1.6E-09 2.0E-08 7.4E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Muscle 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Ovaries 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Pancreas 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Red Marrow 1.0E-09 1.2E-08 4.5E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Respiratory Tract ET Airways 2.2E-07 1.4E-06 5.7E-06 3.0E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 Lungs 7.7E-07 3.5E-06 1.0E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Skin 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Spleen 3.2E-09 3.9E-08 1.5E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Testes 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Thymus 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Thyroid 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Uterus 1.7E-10 1.0E-09 3.6E-09 8.8E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 Remainder 1.1E-07 7.2E-07 2.9E-06 1.5E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Effective dose 1.0E-07 4.7E-07 1.4E-06 3.0E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Po-210, 5-year-old member of the public Ingestion: f1 = 0.5 Highest committed equivalent dose coefficient: Spleen, 4.1E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 65 years Adrenals 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Bladder Wall 2.3E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Bone Surface 1.0E-07 1.1E-06 3.8E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 Brain 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Breast 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 GI-Tract Oesophagus 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 St Wall 2.7E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 SI Wall 2.8E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 ULI Wall 5.0E-08 1.6E-07 4.7E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 LLI Wall 5.5E-08 2.3E-07 5.5E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Colon 5.2E-08 1.9E-07 5.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Kidneys 3.6E-07 3.9E-06 1.5E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 3.4E-05 Liver 2.2E-07 2.4E-06 8.7E-06 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Muscle 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Ovaries 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Pancreas 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Red Marrow 1.4E-07 1.4E-06 5.3E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Respiratory Tract ET Airways 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Lungs 2.3E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Skin 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Spleen 4.3E-07 4.7E-06 1.7E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 4.1E-05 Testes 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Thymus 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Thyroid 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Uterus 2.2E-08 1.3E-07 4.3E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Remainder 2.3E-07 2.5E-06 9.0E-06 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Effective dose 6.2E-08 5.3E-07 1.9E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 1.7E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Bladder Wall 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Bone Surface 4.5E-08 3.9E-07 1.4E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Brain 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Breast 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 GI-Tract Oesophagus 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 St Wall 1.1E-08 5.3E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 SI Wall 1.1E-08 5.4E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 ULI Wall 1.6E-08 6.1E-08 1.9E-07 4.1E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 4.2E-07 LLI Wall 1.7E-08 7.8E-08 2.1E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Colon 1.7E-08 6.8E-08 2.0E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Kidneys 1.9E-07 1.8E-06 6.7E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Liver 1.2E-07 1.1E-06 3.9E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 Muscle 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Ovaries 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Pancreas 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Red Marrow 5.9E-08 5.3E-07 1.9E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 4.4E-06 Respiratory Tract ET Airways 2.0E-08 6.7E-08 1.9E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Lungs 8.7E-08 1.3E-07 2.5E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Skin 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Spleen 2.2E-07 2.1E-06 7.5E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Testes 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Thymus 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Thyroid 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Uterus 1.0E-08 5.2E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Remainder 1.1E-07 1.1E-06 3.9E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 9.0E-06 Effective dose 3.7E-08 2.3E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 2.4E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Bladder Wall 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Bone Surface 6.2E-08 5.3E-07 1.9E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 Brain 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Breast 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 GI-Tract Oesophagus 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 St Wall 1.4E-08 7.2E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 SI Wall 1.5E-08 7.2E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 ULI Wall 1.9E-08 7.9E-08 2.5E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 5.6E-07 LLI Wall 1.9E-08 9.3E-08 2.7E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 Colon 1.9E-08 8.5E-08 2.6E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 5.7E-07 Kidneys 2.7E-07 2.5E-06 9.1E-06 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Liver 1.6E-07 1.5E-06 5.4E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Muscle 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Ovaries 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Pancreas 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Red Marrow 8.1E-08 7.2E-07 2.6E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 Respiratory Tract ET Airways 2.1E-08 8.2E-08 2.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 Lungs 2.2E-07 2.8E-07 4.4E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 Skin 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Spleen 3.0E-07 2.8E-06 1.0E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Testes 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Thymus 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Thyroid 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Uterus 1.4E-08 7.1E-08 2.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Remainder 1.6E-07 1.5E-06 5.3E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Effective dose 6.2E-08 3.2E-07 1.1E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 3.3E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Bladder Wall 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Bone Surface 8.7E-08 7.6E-07 2.7E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 Brain 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Breast 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 GI-Tract Oesophagus 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 St Wall 2.0E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 SI Wall 2.0E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 ULI Wall 2.2E-08 1.1E-07 3.5E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 LLI Wall 2.2E-08 1.1E-07 3.6E-07 8.1E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 Colon 2.2E-08 1.1E-07 3.5E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 Kidneys 3.8E-07 3.5E-06 1.3E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 Liver 2.3E-07 2.1E-06 7.6E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Muscle 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Ovaries 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Pancreas 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Red Marrow 1.1E-07 1.0E-06 3.7E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 Respiratory Tract ET Airways 2.3E-08 1.1E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Lungs 3.0E-07 3.8E-07 6.2E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Skin 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Spleen 4.2E-07 4.0E-06 1.4E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 Testes 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Thymus 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Thyroid 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Uterus 1.9E-08 1.0E-07 3.4E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Remainder 2.2E-07 2.0E-06 7.4E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Effective dose 8.6E-08 4.5E-07 1.5E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 3.5E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Bladder Wall 2.0E-08 1.0E-07 3.5E-07 7.9E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 Bone Surface 9.1E-08 7.8E-07 2.8E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Brain 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Breast 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 GI-Tract Oesophagus 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 St Wall 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 SI Wall 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 ULI Wall 2.1E-08 1.1E-07 3.6E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 LLI Wall 2.1E-08 1.1E-07 3.7E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 Colon 2.1E-08 1.1E-07 3.6E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 Kidneys 3.9E-07 3.7E-06 1.3E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Liver 2.3E-07 2.2E-06 7.8E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Muscle 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Ovaries 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Pancreas 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Red Marrow 1.2E-07 1.0E-06 3.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 Respiratory Tract ET Airways 2.2E-08 1.1E-07 3.5E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 Lungs 1.8E-07 2.6E-07 5.1E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 Skin 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Spleen 4.3E-07 4.1E-06 1.5E-05 3.4E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Testes 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Thymus 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Thyroid 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Uterus 2.0E-08 1.0E-07 3.5E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Remainder 2.3E-07 2.1E-06 7.7E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Effective dose 7.3E-08 4.5E-07 1.5E-06 3.5E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 1.9E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Bladder Wall 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Bone Surface 4.9E-08 4.3E-07 1.5E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Brain 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Breast 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 GI-Tract Oesophagus 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 St Wall 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 SI Wall 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 ULI Wall 1.2E-08 5.8E-08 1.9E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 LLI Wall 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Colon 1.2E-08 5.9E-08 2.0E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Kidneys 2.1E-07 2.0E-06 7.3E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Liver 1.3E-07 1.2E-06 4.3E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 9.9E-06 Muscle 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Ovaries 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Pancreas 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Red Marrow 6.5E-08 5.7E-07 2.1E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 Respiratory Tract ET Airways 1.2E-08 5.8E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Lungs 8.7E-08 1.3E-07 2.7E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 Skin 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Spleen 2.4E-07 2.2E-06 8.1E-06 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Testes 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Thymus 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Thyroid 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Uterus 1.1E-08 5.7E-08 1.9E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Remainder 1.3E-07 1.2E-06 4.2E-06 9.7E-06 9.7E-06 9.7E-06 9.7E-06 9.7E-06 9.7E-06 9.7E-06 Effective dose 3.9E-08 2.4E-07 8.4E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 1.1E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Bladder Wall 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Bone Surface 2.9E-08 2.5E-07 8.9E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Brain 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Breast 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 GI-Tract Oesophagus 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 St Wall 6.5E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 SI Wall 6.6E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 ULI Wall 7.4E-09 3.5E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 LLI Wall 7.4E-09 3.8E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Colon 7.4E-09 3.6E-08 1.2E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Kidneys 1.2E-07 1.2E-06 4.2E-06 9.8E-06 9.8E-06 9.8E-06 9.8E-06 9.8E-06 9.8E-06 9.8E-06 Liver 7.4E-08 6.8E-07 2.5E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Muscle 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Ovaries 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Pancreas 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Red Marrow 3.7E-08 3.3E-07 1.2E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Respiratory Tract ET Airways 7.7E-09 3.5E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Lungs 4.3E-08 6.9E-08 1.5E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Skin 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Spleen 1.4E-07 1.3E-06 4.7E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Testes 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Thymus 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Thyroid 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Uterus 6.4E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Remainder 7.3E-08 6.7E-07 2.4E-06 5.6E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Effective dose 2.2E-08 1.4E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 1.3E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Bladder Wall 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Bone Surface 3.3E-08 2.9E-07 1.0E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Brain 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Breast 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 GI-Tract Oesophagus 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 St Wall 7.6E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 SI Wall 8.0E-09 3.9E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 ULI Wall 1.1E-08 4.3E-08 1.3E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 LLI Wall 1.1E-08 5.1E-08 1.5E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Colon 1.1E-08 4.7E-08 1.4E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Kidneys 1.4E-07 1.3E-06 4.9E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Liver 8.5E-08 7.9E-07 2.9E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 Muscle 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Ovaries 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Pancreas 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Red Marrow 4.3E-08 3.8E-07 1.4E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Respiratory Tract ET Airways 1.1E-08 4.4E-08 1.3E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Lungs 3.1E-08 6.2E-08 1.5E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Skin 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Spleen 1.6E-07 1.5E-06 5.4E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Testes 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Thymus 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Thyroid 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Uterus 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Remainder 8.3E-08 7.7E-07 2.8E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Effective dose 2.3E-08 1.6E-07 5.6E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 1.5E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Bladder Wall 9.0E-09 4.7E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Bone Surface 4.0E-08 3.5E-07 1.3E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 Brain 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Breast 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 GI-Tract Oesophagus 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 St Wall 9.4E-09 4.7E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 SI Wall 1.0E-08 4.8E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 ULI Wall 1.4E-08 5.4E-08 1.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 LLI Wall 1.5E-08 6.8E-08 1.8E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Colon 1.5E-08 6.0E-08 1.7E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Kidneys 1.7E-07 1.6E-06 6.0E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Liver 1.0E-07 9.6E-07 3.5E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 Muscle 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Ovaries 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Pancreas 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Red Marrow 5.2E-08 4.7E-07 1.7E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Respiratory Tract ET Airways 1.6E-08 5.7E-08 1.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Lungs 3.2E-08 6.9E-08 1.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Skin 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Spleen 1.9E-07 1.8E-06 6.7E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Testes 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Thymus 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Thyroid 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Uterus 9.0E-09 4.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Remainder 1.0E-07 9.5E-07 3.4E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 Effective dose 2.7E-08 2.0E-07 6.9E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 1.5E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Bladder Wall 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Bone Surface 3.9E-08 3.4E-07 1.2E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Brain 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Breast 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 GI-Tract Oesophagus 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 St Wall 9.1E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 SI Wall 9.9E-09 4.6E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 ULI Wall 1.4E-08 5.3E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 LLI Wall 1.5E-08 6.8E-08 1.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Colon 1.5E-08 5.9E-08 1.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Kidneys 1.7E-07 1.6E-06 5.7E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Liver 1.0E-07 9.3E-07 3.4E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 Muscle 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Ovaries 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Pancreas 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Red Marrow 5.0E-08 4.5E-07 1.6E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Respiratory Tract ET Airways 1.6E-08 5.6E-08 1.6E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Lungs 2.8E-08 6.4E-08 1.7E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Skin 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Spleen 1.9E-07 1.8E-06 6.4E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Testes 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Thymus 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Thyroid 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Uterus 8.6E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Remainder 9.8E-08 9.1E-07 3.3E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 Effective dose 2.6E-08 1.9E-07 6.6E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 1.3E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Bladder Wall 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Bone Surface 3.3E-08 2.8E-07 1.0E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Brain 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Breast 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 GI-Tract Oesophagus 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 St Wall 7.7E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 SI Wall 8.5E-09 3.9E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 ULI Wall 1.3E-08 4.6E-08 1.4E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 LLI Wall 1.3E-08 6.0E-08 1.5E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Colon 1.3E-08 5.2E-08 1.4E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Kidneys 1.4E-07 1.3E-06 4.9E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Liver 8.4E-08 7.9E-07 2.9E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 Muscle 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Ovaries 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Pancreas 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Red Marrow 4.3E-08 3.8E-07 1.4E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Respiratory Tract ET Airways 1.5E-08 4.9E-08 1.4E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Lungs 1.9E-08 5.0E-08 1.4E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Skin 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Spleen 1.6E-07 1.5E-06 5.4E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Testes 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Thymus 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Thyroid 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Uterus 7.3E-09 3.8E-08 1.3E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Remainder 8.3E-08 7.7E-07 2.8E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Effective dose 2.2E-08 1.6E-07 5.6E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.0E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Bladder Wall 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Bone Surface 8.9E-09 9.0E-08 3.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 Brain 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Breast 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 GI-Tract Oesophagus 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 St Wall 3.2E-09 1.3E-08 4.3E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 SI Wall 4.9E-09 1.5E-08 4.5E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 ULI Wall 1.5E-08 3.0E-08 6.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 LLI Wall 1.6E-08 6.2E-08 9.6E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Colon 1.5E-08 4.4E-08 7.6E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Kidneys 3.8E-08 4.2E-07 1.6E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Liver 2.3E-08 2.5E-07 9.5E-07 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Muscle 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Ovaries 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Pancreas 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Red Marrow 1.2E-08 1.2E-07 4.6E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Respiratory Tract ET Airways 1.5E-07 9.7E-07 3.7E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Lungs 4.7E-06 2.5E-05 6.9E-05 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 Skin 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Spleen 4.2E-08 4.7E-07 1.8E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 Testes 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Thymus 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Thyroid 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Uterus 2.1E-09 1.2E-08 4.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Remainder 2.8E-09 2.0E-08 7.2E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Effective dose 5.7E-07 3.0E-06 8.4E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.6E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bladder Wall 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bone Surface 1.0E-08 1.0E-07 4.2E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Brain 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Breast 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 GI-Tract Oesophagus 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 St Wall 3.4E-09 1.5E-08 5.3E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 SI Wall 5.0E-09 1.7E-08 5.5E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 ULI Wall 1.4E-08 3.2E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 LLI Wall 1.5E-08 6.4E-08 1.1E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Colon 1.4E-08 4.6E-08 8.8E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Kidneys 4.3E-08 4.9E-07 2.0E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 Liver 2.6E-08 2.9E-07 1.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Muscle 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Ovaries 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Pancreas 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Red Marrow 1.3E-08 1.4E-07 5.6E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Respiratory Tract ET Airways 1.2E-07 7.9E-07 3.0E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Lungs 1.3E-05 6.5E-05 1.8E-04 2.6E-04 2.6E-04 2.6E-04 2.6E-04 2.6E-04 2.6E-04 2.6E-04 Skin 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Spleen 4.8E-08 5.5E-07 2.2E-06 6.0E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Testes 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thymus 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thyroid 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Uterus 2.4E-09 1.4E-08 5.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Remainder 3.2E-09 2.3E-08 8.7E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Effective dose 1.6E-06 7.8E-06 2.2E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.5E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Bladder Wall 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Bone Surface 1.1E-08 1.2E-07 5.2E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Brain 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Breast 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 GI-Tract Oesophagus 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 St Wall 3.3E-09 1.7E-08 6.6E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 SI Wall 4.4E-09 1.8E-08 6.7E-08 2.4E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 ULI Wall 9.9E-09 2.9E-08 8.2E-08 2.6E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 LLI Wall 9.8E-09 5.3E-08 1.1E-07 3.0E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Colon 9.8E-09 3.9E-08 9.5E-08 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Kidneys 4.8E-08 5.5E-07 2.5E-06 9.4E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 9.5E-06 Liver 2.9E-08 3.2E-07 1.4E-06 5.5E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 5.6E-06 Muscle 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Ovaries 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Pancreas 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Red Marrow 1.5E-08 1.6E-07 7.0E-07 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Respiratory Tract ET Airways 6.2E-08 4.0E-07 1.5E-06 5.3E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 Lungs 1.8E-05 8.8E-05 2.4E-04 3.5E-04 3.5E-04 3.5E-04 3.5E-04 3.5E-04 3.5E-04 3.5E-04 Skin 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Spleen 5.3E-08 6.2E-07 2.8E-06 1.0E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Testes 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Thymus 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Thyroid 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Uterus 2.6E-09 1.6E-08 6.5E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Remainder 3.4E-09 2.5E-08 1.1E-07 4.0E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Effective dose 2.2E-06 1.1E-05 2.9E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.2E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Bladder Wall 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Bone Surface 1.0E-08 1.0E-07 5.0E-07 2.4E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Brain 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Breast 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 GI-Tract Oesophagus 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 St Wall 2.7E-09 1.5E-08 6.4E-08 3.0E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 SI Wall 3.1E-09 1.5E-08 6.4E-08 3.0E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 ULI Wall 5.6E-09 2.1E-08 7.3E-08 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 LLI Wall 5.5E-09 3.3E-08 9.2E-08 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Colon 5.6E-09 2.6E-08 8.1E-08 3.3E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Kidneys 4.4E-08 4.9E-07 2.4E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Liver 2.6E-08 2.9E-07 1.4E-06 6.8E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Muscle 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Ovaries 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Pancreas 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Red Marrow 1.3E-08 1.4E-07 6.8E-07 3.3E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Respiratory Tract ET Airways 2.6E-08 1.7E-07 6.5E-07 2.3E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Lungs 1.1E-05 5.2E-05 1.4E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 2.2E-04 Skin 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Spleen 4.9E-08 5.5E-07 2.7E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Testes 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Thymus 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Thyroid 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Uterus 2.3E-09 1.4E-08 6.3E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Remainder 3.1E-09 2.3E-08 1.0E-07 5.0E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 5.1E-07 Effective dose 1.3E-06 6.2E-06 1.7E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.1E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bladder Wall 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bone Surface 5.5E-09 5.6E-08 2.7E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Brain 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Breast 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 GI-Tract Oesophagus 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 St Wall 1.4E-09 7.8E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 SI Wall 1.6E-09 8.1E-09 3.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 2.8E-09 1.1E-08 3.9E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 LLI Wall 2.7E-09 1.7E-08 4.8E-08 1.9E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Colon 2.8E-09 1.3E-08 4.3E-08 1.8E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Kidneys 2.4E-08 2.6E-07 1.3E-06 6.5E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 Liver 1.4E-08 1.6E-07 7.6E-07 3.8E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Muscle 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Ovaries 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Pancreas 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Red Marrow 7.2E-09 7.6E-08 3.7E-07 1.8E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Respiratory Tract ET Airways 1.3E-08 8.1E-08 3.1E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Lungs 5.1E-06 2.5E-05 6.9E-05 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 Skin 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Spleen 2.6E-08 2.9E-07 1.4E-06 7.2E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 7.4E-06 Testes 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thymus 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thyroid 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Uterus 1.3E-09 7.6E-09 3.4E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Remainder 1.7E-09 1.2E-08 5.6E-08 2.8E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 2.9E-07 Effective dose 6.1E-07 3.0E-06 8.4E-06 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 5.3E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Bladder Wall 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Bone Surface 3.6E-09 3.7E-08 1.7E-07 7.6E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 7.8E-07 Brain 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Breast 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 GI-Tract Oesophagus 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 St Wall 1.0E-09 5.1E-09 2.1E-08 9.4E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 SI Wall 1.3E-09 5.5E-09 2.2E-08 9.4E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 ULI Wall 3.0E-09 8.4E-09 2.5E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 LLI Wall 3.0E-09 1.4E-08 3.3E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Colon 3.0E-09 1.1E-08 2.9E-08 1.0E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Kidneys 1.5E-08 1.7E-07 8.0E-07 3.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Liver 9.3E-09 1.0E-07 4.7E-07 2.1E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Muscle 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Ovaries 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Pancreas 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Red Marrow 4.7E-09 4.9E-08 2.3E-07 1.0E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Respiratory Tract ET Airways 2.3E-08 1.5E-07 5.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Lungs 2.4E-06 1.2E-05 3.4E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 5.3E-05 Skin 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Spleen 1.7E-08 1.9E-07 8.9E-07 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Testes 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Thymus 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Thyroid 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Uterus 8.3E-10 4.9E-09 2.1E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Remainder 1.1E-09 7.9E-09 3.5E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Effective dose 2.9E-07 1.4E-06 4.1E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Bladder Wall 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Bone Surface 5.5E-09 5.5E-08 2.2E-07 7.8E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Brain 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Breast 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 GI-Tract Oesophagus 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 St Wall 1.8E-09 7.9E-09 2.9E-08 9.6E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 SI Wall 2.7E-09 8.8E-09 2.9E-08 9.7E-08 9.8E-08 9.8E-08 9.8E-08 9.8E-08 9.8E-08 9.8E-08 ULI Wall 7.7E-09 1.6E-08 3.8E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 LLI Wall 8.1E-09 3.2E-08 5.5E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Colon 7.8E-09 2.3E-08 4.5E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Kidneys 2.3E-08 2.6E-07 1.1E-06 3.7E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Liver 1.4E-08 1.5E-07 6.2E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Muscle 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Ovaries 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Pancreas 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Red Marrow 7.1E-09 7.4E-08 3.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Respiratory Tract ET Airways 7.7E-08 5.0E-07 1.9E-06 6.5E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 Lungs 1.5E-06 7.8E-06 2.2E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 3.5E-05 Skin 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Spleen 2.6E-08 2.9E-07 1.2E-06 4.1E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Testes 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Thymus 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Thyroid 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Uterus 1.3E-09 7.4E-09 2.8E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Remainder 1.7E-09 1.2E-08 4.7E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Effective dose 1.9E-07 9.6E-07 2.7E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.0E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Bladder Wall 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Bone Surface 7.6E-09 7.6E-08 3.0E-07 8.7E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Brain 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Breast 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 GI-Tract Oesophagus 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 St Wall 2.6E-09 1.1E-08 3.8E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 SI Wall 4.1E-09 1.3E-08 3.9E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 ULI Wall 1.2E-08 2.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 LLI Wall 1.3E-08 5.1E-08 8.0E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Colon 1.3E-08 3.6E-08 6.4E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Kidneys 3.2E-08 3.6E-07 1.4E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Liver 1.9E-08 2.1E-07 8.2E-07 2.4E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Muscle 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Ovaries 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Pancreas 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Red Marrow 9.9E-09 1.0E-07 4.0E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Respiratory Tract ET Airways 1.3E-07 8.3E-07 3.1E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Lungs 1.3E-06 6.6E-06 1.9E-05 2.9E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 Skin 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Spleen 3.6E-08 4.0E-07 1.6E-06 4.6E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 Testes 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Thymus 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Thyroid 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Uterus 1.8E-09 1.0E-08 3.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Remainder 2.4E-09 1.7E-08 6.2E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Effective dose 1.6E-07 8.3E-07 2.4E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.2E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Bladder Wall 1.8E-09 1.0E-08 3.6E-08 9.9E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Bone Surface 7.7E-09 7.7E-08 2.9E-07 8.1E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 8.2E-07 Brain 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Breast 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 GI-Tract Oesophagus 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 St Wall 2.7E-09 1.1E-08 3.7E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 SI Wall 4.2E-09 1.3E-08 3.9E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 ULI Wall 1.3E-08 2.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 LLI Wall 1.4E-08 5.3E-08 8.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 1.3E-08 3.7E-08 6.5E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Kidneys 3.3E-08 3.6E-07 1.4E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Liver 2.0E-08 2.1E-07 8.1E-07 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Muscle 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Ovaries 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Pancreas 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Red Marrow 1.0E-08 1.0E-07 3.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Respiratory Tract ET Airways 1.4E-07 8.9E-07 3.3E-06 1.1E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Lungs 1.0E-06 5.1E-06 1.4E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Skin 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Spleen 3.6E-08 4.0E-07 1.5E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 Testes 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Thymus 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Thyroid 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Uterus 1.8E-09 1.0E-08 3.6E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Remainder 2.4E-09 1.7E-08 6.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Effective dose 1.3E-07 6.4E-07 1.8E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type M, f1 = 0.1 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Bladder Wall 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Bone Surface 6.9E-09 6.9E-08 2.6E-07 6.5E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 Brain 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Breast 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 GI-Tract Oesophagus 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 St Wall 2.5E-09 1.0E-08 3.3E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 SI Wall 3.9E-09 1.1E-08 3.4E-08 8.2E-08 8.3E-08 8.3E-08 8.3E-08 8.3E-08 8.3E-08 8.3E-08 ULI Wall 1.2E-08 2.3E-08 4.7E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 9.6E-08 LLI Wall 1.3E-08 4.9E-08 7.4E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Colon 1.2E-08 3.5E-08 5.8E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Kidneys 2.9E-08 3.2E-07 1.2E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 Liver 1.8E-08 1.9E-07 7.1E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Muscle 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Ovaries 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Pancreas 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Red Marrow 8.9E-09 9.2E-08 3.5E-07 8.8E-07 8.9E-07 8.9E-07 8.9E-07 8.9E-07 8.9E-07 8.9E-07 Respiratory Tract ET Airways 1.3E-07 8.4E-07 3.2E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Lungs 5.7E-07 2.6E-06 7.1E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Skin 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Spleen 3.3E-08 3.6E-07 1.4E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 Testes 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Thymus 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Thyroid 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Uterus 1.6E-09 9.2E-09 3.2E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 8.0E-08 Remainder 2.2E-09 1.5E-08 5.4E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Effective dose 7.3E-08 3.4E-07 9.6E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Bladder Wall 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Bone Surface 5.2E-10 5.9E-09 2.2E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Brain 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Breast 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 GI-Tract Oesophagus 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 St Wall 1.3E-09 1.9E-09 4.0E-09 8.0E-09 8.0E-09 8.0E-09 8.0E-09 8.0E-09 8.0E-09 8.0E-09 SI Wall 3.4E-09 4.2E-09 6.3E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 ULI Wall 1.5E-08 2.1E-08 2.4E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 LLI Wall 1.6E-08 5.9E-08 6.3E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Colon 1.5E-08 3.8E-08 4.1E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 Kidneys 2.2E-09 2.8E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Liver 1.3E-09 1.6E-08 6.2E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Muscle 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Ovaries 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Pancreas 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Red Marrow 6.7E-10 7.9E-09 3.0E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 Respiratory Tract ET Airways 1.6E-07 1.1E-06 4.3E-06 2.2E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Lungs 5.2E-06 2.8E-05 8.1E-05 1.3E-04 1.3E-04 1.3E-04 1.3E-04 1.3E-04 1.3E-04 1.3E-04 Skin 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Spleen 2.4E-09 3.1E-08 1.2E-07 2.9E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Testes 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Thymus 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Thyroid 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Uterus 1.3E-10 7.9E-10 2.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Remainder 3.0E-10 1.8E-09 6.7E-09 2.2E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Effective dose 6.2E-07 3.3E-06 9.8E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Bladder Wall 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Bone Surface 4.8E-10 6.0E-09 2.4E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 Brain 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Breast 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 GI-Tract Oesophagus 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 St Wall 1.2E-09 2.0E-09 4.3E-09 9.5E-09 9.5E-09 9.5E-09 9.5E-09 9.5E-09 9.5E-09 9.5E-09 SI Wall 3.2E-09 4.2E-09 6.7E-09 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 ULI Wall 1.4E-08 2.2E-08 2.6E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 LLI Wall 1.4E-08 5.9E-08 6.7E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 Colon 1.4E-08 3.8E-08 4.4E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Kidneys 2.0E-09 2.8E-08 1.1E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Liver 1.2E-09 1.6E-08 6.7E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Muscle 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Ovaries 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Pancreas 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Red Marrow 6.3E-10 8.0E-09 3.3E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 9.0E-08 Respiratory Tract ET Airways 1.3E-07 8.7E-07 3.5E-06 1.8E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 2.0E-05 Lungs 1.4E-05 7.3E-05 2.1E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 Skin 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Spleen 2.3E-09 3.1E-08 1.3E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Testes 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Thymus 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Thyroid 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Uterus 1.2E-10 8.0E-10 3.0E-09 8.1E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 Remainder 2.7E-10 1.7E-09 6.6E-09 2.2E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Effective dose 1.7E-06 8.8E-06 2.5E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 4.6E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Bladder Wall 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Bone Surface 3.4E-10 4.8E-09 2.2E-08 8.8E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 Brain 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Breast 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 GI-Tract Oesophagus 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 St Wall 8.3E-10 1.5E-09 3.8E-09 1.2E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 SI Wall 2.2E-09 3.2E-09 5.9E-09 1.4E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 ULI Wall 8.6E-09 1.6E-08 2.2E-08 3.4E-08 3.4E-08 3.4E-08 3.4E-08 3.4E-08 3.4E-08 3.4E-08 LLI Wall 8.3E-09 4.4E-08 5.7E-08 7.6E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 Colon 8.5E-09 2.8E-08 3.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Kidneys 1.4E-09 2.2E-08 1.0E-07 4.2E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Liver 8.6E-10 1.3E-08 6.1E-08 2.4E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Muscle 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Ovaries 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Pancreas 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Red Marrow 4.4E-10 6.4E-09 3.0E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Respiratory Tract ET Airways 6.6E-08 4.4E-07 1.7E-06 9.1E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Lungs 2.0E-05 9.9E-05 2.8E-04 4.5E-04 4.6E-04 4.6E-04 4.6E-04 4.6E-04 4.6E-04 4.6E-04 Skin 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Spleen 1.6E-09 2.5E-08 1.2E-07 4.7E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Testes 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Thymus 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Thyroid 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Uterus 8.6E-11 6.4E-10 2.7E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Remainder 1.8E-10 1.3E-09 5.4E-09 2.2E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Effective dose 2.4E-06 1.2E-05 3.4E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 5.5E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.0E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Bladder Wall 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Bone Surface 2.0E-10 2.9E-09 1.6E-08 9.3E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Brain 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Breast 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 GI-Tract Oesophagus 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 St Wall 4.0E-10 8.5E-10 2.6E-09 1.2E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 SI Wall 1.0E-09 1.7E-09 3.8E-09 1.4E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 ULI Wall 3.9E-09 8.4E-09 1.3E-08 2.8E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 2.9E-08 LLI Wall 3.7E-09 2.2E-08 3.4E-08 5.7E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 Colon 3.8E-09 1.4E-08 2.2E-08 4.0E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 Kidneys 8.6E-10 1.4E-08 7.3E-08 4.4E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Liver 5.2E-10 8.0E-09 4.3E-08 2.6E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Muscle 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Ovaries 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Pancreas 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Red Marrow 2.7E-10 3.9E-09 2.1E-08 1.3E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Respiratory Tract ET Airways 2.7E-08 1.8E-07 7.0E-07 3.7E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Lungs 1.2E-05 5.8E-05 1.7E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 3.0E-04 Skin 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Spleen 9.6E-10 1.5E-08 8.2E-08 4.9E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 5.4E-07 Testes 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Thymus 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Thyroid 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Uterus 5.1E-11 3.9E-10 1.9E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Remainder 9.6E-11 7.3E-10 3.6E-09 2.1E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Effective dose 1.4E-06 7.0E-06 2.0E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.5E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Bladder Wall 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Bone Surface 1.0E-10 1.5E-09 8.0E-09 5.1E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Brain 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Breast 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 GI-Tract Oesophagus 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 St Wall 1.9E-10 4.1E-10 1.3E-09 6.7E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 SI Wall 4.8E-10 8.3E-10 1.9E-09 7.6E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 8.2E-09 ULI Wall 1.8E-09 4.0E-09 6.6E-09 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 LLI Wall 1.7E-09 1.1E-08 1.7E-08 3.0E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 Colon 1.8E-09 6.9E-09 1.1E-08 2.1E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 Kidneys 4.4E-10 6.8E-09 3.8E-08 2.4E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Liver 2.6E-10 4.0E-09 2.2E-08 1.4E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Muscle 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Ovaries 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Pancreas 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Red Marrow 1.3E-10 2.0E-09 1.1E-08 6.9E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 Respiratory Tract ET Airways 1.3E-08 8.3E-08 3.3E-07 1.7E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Lungs 5.7E-06 2.8E-05 8.1E-05 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 1.5E-04 Skin 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Spleen 4.8E-10 7.6E-09 4.2E-08 2.7E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Testes 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Thymus 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Thyroid 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Uterus 2.5E-11 2.0E-10 1.0E-09 6.2E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Remainder 4.7E-11 3.6E-10 1.8E-09 1.1E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Effective dose 6.8E-07 3.3E-06 9.8E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 7.4E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Bladder Wall 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Bone Surface 1.1E-10 1.3E-09 6.2E-09 3.1E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Brain 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Breast 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 GI-Tract Oesophagus 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 St Wall 2.2E-10 4.0E-10 1.0E-09 4.1E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 4.4E-09 SI Wall 5.9E-10 8.3E-10 1.6E-09 4.8E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 ULI Wall 2.5E-09 4.1E-09 5.7E-09 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 1.0E-08 LLI Wall 2.5E-09 1.1E-08 1.5E-08 2.1E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 Colon 2.5E-09 7.2E-09 9.5E-09 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 Kidneys 4.5E-10 6.2E-09 2.9E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Liver 2.7E-10 3.6E-09 1.7E-08 8.6E-08 9.3E-08 9.3E-08 9.3E-08 9.3E-08 9.3E-08 9.3E-08 Muscle 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Ovaries 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Pancreas 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Red Marrow 1.4E-10 1.8E-09 8.3E-09 4.2E-08 4.5E-08 4.5E-08 4.5E-08 4.5E-08 4.5E-08 4.5E-08 Respiratory Tract ET Airways 2.5E-08 1.7E-07 6.6E-07 3.4E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Lungs 2.7E-06 1.3E-05 4.0E-05 7.2E-05 7.4E-05 7.4E-05 7.4E-05 7.4E-05 7.4E-05 7.4E-05 Skin 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Spleen 5.0E-10 6.9E-09 3.3E-08 1.6E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Testes 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Thymus 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Thyroid 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Uterus 2.6E-11 1.8E-10 7.7E-10 3.8E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 4.1E-09 Remainder 5.6E-11 3.7E-10 1.6E-09 7.9E-09 8.6E-09 8.6E-09 8.6E-09 8.6E-09 8.6E-09 8.6E-09 Effective dose 3.3E-07 1.6E-06 4.7E-06 8.6E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 4.9E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Bladder Wall 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 Bone Surface 2.7E-10 3.0E-09 1.2E-08 4.0E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Brain 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Breast 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 GI-Tract Oesophagus 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 St Wall 6.2E-10 9.8E-10 2.1E-09 5.5E-09 5.7E-09 5.7E-09 5.7E-09 5.7E-09 5.7E-09 5.7E-09 SI Wall 1.7E-09 2.1E-09 3.3E-09 6.8E-09 7.0E-09 7.0E-09 7.0E-09 7.0E-09 7.0E-09 7.0E-09 ULI Wall 7.4E-09 1.1E-08 1.2E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 LLI Wall 7.8E-09 2.9E-08 3.2E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Colon 7.5E-09 1.9E-08 2.1E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 2.6E-08 Kidneys 1.1E-09 1.4E-08 5.7E-08 1.9E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Liver 6.8E-10 8.4E-09 3.4E-08 1.1E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Muscle 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Ovaries 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Pancreas 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Red Marrow 3.5E-10 4.1E-09 1.6E-08 5.3E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Respiratory Tract ET Airways 8.4E-08 5.6E-07 2.2E-06 1.2E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Lungs 1.7E-06 8.8E-06 2.6E-05 4.8E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 4.9E-05 Skin 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Spleen 1.3E-09 1.6E-08 6.4E-08 2.1E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Testes 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Thymus 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Thyroid 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Uterus 6.6E-11 4.1E-10 1.5E-09 4.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Remainder 1.5E-10 9.4E-10 3.5E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 Effective dose 2.0E-07 1.1E-06 3.1E-06 5.8E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 5.9E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 4.0E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Bladder Wall 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Bone Surface 4.3E-10 4.8E-09 1.8E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Brain 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Breast 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 GI-Tract Oesophagus 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 St Wall 1.0E-09 1.6E-09 3.2E-09 7.2E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 SI Wall 2.8E-09 3.3E-09 5.0E-09 9.1E-09 9.2E-09 9.2E-09 9.2E-09 9.2E-09 9.2E-09 9.2E-09 ULI Wall 1.2E-08 1.7E-08 1.9E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 LLI Wall 1.3E-08 4.7E-08 5.0E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Colon 1.2E-08 3.0E-08 3.3E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 3.8E-08 Kidneys 1.8E-09 2.2E-08 8.7E-08 2.4E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Liver 1.1E-09 1.3E-08 5.1E-08 1.4E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Muscle 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Ovaries 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Pancreas 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Red Marrow 5.5E-10 6.4E-09 2.5E-08 6.8E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 Respiratory Tract ET Airways 1.4E-07 9.3E-07 3.7E-06 1.9E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Lungs 1.5E-06 7.4E-06 2.2E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 4.0E-05 Skin 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Spleen 2.0E-09 2.5E-08 9.7E-08 2.7E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Testes 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Thymus 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Thyroid 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Uterus 1.0E-10 6.4E-10 2.3E-09 6.2E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 6.4E-09 Remainder 2.5E-10 1.5E-09 5.5E-09 1.9E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Effective dose 1.8E-07 9.0E-07 2.6E-06 4.8E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.0E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Bladder Wall 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Bone Surface 4.5E-10 5.0E-09 1.9E-08 5.0E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 Brain 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Breast 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 GI-Tract Oesophagus 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 St Wall 1.1E-09 1.6E-09 3.3E-09 7.1E-09 7.2E-09 7.2E-09 7.2E-09 7.2E-09 7.2E-09 7.2E-09 SI Wall 2.9E-09 3.5E-09 5.3E-09 9.1E-09 9.2E-09 9.2E-09 9.2E-09 9.2E-09 9.2E-09 9.2E-09 ULI Wall 1.3E-08 1.8E-08 2.0E-08 2.4E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 LLI Wall 1.4E-08 5.0E-08 5.3E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 Colon 1.3E-08 3.2E-08 3.4E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Kidneys 1.9E-09 2.4E-08 9.0E-08 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Liver 1.1E-09 1.4E-08 5.3E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Muscle 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Ovaries 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Pancreas 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Red Marrow 5.8E-10 6.7E-09 2.6E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Respiratory Tract ET Airways 1.5E-07 9.9E-07 3.9E-06 2.1E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Lungs 1.2E-06 5.7E-06 1.7E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 3.0E-05 Skin 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Spleen 2.1E-09 2.6E-08 1.0E-07 2.6E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Testes 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Thymus 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Thyroid 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Uterus 1.1E-10 6.7E-10 2.4E-09 6.1E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 6.2E-09 Remainder 2.6E-10 1.6E-09 5.8E-09 2.0E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Effective dose 1.4E-07 6.9E-07 2.0E-06 3.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Po-210, 10-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: ET Airways, 2.2E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Bladder Wall 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Bone Surface 4.2E-10 4.7E-09 1.8E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Brain 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Breast 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 GI-Tract Oesophagus 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 St Wall 1.0E-09 1.5E-09 3.1E-09 6.2E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 SI Wall 2.8E-09 3.3E-09 4.9E-09 8.0E-09 8.1E-09 8.1E-09 8.1E-09 8.1E-09 8.1E-09 8.1E-09 ULI Wall 1.2E-08 1.7E-08 1.9E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 LLI Wall 1.3E-08 4.7E-08 4.9E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Colon 1.2E-08 3.0E-08 3.2E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 3.5E-08 Kidneys 1.8E-09 2.2E-08 8.3E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Liver 1.1E-09 1.3E-08 4.9E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Muscle 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Ovaries 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Pancreas 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Red Marrow 5.5E-10 6.3E-09 2.4E-08 5.8E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 Respiratory Tract ET Airways 1.4E-07 9.4E-07 3.7E-06 2.0E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Lungs 6.3E-07 2.9E-06 8.3E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Skin 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Spleen 2.0E-09 2.5E-08 9.2E-08 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Testes 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Thymus 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Thyroid 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Uterus 1.0E-10 6.3E-10 2.2E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 5.3E-09 Remainder 7.1E-08 4.7E-07 1.9E-06 9.8E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Effective dose 8.1E-08 3.8E-07 1.1E-06 2.3E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Po-210, 10-year-old member of the public Ingestion: f1 = 0.5 Highest committed equivalent dose coefficient: Spleen, 2.5E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 60 years Adrenals 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Bladder Wall 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Bone Surface 5.7E-08 5.6E-07 2.1E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 4.8E-06 Brain 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Breast 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 GI-Tract Oesophagus 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 St Wall 1.6E-08 7.7E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 SI Wall 1.7E-08 7.9E-08 2.6E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 5.9E-07 ULI Wall 3.0E-08 9.7E-08 2.8E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 6.1E-07 LLI Wall 3.2E-08 1.4E-07 3.3E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Colon 3.1E-08 1.1E-07 3.0E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Kidneys 2.4E-07 2.6E-06 9.7E-06 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Liver 1.4E-07 1.6E-06 5.7E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Muscle 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Ovaries 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Pancreas 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Red Marrow 7.4E-08 7.6E-07 2.8E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 6.4E-06 Respiratory Tract ET Airways 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Lungs 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Skin 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Spleen 2.7E-07 3.0E-06 1.1E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Testes 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Thymus 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Thyroid 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Uterus 1.3E-08 7.5E-08 2.6E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Remainder 1.4E-07 1.5E-06 5.6E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Effective dose 3.7E-08 3.1E-07 1.1E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 2.6E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type F, f1 = 0.1 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Bladder Wall 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Bone Surface 2.8E-08 2.4E-07 8.8E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Brain 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Breast 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 GI-Tract Oesophagus 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 St Wall 6.7E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 SI Wall 7.1E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 ULI Wall 9.9E-09 3.8E-08 1.2E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 LLI Wall 1.0E-08 4.8E-08 1.3E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Colon 1.0E-08 4.2E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Kidneys 1.4E-07 1.4E-06 5.0E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Liver 7.9E-08 7.3E-07 2.7E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 Muscle 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Ovaries 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Pancreas 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Red Marrow 3.7E-08 3.3E-07 1.2E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Respiratory Tract ET Airways 1.3E-08 4.2E-08 1.2E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Lungs 7.4E-08 1.0E-07 1.8E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Skin 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Spleen 1.5E-07 1.4E-06 5.1E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Testes 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Thymus 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Thyroid 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Uterus 6.3E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Remainder 7.7E-08 7.2E-07 2.6E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Effective dose 2.6E-08 1.5E-07 5.1E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type F, f1 = 0.1 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Bladder Wall 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Bone Surface 3.7E-08 3.2E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Brain 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Breast 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 GI-Tract Oesophagus 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 St Wall 8.7E-09 4.4E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 SI Wall 9.0E-09 4.4E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 ULI Wall 1.1E-08 4.8E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 LLI Wall 1.2E-08 5.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 Colon 1.1E-08 5.1E-08 1.6E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 3.5E-07 Kidneys 1.9E-07 1.8E-06 6.6E-06 1.5E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Liver 1.0E-07 9.7E-07 3.5E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 8.2E-06 Muscle 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Ovaries 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Pancreas 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Red Marrow 4.9E-08 4.4E-07 1.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Respiratory Tract ET Airways 1.3E-08 5.0E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Lungs 1.7E-07 2.0E-07 3.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Skin 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Spleen 1.9E-07 1.8E-06 6.7E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Testes 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Thymus 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Thyroid 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Uterus 8.4E-09 4.3E-08 1.5E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 3.3E-07 Remainder 1.0E-07 9.5E-07 3.5E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 Effective dose 4.3E-08 2.1E-07 6.8E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 2.2E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Bladder Wall 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Bone Surface 5.2E-08 4.5E-07 1.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Brain 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Breast 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 GI-Tract Oesophagus 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 St Wall 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 SI Wall 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 ULI Wall 1.3E-08 6.2E-08 2.1E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 LLI Wall 1.3E-08 6.7E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Colon 1.3E-08 6.4E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Kidneys 2.7E-07 2.5E-06 9.2E-06 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 2.1E-05 Liver 1.4E-07 1.3E-06 4.9E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Muscle 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Ovaries 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Pancreas 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Red Marrow 6.8E-08 6.0E-07 2.2E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 Respiratory Tract ET Airways 1.4E-08 6.3E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Lungs 2.1E-07 2.6E-07 4.0E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 6.6E-07 Skin 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Spleen 2.7E-07 2.5E-06 9.2E-06 2.1E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Testes 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Thymus 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Thyroid 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Uterus 1.2E-08 6.0E-08 2.0E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Remainder 1.4E-07 1.3E-06 4.8E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Effective dose 5.6E-08 2.8E-07 9.4E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type F, f1 = 0.1 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Bladder Wall 1.2E-08 6.1E-08 2.0E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Bone Surface 5.2E-08 4.5E-07 1.6E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Brain 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Breast 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 GI-Tract Oesophagus 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 St Wall 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 SI Wall 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 ULI Wall 1.2E-08 6.2E-08 2.1E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 LLI Wall 1.2E-08 6.5E-08 2.1E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Colon 1.2E-08 6.3E-08 2.1E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 4.8E-07 Kidneys 2.7E-07 2.6E-06 9.3E-06 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Liver 1.5E-07 1.4E-06 4.9E-06 1.1E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Muscle 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Ovaries 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Pancreas 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Red Marrow 6.9E-08 6.1E-07 2.2E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 Respiratory Tract ET Airways 1.3E-08 6.2E-08 2.0E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Lungs 1.2E-07 1.7E-07 3.2E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Skin 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Spleen 2.7E-07 2.6E-06 9.4E-06 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Testes 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Thymus 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Thyroid 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Uterus 1.2E-08 6.1E-08 2.0E-07 4.6E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 4.7E-07 Remainder 1.4E-07 1.3E-06 4.8E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Effective dose 4.6E-08 2.7E-07 9.4E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type F, f1 = 0.1 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Bladder Wall 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Bone Surface 2.8E-08 2.4E-07 8.7E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Brain 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Breast 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 GI-Tract Oesophagus 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 St Wall 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 SI Wall 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 ULI Wall 6.6E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 LLI Wall 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Colon 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Kidneys 1.4E-07 1.4E-06 5.0E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Liver 7.9E-08 7.3E-07 2.6E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 Muscle 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Ovaries 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Pancreas 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Red Marrow 3.7E-08 3.3E-07 1.2E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Respiratory Tract ET Airways 6.7E-09 3.3E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Lungs 5.9E-08 8.5E-08 1.6E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Skin 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Spleen 1.5E-07 1.4E-06 5.0E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Testes 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Thymus 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Thyroid 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Uterus 6.3E-09 3.2E-08 1.1E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Remainder 7.7E-08 7.1E-07 2.6E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 6.0E-06 Effective dose 2.4E-08 1.4E-07 5.0E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 6.6E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bladder Wall 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bone Surface 1.6E-08 1.4E-07 4.9E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Brain 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Breast 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 GI-Tract Oesophagus 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 St Wall 3.6E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 SI Wall 3.6E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 ULI Wall 3.9E-09 1.9E-08 6.3E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 LLI Wall 4.0E-09 2.0E-08 6.5E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 4.0E-09 2.0E-08 6.4E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Kidneys 8.1E-08 7.7E-07 2.8E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Liver 4.4E-08 4.1E-07 1.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 Muscle 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Ovaries 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Pancreas 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Red Marrow 2.1E-08 1.8E-07 6.6E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Respiratory Tract ET Airways 4.2E-09 1.9E-08 6.2E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Lungs 3.0E-08 4.4E-08 8.7E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Skin 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Spleen 8.2E-08 7.8E-07 2.8E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 6.6E-06 Testes 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thymus 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thyroid 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Uterus 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Remainder 4.3E-08 4.0E-07 1.5E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Effective dose 1.3E-08 8.1E-08 2.8E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 6.5E-07 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 7.8E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bladder Wall 4.2E-09 2.2E-08 7.3E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bone Surface 1.9E-08 1.6E-07 5.8E-07 1.3E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Brain 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Breast 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 GI-Tract Oesophagus 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 St Wall 4.3E-09 2.2E-08 7.3E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 SI Wall 4.5E-09 2.2E-08 7.3E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 5.6E-09 2.4E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 LLI Wall 5.8E-09 2.8E-08 8.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Colon 5.7E-09 2.5E-08 7.8E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Kidneys 9.6E-08 9.1E-07 3.3E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 Liver 5.2E-08 4.8E-07 1.8E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Muscle 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Ovaries 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Pancreas 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Red Marrow 2.4E-08 2.2E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Respiratory Tract ET Airways 6.4E-09 2.5E-08 7.6E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Lungs 2.7E-08 4.4E-08 9.5E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Skin 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Spleen 9.7E-08 9.2E-07 3.3E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 Testes 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thymus 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thyroid 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Uterus 4.2E-09 2.2E-08 7.2E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Remainder 5.1E-08 4.7E-07 1.7E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Effective dose 1.4E-08 9.5E-08 3.3E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 7.7E-07 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type F, f1 = 0.1 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Bladder Wall 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Bone Surface 2.5E-08 2.1E-07 7.7E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Brain 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Breast 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 GI-Tract Oesophagus 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 St Wall 5.8E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 SI Wall 6.1E-09 2.9E-08 9.7E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 ULI Wall 8.2E-09 3.3E-08 1.0E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 LLI Wall 8.5E-09 4.0E-08 1.1E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Colon 8.3E-09 3.6E-08 1.1E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Kidneys 1.3E-07 1.2E-06 4.4E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Liver 6.9E-08 6.4E-07 2.3E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 Muscle 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Ovaries 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Pancreas 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Red Marrow 3.2E-08 2.9E-07 1.0E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Respiratory Tract ET Airways 9.7E-09 3.5E-08 1.0E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Lungs 3.4E-08 5.7E-08 1.2E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Skin 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Spleen 1.3E-07 1.2E-06 4.4E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Testes 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Thymus 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Thyroid 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Uterus 5.5E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Remainder 6.7E-08 6.3E-07 2.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 Effective dose 1.9E-08 1.3E-07 4.4E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type F, f1 = 0.1 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Bladder Wall 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Bone Surface 2.4E-08 2.1E-07 7.6E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Brain 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Breast 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 GI-Tract Oesophagus 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 St Wall 5.8E-09 2.9E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 SI Wall 6.1E-09 2.9E-08 9.6E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 ULI Wall 8.5E-09 3.3E-08 1.0E-07 2.2E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 LLI Wall 8.8E-09 4.1E-08 1.1E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Colon 8.6E-09 3.6E-08 1.0E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Kidneys 1.3E-07 1.2E-06 4.3E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Liver 6.8E-08 6.4E-07 2.3E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 Muscle 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Ovaries 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Pancreas 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Red Marrow 3.2E-08 2.8E-07 1.0E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Respiratory Tract ET Airways 1.0E-08 3.5E-08 1.0E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Lungs 3.1E-08 5.4E-08 1.2E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 Skin 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Spleen 1.3E-07 1.2E-06 4.4E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Testes 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Thymus 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Thyroid 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Uterus 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Remainder 6.7E-08 6.2E-07 2.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 Effective dose 1.9E-08 1.2E-07 4.4E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Spleen, 8.8E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Bladder Wall 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Bone Surface 2.1E-08 1.8E-07 6.5E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Brain 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Breast 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 GI-Tract Oesophagus 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 St Wall 5.0E-09 2.5E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 SI Wall 5.3E-09 2.5E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 ULI Wall 7.7E-09 2.9E-08 8.7E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 LLI Wall 8.1E-09 3.7E-08 9.7E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Colon 7.9E-09 3.2E-08 9.1E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Kidneys 1.1E-07 1.0E-06 3.7E-06 8.7E-06 8.7E-06 8.7E-06 8.7E-06 8.7E-06 8.7E-06 8.7E-06 Liver 5.8E-08 5.5E-07 2.0E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Muscle 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Ovaries 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Pancreas 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Red Marrow 2.7E-08 2.4E-07 8.8E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Respiratory Tract ET Airways 9.6E-09 3.1E-08 8.9E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Lungs 2.2E-08 4.2E-08 9.9E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Skin 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Spleen 1.1E-07 1.0E-06 3.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 Testes 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Thymus 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Thyroid 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Uterus 4.7E-09 2.4E-08 8.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Remainder 5.7E-08 5.3E-07 1.9E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 Effective dose 1.5E-08 1.1E-07 3.8E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 8.7E-07 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 8.8E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Bladder Wall 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Bone Surface 5.4E-09 5.5E-08 2.1E-07 5.2E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 5.3E-07 Brain 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Breast 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 GI-Tract Oesophagus 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 St Wall 2.0E-09 8.2E-09 2.7E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 SI Wall 2.9E-09 9.1E-09 2.8E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 ULI Wall 8.7E-09 1.8E-08 3.7E-08 7.6E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 LLI Wall 9.3E-09 3.7E-08 5.8E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Colon 8.9E-09 2.6E-08 4.6E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 Kidneys 2.8E-08 3.1E-07 1.2E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 Liver 1.5E-08 1.7E-07 6.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Muscle 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Ovaries 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Pancreas 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Red Marrow 7.1E-09 7.4E-08 2.8E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Respiratory Tract ET Airways 1.1E-07 6.8E-07 2.6E-06 8.9E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 9.1E-06 Lungs 4.2E-06 2.2E-05 6.1E-05 8.8E-05 8.8E-05 8.8E-05 8.8E-05 8.8E-05 8.8E-05 8.8E-05 Skin 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Spleen 2.8E-08 3.1E-07 1.2E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 Testes 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Thymus 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Thyroid 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Uterus 1.3E-09 7.4E-09 2.6E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Remainder 1.8E-09 1.3E-08 4.6E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Effective dose 5.0E-07 2.6E-06 7.4E-06 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 1.1E-05 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.0E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Bladder Wall 1.4E-09 8.5E-09 3.2E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Bone Surface 6.0E-09 6.3E-08 2.5E-07 7.0E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Brain 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Breast 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 GI-Tract Oesophagus 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 St Wall 2.1E-09 9.2E-09 3.2E-08 8.7E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 8.8E-08 SI Wall 2.9E-09 1.0E-08 3.3E-08 8.8E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 ULI Wall 8.0E-09 1.8E-08 4.3E-08 9.9E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 LLI Wall 8.4E-09 3.7E-08 6.4E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Colon 8.1E-09 2.7E-08 5.2E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Kidneys 3.1E-08 3.5E-07 1.4E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Liver 1.7E-08 1.9E-07 7.6E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Muscle 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Ovaries 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Pancreas 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Red Marrow 7.9E-09 8.4E-08 3.4E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 9.5E-07 Respiratory Tract ET Airways 8.3E-08 5.4E-07 2.0E-06 7.0E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 Lungs 1.0E-05 5.1E-05 1.4E-04 2.0E-04 2.0E-04 2.0E-04 2.0E-04 2.0E-04 2.0E-04 2.0E-04 Skin 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Spleen 3.1E-08 3.6E-07 1.4E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 4.1E-06 Testes 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Thymus 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Thyroid 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Uterus 1.4E-09 8.4E-09 3.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Remainder 2.0E-09 1.4E-08 5.5E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Effective dose 1.2E-06 6.1E-06 1.7E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 2.4E-05 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.5E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bladder Wall 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bone Surface 6.6E-09 6.9E-08 3.1E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Brain 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Breast 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 GI-Tract Oesophagus 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 St Wall 2.0E-09 9.8E-09 3.9E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 SI Wall 2.5E-09 1.0E-08 4.0E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 ULI Wall 5.5E-09 1.6E-08 4.8E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 LLI Wall 5.5E-09 3.0E-08 6.5E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Colon 5.5E-09 2.2E-08 5.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Kidneys 3.4E-08 3.9E-07 1.7E-06 6.8E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 6.9E-06 Liver 1.8E-08 2.1E-07 9.3E-07 3.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Muscle 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Ovaries 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Pancreas 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Red Marrow 8.6E-09 9.2E-08 4.1E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Respiratory Tract ET Airways 4.2E-08 2.7E-07 1.0E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Lungs 1.3E-05 6.3E-05 1.7E-04 2.5E-04 2.5E-04 2.5E-04 2.5E-04 2.5E-04 2.5E-04 2.5E-04 Skin 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Spleen 3.4E-08 3.9E-07 1.8E-06 6.9E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Testes 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thymus 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thyroid 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Uterus 1.5E-09 9.3E-09 3.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Remainder 2.1E-09 1.5E-08 6.6E-08 2.5E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Effective dose 1.6E-06 7.6E-06 2.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.6E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Bladder Wall 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Bone Surface 5.9E-09 6.1E-08 2.9E-07 1.4E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Brain 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Breast 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 GI-Tract Oesophagus 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 St Wall 1.6E-09 8.5E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 SI Wall 1.8E-09 8.8E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 ULI Wall 3.1E-09 1.2E-08 4.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 LLI Wall 3.1E-09 1.9E-08 5.3E-08 2.0E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Colon 3.1E-09 1.5E-08 4.7E-08 1.9E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Kidneys 3.0E-08 3.4E-07 1.7E-06 8.2E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 8.4E-06 Liver 1.7E-08 1.8E-07 8.8E-07 4.4E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 Muscle 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Ovaries 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Pancreas 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Red Marrow 7.7E-09 8.1E-08 3.9E-07 1.9E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Respiratory Tract ET Airways 1.8E-08 1.1E-07 4.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Lungs 7.5E-06 3.6E-05 1.0E-04 1.6E-04 1.6E-04 1.6E-04 1.6E-04 1.6E-04 1.6E-04 1.6E-04 Skin 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Spleen 3.1E-08 3.4E-07 1.7E-06 8.3E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 Testes 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Thymus 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Thyroid 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Uterus 1.4E-09 8.2E-09 3.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Remainder 1.8E-09 1.4E-08 6.3E-08 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Effective dose 9.1E-07 4.4E-06 1.2E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 7.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Bladder Wall 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Bone Surface 3.1E-09 3.2E-08 1.5E-07 7.8E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 8.0E-07 Brain 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Breast 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 GI-Tract Oesophagus 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 St Wall 8.1E-10 4.4E-09 2.0E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 SI Wall 9.2E-10 4.6E-09 2.0E-08 9.7E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 ULI Wall 1.5E-09 6.1E-09 2.2E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 LLI Wall 1.5E-09 9.2E-09 2.7E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Colon 1.5E-09 7.4E-09 2.4E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Kidneys 1.6E-08 1.8E-07 8.8E-07 4.5E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Liver 8.7E-09 9.6E-08 4.7E-07 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Muscle 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Ovaries 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Pancreas 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Red Marrow 4.1E-09 4.3E-08 2.1E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Respiratory Tract ET Airways 8.2E-09 5.3E-08 2.0E-07 7.3E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 Lungs 3.6E-06 1.7E-05 4.8E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 7.5E-05 Skin 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Spleen 1.6E-08 1.8E-07 8.9E-07 4.5E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 4.6E-06 Testes 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Thymus 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Thyroid 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Uterus 7.1E-10 4.3E-09 1.9E-08 9.7E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Remainder 9.6E-10 7.1E-09 3.3E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Effective dose 4.3E-07 2.1E-06 5.8E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 9.3E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.7E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Bladder Wall 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Bone Surface 1.9E-09 1.9E-08 9.1E-08 4.3E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Brain 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Breast 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 GI-Tract Oesophagus 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 St Wall 5.4E-10 2.7E-09 1.2E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 SI Wall 6.5E-10 2.9E-09 1.2E-08 5.3E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 ULI Wall 1.4E-09 4.2E-09 1.3E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 LLI Wall 1.4E-09 7.0E-09 1.7E-08 6.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Colon 1.4E-09 5.4E-09 1.5E-08 5.9E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 Kidneys 9.8E-09 1.1E-07 5.2E-07 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Liver 5.3E-09 5.8E-08 2.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Muscle 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Ovaries 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Pancreas 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Red Marrow 2.5E-09 2.6E-08 1.2E-07 5.8E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 Respiratory Tract ET Airways 1.2E-08 7.7E-08 2.9E-07 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 1.0E-06 Lungs 1.7E-06 8.5E-06 2.4E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 3.7E-05 Skin 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Spleen 9.9E-09 1.1E-07 5.2E-07 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Testes 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Thymus 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Thyroid 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Uterus 4.4E-10 2.6E-09 1.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 Remainder 6.0E-10 4.4E-09 2.0E-08 9.2E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 Effective dose 2.1E-07 1.0E-06 2.9E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.1E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Bladder Wall 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Bone Surface 2.9E-09 2.9E-08 1.2E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Brain 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Breast 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 GI-Tract Oesophagus 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 St Wall 9.7E-10 4.2E-09 1.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 SI Wall 1.3E-09 4.6E-09 1.6E-08 5.7E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 ULI Wall 3.6E-09 8.0E-09 2.0E-08 6.2E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 LLI Wall 3.8E-09 1.6E-08 2.9E-08 7.2E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 7.3E-08 Colon 3.7E-09 1.1E-08 2.4E-08 6.6E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 6.7E-08 Kidneys 1.5E-08 1.6E-07 7.0E-07 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Liver 8.1E-09 8.8E-08 3.7E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Muscle 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Ovaries 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Pancreas 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Red Marrow 3.8E-09 3.9E-08 1.6E-07 6.2E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 6.3E-07 Respiratory Tract ET Airways 4.2E-08 2.7E-07 1.0E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 3.6E-06 Lungs 1.4E-06 7.1E-06 2.0E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Skin 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Spleen 1.5E-08 1.7E-07 7.0E-07 2.6E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Testes 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Thymus 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Thyroid 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Uterus 6.8E-10 3.9E-09 1.5E-08 5.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Remainder 9.3E-10 6.6E-09 2.7E-08 9.8E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Effective dose 1.7E-07 8.7E-07 2.5E-06 3.9E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.3E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Bladder Wall 1.0E-09 5.9E-09 2.2E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Bone Surface 4.4E-09 4.4E-08 1.7E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 Brain 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Breast 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 GI-Tract Oesophagus 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 St Wall 1.6E-09 6.5E-09 2.2E-08 6.8E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 SI Wall 2.2E-09 7.1E-09 2.3E-08 6.9E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 ULI Wall 6.4E-09 1.3E-08 3.0E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 7.7E-08 LLI Wall 6.9E-09 2.7E-08 4.5E-08 9.4E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Colon 6.6E-09 1.9E-08 3.6E-08 8.4E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Kidneys 2.2E-08 2.5E-07 9.9E-07 3.1E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Liver 1.2E-08 1.3E-07 5.3E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Muscle 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Ovaries 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Pancreas 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Red Marrow 5.7E-09 5.9E-08 2.4E-07 7.4E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 7.5E-07 Respiratory Tract ET Airways 7.8E-08 5.1E-07 1.9E-06 6.7E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 Lungs 1.5E-06 7.7E-06 2.2E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 3.3E-05 Skin 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Spleen 2.3E-08 2.5E-07 1.0E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Testes 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Thymus 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Thyroid 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Uterus 1.0E-09 5.9E-09 2.2E-08 6.7E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Remainder 1.4E-09 1.0E-08 3.8E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Effective dose 1.9E-07 9.4E-07 2.7E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 4.2E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.7E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Bladder Wall 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 Bone Surface 4.6E-09 4.6E-08 1.8E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 Brain 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Breast 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 GI-Tract Oesophagus 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 St Wall 1.7E-09 6.8E-09 2.3E-08 6.4E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 6.5E-08 SI Wall 2.4E-09 7.5E-09 2.4E-08 6.5E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 ULI Wall 7.1E-09 1.4E-08 3.1E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 LLI Wall 7.6E-09 3.0E-08 4.8E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 Colon 7.3E-09 2.1E-08 3.8E-08 8.1E-08 8.2E-08 8.2E-08 8.2E-08 8.2E-08 8.2E-08 8.2E-08 Kidneys 2.3E-08 2.6E-07 1.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 Liver 1.3E-08 1.4E-07 5.4E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Muscle 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Ovaries 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Pancreas 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Red Marrow 6.0E-09 6.2E-08 2.4E-07 7.0E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Respiratory Tract ET Airways 8.8E-08 5.7E-07 2.1E-06 7.5E-06 7.6E-06 7.6E-06 7.6E-06 7.6E-06 7.6E-06 7.6E-06 Lungs 1.3E-06 6.3E-06 1.8E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 2.7E-05 Skin 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Spleen 2.4E-08 2.6E-07 1.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 Testes 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Thymus 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Thyroid 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Uterus 1.1E-09 6.2E-09 2.2E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 6.4E-08 Remainder 1.5E-09 1.0E-08 3.9E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Effective dose 1.6E-07 7.8E-07 2.2E-06 3.4E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.5E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Bladder Wall 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Bone Surface 4.2E-09 4.2E-08 1.6E-07 4.2E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 4.3E-07 Brain 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Breast 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 GI-Tract Oesophagus 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 St Wall 1.6E-09 6.3E-09 2.1E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 SI Wall 2.3E-09 7.0E-09 2.1E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 ULI Wall 7.0E-09 1.4E-08 2.8E-08 6.1E-08 6.1E-08 6.1E-08 6.1E-08 6.1E-08 6.1E-08 6.1E-08 LLI Wall 7.6E-09 2.9E-08 4.5E-08 7.8E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 Colon 7.2E-09 2.0E-08 3.5E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 Kidneys 2.2E-08 2.4E-07 9.1E-07 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Liver 1.2E-08 1.3E-07 4.8E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Muscle 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Ovaries 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Pancreas 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Red Marrow 5.5E-09 5.7E-08 2.2E-07 5.7E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 5.8E-07 Respiratory Tract ET Airways 8.8E-08 5.8E-07 2.2E-06 7.5E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 7.7E-06 Lungs 7.7E-07 3.5E-06 9.5E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Skin 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Spleen 2.2E-08 2.4E-07 9.2E-07 2.4E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Testes 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Thymus 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Thyroid 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Uterus 1.0E-09 5.7E-09 2.0E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Remainder 1.4E-09 9.7E-09 3.5E-08 9.3E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 9.4E-08 Effective dose 9.6E-08 4.4E-07 1.2E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.1E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Bladder Wall 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Bone Surface 3.1E-10 3.6E-09 1.4E-08 3.4E-08 3.4E-08 3.4E-08 3.4E-08 3.4E-08 3.4E-08 3.4E-08 Brain 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Breast 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 GI-Tract Oesophagus 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 St Wall 8.7E-10 1.3E-09 2.6E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 5.1E-09 SI Wall 2.0E-09 2.4E-09 3.8E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 6.3E-09 ULI Wall 8.5E-09 1.2E-08 1.4E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 LLI Wall 9.2E-09 3.5E-08 3.8E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 Colon 8.8E-09 2.2E-08 2.4E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 2.8E-08 Kidneys 1.6E-09 2.0E-08 7.8E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Liver 8.5E-10 1.1E-08 4.1E-08 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 1.0E-07 Muscle 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Ovaries 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Pancreas 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Red Marrow 4.0E-10 4.8E-09 1.8E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 Respiratory Tract ET Airways 1.1E-07 7.6E-07 3.0E-06 1.6E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Lungs 4.6E-06 2.5E-05 7.2E-05 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 1.1E-04 Skin 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Spleen 1.6E-09 2.0E-08 7.9E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Testes 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Thymus 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Thyroid 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Uterus 7.7E-11 4.8E-10 1.7E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 4.2E-09 Remainder 2.0E-10 1.2E-09 4.4E-09 1.5E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 Effective dose 5.6E-07 3.0E-06 8.6E-06 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 2.6E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Bladder Wall 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Bone Surface 2.8E-10 3.5E-09 1.4E-08 4.0E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 4.1E-08 Brain 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Breast 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 GI-Tract Oesophagus 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 St Wall 8.2E-10 1.3E-09 2.7E-09 5.9E-09 6.0E-09 6.0E-09 6.0E-09 6.0E-09 6.0E-09 6.0E-09 SI Wall 1.8E-09 2.4E-09 3.9E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 7.3E-09 ULI Wall 7.6E-09 1.2E-08 1.5E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 1.9E-08 LLI Wall 8.0E-09 3.4E-08 3.9E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 Colon 7.8E-09 2.2E-08 2.5E-08 3.0E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 Kidneys 1.4E-09 2.0E-08 8.2E-08 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Liver 7.8E-10 1.1E-08 4.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Muscle 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Ovaries 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Pancreas 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Red Marrow 3.7E-10 4.7E-09 1.9E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Respiratory Tract ET Airways 9.0E-08 6.0E-07 2.4E-06 1.3E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 1.4E-05 Lungs 1.1E-05 5.7E-05 1.6E-04 2.6E-04 2.6E-04 2.6E-04 2.6E-04 2.6E-04 2.6E-04 2.6E-04 Skin 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Spleen 1.4E-09 2.0E-08 8.2E-08 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 2.3E-07 Testes 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Thymus 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Thyroid 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Uterus 7.1E-11 4.8E-10 1.8E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 Remainder 1.7E-10 1.1E-09 4.2E-09 1.4E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 Effective dose 1.4E-06 6.9E-06 2.0E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 3.1E-05 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Bladder Wall 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Bone Surface 2.0E-10 2.7E-09 1.3E-08 5.2E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Brain 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Breast 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 GI-Tract Oesophagus 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 St Wall 5.4E-10 9.6E-10 2.3E-09 7.3E-09 7.7E-09 7.7E-09 7.7E-09 7.7E-09 7.7E-09 7.7E-09 SI Wall 1.2E-09 1.8E-09 3.3E-09 8.5E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 8.9E-09 ULI Wall 4.6E-09 8.8E-09 1.2E-08 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 LLI Wall 4.6E-09 2.4E-08 3.2E-08 4.3E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Colon 4.6E-09 1.6E-08 2.1E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 3.0E-08 Kidneys 9.8E-10 1.5E-08 7.2E-08 3.0E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Liver 5.4E-10 8.2E-09 3.8E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Muscle 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Ovaries 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Pancreas 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Red Marrow 2.6E-10 3.7E-09 1.7E-08 7.1E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 7.5E-08 Respiratory Tract ET Airways 4.5E-08 3.0E-07 1.2E-06 6.2E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Lungs 1.5E-05 7.1E-05 2.0E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 3.3E-04 Skin 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Spleen 9.9E-10 1.6E-08 7.3E-08 3.0E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 3.2E-07 Testes 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Thymus 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Thyroid 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Uterus 5.0E-11 3.7E-10 1.6E-09 6.5E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 6.8E-09 Remainder 1.1E-10 7.8E-10 3.3E-09 1.4E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 1.5E-08 Effective dose 1.8E-06 8.5E-06 2.5E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 3.9E-05 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 2.1E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Bladder Wall 2.9E-11 2.3E-10 1.1E-09 6.8E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Bone Surface 1.2E-10 1.7E-09 8.9E-09 5.5E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 Brain 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Breast 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 GI-Tract Oesophagus 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 St Wall 2.6E-10 5.3E-10 1.5E-09 7.3E-09 8.0E-09 8.0E-09 8.0E-09 8.0E-09 8.0E-09 8.0E-09 SI Wall 5.5E-10 9.4E-10 2.1E-09 8.2E-09 8.8E-09 8.8E-09 8.8E-09 8.8E-09 8.8E-09 8.8E-09 ULI Wall 2.1E-09 4.5E-09 7.3E-09 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 1.6E-08 LLI Wall 2.0E-09 1.2E-08 1.9E-08 3.2E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Colon 2.1E-09 7.9E-09 1.2E-08 2.3E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 2.4E-08 Kidneys 5.9E-10 9.3E-09 5.1E-08 3.1E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Liver 3.2E-10 5.0E-09 2.7E-08 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Muscle 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Ovaries 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Pancreas 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Red Marrow 1.5E-10 2.2E-09 1.2E-08 7.4E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Respiratory Tract ET Airways 1.8E-08 1.2E-07 4.8E-07 2.5E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Lungs 8.4E-06 4.1E-05 1.2E-04 2.1E-04 2.1E-04 2.1E-04 2.1E-04 2.1E-04 2.1E-04 2.1E-04 Skin 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Spleen 6.0E-10 9.4E-09 5.1E-08 3.2E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Testes 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Thymus 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Thyroid 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Uterus 2.9E-11 2.3E-10 1.1E-09 6.7E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 7.4E-09 Remainder 5.8E-11 4.4E-10 2.1E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 Effective dose 1.0E-06 4.9E-06 1.4E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 2.5E-05 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.0E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Bladder Wall 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Bone Surface 5.8E-11 8.2E-10 4.5E-09 2.9E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 Brain 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Breast 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 GI-Tract Oesophagus 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 St Wall 1.2E-10 2.5E-10 7.7E-10 3.9E-09 4.3E-09 4.3E-09 4.3E-09 4.3E-09 4.3E-09 4.3E-09 SI Wall 2.6E-10 4.5E-10 1.1E-09 4.3E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 4.7E-09 ULI Wall 9.7E-10 2.1E-09 3.6E-09 8.1E-09 8.6E-09 8.6E-09 8.6E-09 8.6E-09 8.6E-09 8.6E-09 LLI Wall 9.4E-10 5.8E-09 9.2E-09 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 1.7E-08 Colon 9.5E-10 3.7E-09 6.0E-09 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 1.2E-08 Kidneys 2.9E-10 4.6E-09 2.6E-08 1.7E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Liver 1.6E-10 2.5E-09 1.4E-08 8.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 9.9E-08 Muscle 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Ovaries 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Pancreas 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Red Marrow 7.6E-11 1.1E-09 6.1E-09 4.0E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 4.4E-08 Respiratory Tract ET Airways 8.3E-09 5.5E-08 2.2E-07 1.2E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Lungs 4.0E-06 1.9E-05 5.7E-05 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 1.0E-04 Skin 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Spleen 3.0E-10 4.6E-09 2.6E-08 1.7E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Testes 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Thymus 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Thyroid 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Uterus 1.4E-11 1.1E-10 5.7E-10 3.6E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 Remainder 2.8E-11 2.2E-10 1.1E-09 6.8E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 7.5E-09 Effective dose 4.8E-07 2.3E-06 6.8E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 5.1E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Bladder Wall 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Bone Surface 5.0E-11 6.4E-10 3.1E-09 1.7E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 1.8E-08 Brain 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Breast 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 GI-Tract Oesophagus 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 St Wall 1.2E-10 2.1E-10 5.5E-10 2.3E-09 2.5E-09 2.5E-09 2.5E-09 2.5E-09 2.5E-09 2.5E-09 SI Wall 2.6E-10 3.8E-10 7.7E-10 2.6E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 ULI Wall 1.1E-09 1.9E-09 2.7E-09 5.1E-09 5.4E-09 5.4E-09 5.4E-09 5.4E-09 5.4E-09 5.4E-09 LLI Wall 1.1E-09 5.1E-09 7.0E-09 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 1.1E-08 Colon 1.1E-09 3.3E-09 4.5E-09 7.6E-09 7.9E-09 7.9E-09 7.9E-09 7.9E-09 7.9E-09 7.9E-09 Kidneys 2.5E-10 3.6E-09 1.8E-08 9.8E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Liver 1.4E-10 1.9E-09 9.4E-09 5.2E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 Muscle 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Ovaries 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Pancreas 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Red Marrow 6.5E-11 8.6E-10 4.2E-09 2.3E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 2.5E-08 Respiratory Tract ET Airways 1.3E-08 8.4E-08 3.3E-07 1.8E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Lungs 1.9E-06 9.6E-06 2.8E-05 5.0E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 5.1E-05 Skin 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Spleen 2.6E-10 3.6E-09 1.8E-08 9.8E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Testes 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Thymus 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Thyroid 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Uterus 1.2E-11 8.7E-11 3.9E-10 2.1E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 2.3E-09 Remainder 2.8E-11 1.9E-10 8.3E-10 4.4E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 4.9E-09 Effective dose 2.3E-07 1.2E-06 3.4E-06 6.0E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 4.3E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Bladder Wall 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.9E-09 2.9E-09 2.9E-09 2.9E-09 2.9E-09 2.9E-09 Bone Surface 1.3E-10 1.5E-09 6.1E-09 2.2E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 2.3E-08 Brain 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Breast 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 GI-Tract Oesophagus 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 St Wall 3.4E-10 5.2E-10 1.1E-09 3.1E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 3.2E-09 SI Wall 7.7E-10 9.8E-10 1.6E-09 3.6E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 ULI Wall 3.3E-09 4.9E-09 5.9E-09 8.4E-09 8.6E-09 8.6E-09 8.6E-09 8.6E-09 8.6E-09 8.6E-09 LLI Wall 3.6E-09 1.4E-08 1.6E-08 1.9E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 2.0E-08 Colon 3.4E-09 8.7E-09 1.0E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Kidneys 6.5E-10 8.4E-09 3.5E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Liver 3.5E-10 4.5E-09 1.8E-08 6.7E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 Muscle 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Ovaries 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Pancreas 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Red Marrow 1.7E-10 2.0E-09 8.2E-09 3.0E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 Respiratory Tract ET Airways 4.5E-08 3.0E-07 1.2E-06 6.4E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 Lungs 1.5E-06 8.0E-06 2.4E-05 4.2E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 4.3E-05 Skin 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Spleen 6.6E-10 8.5E-09 3.5E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Testes 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Thymus 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Thyroid 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Uterus 3.2E-11 2.0E-10 7.6E-10 2.7E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 2.8E-09 Remainder 7.9E-11 4.9E-10 1.9E-09 7.6E-09 8.3E-09 8.3E-09 8.3E-09 8.3E-09 8.3E-09 8.3E-09 Effective dose 1.9E-07 9.6E-07 2.8E-06 5.0E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 5.1E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 4.4E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Bladder Wall 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 3.9E-09 Bone Surface 2.3E-10 2.6E-09 1.0E-08 3.0E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 Brain 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Breast 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 GI-Tract Oesophagus 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 St Wall 6.3E-10 9.4E-10 1.9E-09 4.4E-09 4.5E-09 4.5E-09 4.5E-09 4.5E-09 4.5E-09 4.5E-09 SI Wall 1.4E-09 1.8E-09 2.7E-09 5.3E-09 5.4E-09 5.4E-09 5.4E-09 5.4E-09 5.4E-09 5.4E-09 ULI Wall 6.2E-09 8.9E-09 1.0E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 LLI Wall 6.7E-09 2.5E-08 2.7E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 Colon 6.4E-09 1.6E-08 1.8E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Kidneys 1.2E-09 1.5E-08 5.8E-08 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Liver 6.4E-10 7.9E-09 3.1E-08 9.2E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Muscle 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Ovaries 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Pancreas 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Red Marrow 3.0E-10 3.5E-09 1.4E-08 4.1E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 Respiratory Tract ET Airways 8.5E-08 5.7E-07 2.3E-06 1.2E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 1.3E-05 Lungs 1.7E-06 8.7E-06 2.5E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 4.4E-05 Skin 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Spleen 1.2E-09 1.5E-08 5.9E-08 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Testes 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Thymus 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Thyroid 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Uterus 5.7E-11 3.5E-10 1.3E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Remainder 1.5E-10 8.8E-10 3.3E-09 1.2E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Effective dose 2.1E-07 1.0E-06 3.0E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 5.3E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 3.6E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Bladder Wall 6.3E-11 3.9E-10 1.4E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Bone Surface 2.5E-10 2.9E-09 1.1E-08 3.0E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 3.1E-08 Brain 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Breast 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 GI-Tract Oesophagus 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 St Wall 7.1E-10 1.0E-09 2.0E-09 4.4E-09 4.5E-09 4.5E-09 4.5E-09 4.5E-09 4.5E-09 4.5E-09 SI Wall 1.6E-09 2.0E-09 3.0E-09 5.4E-09 5.5E-09 5.5E-09 5.5E-09 5.5E-09 5.5E-09 5.5E-09 ULI Wall 6.9E-09 9.9E-09 1.1E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 LLI Wall 7.5E-09 2.8E-08 3.0E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 3.3E-08 Colon 7.2E-09 1.8E-08 1.9E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 2.2E-08 Kidneys 1.3E-09 1.6E-08 6.3E-08 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Liver 7.0E-10 8.7E-09 3.3E-08 9.3E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 9.5E-08 Muscle 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Ovaries 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Pancreas 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Red Marrow 3.3E-10 3.9E-09 1.5E-08 4.1E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 4.2E-08 Respiratory Tract ET Airways 9.6E-08 6.4E-07 2.5E-06 1.3E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Lungs 1.5E-06 7.1E-06 2.1E-05 3.5E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 3.6E-05 Skin 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Spleen 1.3E-09 1.6E-08 6.3E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Testes 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Thymus 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Thyroid 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Uterus 6.3E-11 3.9E-10 1.4E-09 3.7E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 3.8E-09 Remainder 1.6E-10 9.7E-10 3.6E-09 1.3E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 1.4E-08 Effective dose 1.8E-07 8.6E-07 2.5E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 4.3E-06 Po-210, 15-year-old member of the public Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type S, f1 = 0.01 Highest committed equivalent dose coefficient: Lungs, 1.9E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Bladder Wall 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Bone Surface 2.5E-10 2.8E-09 1.1E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 2.7E-08 Brain 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Breast 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 GI-Tract Oesophagus 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 St Wall 7.0E-10 1.0E-09 2.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 4.0E-09 SI Wall 1.6E-09 1.9E-09 2.9E-09 4.9E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 5.0E-09 ULI Wall 6.9E-09 9.8E-09 1.1E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 LLI Wall 7.5E-09 2.7E-08 2.9E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 3.2E-08 Colon 7.2E-09 1.7E-08 1.9E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 2.1E-08 Kidneys 1.3E-09 1.6E-08 6.0E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Liver 6.9E-10 8.5E-09 3.2E-08 8.2E-08 8.3E-08 8.3E-08 8.3E-08 8.3E-08 8.3E-08 8.3E-08 Muscle 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Ovaries 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Pancreas 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Red Marrow 3.3E-10 3.8E-09 1.4E-08 3.7E-08 3.7E-08 3.7E-08 3.7E-08 3.7E-08 3.7E-08 3.7E-08 Respiratory Tract ET Airways 9.7E-08 6.4E-07 2.6E-06 1.4E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Lungs 8.6E-07 3.9E-06 1.1E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 1.9E-05 Skin 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Spleen 1.3E-09 1.6E-08 6.1E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Testes 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Thymus 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Thyroid 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Uterus 6.2E-11 3.8E-10 1.3E-09 3.3E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 3.4E-09 Remainder 1.6E-10 9.6E-10 3.5E-09 1.2E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 1.3E-08 Effective dose 1.0E-07 4.7E-07 1.4E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 2.3E-06 Po-210, 15-year-old member of the public Ingestion: f1 = 0.5 More than one organ/tissue have the same highest committed equivalent dose coefficient Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 55 years Adrenals 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Bladder Wall 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Bone Surface 3.3E-08 3.3E-07 1.2E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Brain 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Breast 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 GI-Tract Oesophagus 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 St Wall 9.4E-09 4.5E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 SI Wall 9.7E-09 4.6E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 ULI Wall 1.7E-08 5.6E-08 1.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 3.6E-07 LLI Wall 1.9E-08 7.8E-08 1.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Colon 1.8E-08 6.6E-08 1.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Kidneys 1.7E-07 1.8E-06 6.8E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Liver 9.1E-08 9.8E-07 3.6E-06 8.4E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 Muscle 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Ovaries 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Pancreas 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Red Marrow 4.3E-08 4.4E-07 1.6E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 3.8E-06 Respiratory Tract ET Airways 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Lungs 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Skin 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Spleen 1.7E-07 1.9E-06 6.9E-06 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 1.6E-05 Testes 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Thymus 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Thyroid 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Uterus 7.8E-09 4.4E-08 1.5E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 3.4E-07 Remainder 8.9E-08 9.6E-07 3.5E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 Effective dose 2.2E-08 1.9E-07 6.8E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 8.8E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Bladder Wall 4.8E-09 2.5E-08 8.4E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Bone Surface 1.6E-08 1.3E-07 4.7E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Brain 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Breast 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 GI-Tract Oesophagus 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 St Wall 5.0E-09 2.5E-08 8.4E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 SI Wall 5.4E-09 2.5E-08 8.4E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 ULI Wall 7.6E-09 2.9E-08 8.8E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 LLI Wall 7.9E-09 3.6E-08 9.8E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Colon 7.7E-09 3.2E-08 9.3E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Kidneys 1.1E-07 1.0E-06 3.8E-06 8.7E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 Liver 5.7E-08 5.3E-07 1.9E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 Muscle 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Ovaries 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Pancreas 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Red Marrow 2.4E-08 2.1E-07 7.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Respiratory Tract ET Airways 1.1E-08 3.4E-08 9.3E-08 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 2.0E-07 Lungs 6.3E-08 8.4E-08 1.4E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 2.5E-07 Skin 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Spleen 9.4E-08 8.9E-07 3.2E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 Testes 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Thymus 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Thyroid 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Uterus 4.8E-09 2.5E-08 8.3E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Remainder 5.7E-08 5.3E-07 1.9E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 4.5E-06 Effective dose 2.0E-08 1.1E-07 3.6E-07 8.3E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 8.4E-07 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 1.2E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Bladder Wall 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Bone Surface 2.2E-08 1.8E-07 6.5E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Brain 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Breast 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 GI-Tract Oesophagus 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 St Wall 6.8E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 SI Wall 7.1E-09 3.5E-08 1.2E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 ULI Wall 8.8E-09 3.7E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 LLI Wall 9.1E-09 4.4E-08 1.3E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Colon 8.9E-09 4.0E-08 1.2E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Kidneys 1.5E-07 1.4E-06 5.2E-06 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 1.2E-05 Liver 7.9E-08 7.3E-07 2.7E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 Muscle 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Ovaries 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Pancreas 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Red Marrow 3.4E-08 3.0E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Respiratory Tract ET Airways 1.1E-08 4.1E-08 1.2E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Lungs 1.6E-07 1.8E-07 2.6E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Skin 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Spleen 1.3E-07 1.2E-06 4.4E-06 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 1.0E-05 Testes 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Thymus 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Thyroid 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Uterus 6.6E-09 3.4E-08 1.1E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Remainder 7.8E-08 7.3E-07 2.6E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 6.2E-06 Effective dose 3.5E-08 1.6E-07 5.1E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 1.7E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Bladder Wall 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Bone Surface 3.1E-08 2.6E-07 9.2E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Brain 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Breast 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 GI-Tract Oesophagus 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 St Wall 9.5E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 SI Wall 9.6E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 ULI Wall 1.1E-08 5.1E-08 1.7E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 LLI Wall 1.1E-08 5.5E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Colon 1.1E-08 5.2E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Kidneys 2.1E-07 2.0E-06 7.3E-06 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Liver 1.1E-07 1.0E-06 3.8E-06 8.8E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 8.9E-06 Muscle 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Ovaries 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Pancreas 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Red Marrow 4.8E-08 4.2E-07 1.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 3.5E-06 Respiratory Tract ET Airways 1.2E-08 5.2E-08 1.7E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 3.8E-07 Lungs 1.9E-07 2.3E-07 3.4E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 5.5E-07 Skin 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Spleen 1.8E-07 1.7E-06 6.3E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Testes 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Thymus 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Thyroid 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Uterus 9.4E-09 4.9E-08 1.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Remainder 1.1E-07 1.0E-06 3.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 8.8E-06 Effective dose 4.6E-08 2.2E-07 7.2E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 1.8E-05 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Bladder Wall 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Bone Surface 3.2E-08 2.7E-07 9.6E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Brain 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Breast 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 GI-Tract Oesophagus 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 St Wall 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 SI Wall 9.9E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 ULI Wall 1.0E-08 5.2E-08 1.7E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 LLI Wall 1.0E-08 5.4E-08 1.8E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 4.1E-07 Colon 1.0E-08 5.3E-08 1.8E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 4.0E-07 Kidneys 2.2E-07 2.1E-06 7.6E-06 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 1.8E-05 Liver 1.2E-07 1.1E-06 4.0E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 Muscle 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Ovaries 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Pancreas 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Red Marrow 5.0E-08 4.4E-07 1.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Respiratory Tract ET Airways 1.1E-08 5.2E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Lungs 1.1E-07 1.5E-07 2.7E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Skin 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Spleen 1.9E-07 1.8E-06 6.6E-06 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 1.5E-05 Testes 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Thymus 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Thyroid 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Uterus 9.8E-09 5.1E-08 1.7E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Remainder 1.2E-07 1.1E-06 3.9E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 Effective dose 3.7E-08 2.1E-07 7.4E-07 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 1.7E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 9.6E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Bladder Wall 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Bone Surface 1.7E-08 1.4E-07 5.2E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Brain 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Breast 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 GI-Tract Oesophagus 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 St Wall 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 SI Wall 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 ULI Wall 5.5E-09 2.8E-08 9.3E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 LLI Wall 5.5E-09 2.9E-08 9.7E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Colon 5.5E-09 2.8E-08 9.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Kidneys 1.2E-07 1.1E-06 4.1E-06 9.6E-06 9.6E-06 9.6E-06 9.6E-06 9.6E-06 9.6E-06 9.6E-06 Liver 6.3E-08 5.9E-07 2.1E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 5.0E-06 Muscle 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Ovaries 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Pancreas 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Red Marrow 2.7E-08 2.4E-07 8.5E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Respiratory Tract ET Airways 5.7E-09 2.8E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Lungs 5.1E-08 7.3E-08 1.4E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Skin 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Spleen 1.0E-07 9.8E-07 3.5E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 8.3E-06 Testes 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Thymus 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Thyroid 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Uterus 5.3E-09 2.7E-08 9.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Remainder 6.3E-08 5.8E-07 2.1E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 Effective dose 1.9E-08 1.1E-07 4.0E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 5.5E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bladder Wall 3.0E-09 1.6E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bone Surface 9.9E-09 8.2E-08 2.9E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 6.8E-07 Brain 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Breast 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 GI-Tract Oesophagus 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 St Wall 3.0E-09 1.6E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 SI Wall 3.1E-09 1.6E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 ULI Wall 3.4E-09 1.6E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 LLI Wall 3.4E-09 1.7E-08 5.6E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 Colon 3.4E-09 1.7E-08 5.4E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Kidneys 6.8E-08 6.4E-07 2.3E-06 5.4E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 Liver 3.6E-08 3.3E-07 1.2E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Muscle 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Ovaries 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Pancreas 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Red Marrow 1.5E-08 1.3E-07 4.8E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Respiratory Tract ET Airways 3.7E-09 1.7E-08 5.3E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Lungs 2.5E-08 3.7E-08 7.4E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Skin 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Spleen 5.9E-08 5.5E-07 2.0E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 4.7E-06 Testes 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thymus 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thyroid 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Uterus 3.0E-09 1.5E-08 5.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Remainder 3.6E-08 3.3E-07 1.2E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Effective dose 1.0E-08 6.5E-08 2.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 6.3E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bladder Wall 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bone Surface 1.1E-08 9.4E-08 3.4E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Brain 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Breast 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 GI-Tract Oesophagus 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 St Wall 3.6E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 SI Wall 3.7E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 ULI Wall 4.8E-09 2.0E-08 6.3E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 LLI Wall 4.9E-09 2.4E-08 6.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 4.8E-09 2.1E-08 6.5E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Kidneys 7.8E-08 7.4E-07 2.7E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 Liver 4.1E-08 3.8E-07 1.4E-06 3.2E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Muscle 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Ovaries 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Pancreas 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Red Marrow 1.8E-08 1.5E-07 5.6E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Respiratory Tract ET Airways 5.9E-09 2.1E-08 6.3E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Lungs 2.0E-08 3.4E-08 7.6E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Skin 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Spleen 6.8E-08 6.4E-07 2.3E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 5.4E-06 Testes 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thymus 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thyroid 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Uterus 3.4E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Remainder 4.1E-08 3.8E-07 1.4E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 3.2E-06 Effective dose 1.1E-08 7.4E-08 2.6E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 7.8E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bladder Wall 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Bone Surface 1.4E-08 1.2E-07 4.2E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 9.8E-07 Brain 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Breast 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 GI-Tract Oesophagus 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 St Wall 4.5E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 SI Wall 4.8E-09 2.3E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 6.6E-09 2.6E-08 7.9E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 LLI Wall 6.9E-09 3.2E-08 8.7E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Colon 6.7E-09 2.8E-08 8.2E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Kidneys 9.7E-08 9.2E-07 3.4E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 7.8E-06 Liver 5.1E-08 4.8E-07 1.7E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Muscle 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Ovaries 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Pancreas 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Red Marrow 2.2E-08 1.9E-07 6.9E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Respiratory Tract ET Airways 8.6E-09 2.9E-08 8.1E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Lungs 2.2E-08 4.0E-08 9.2E-08 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 1.9E-07 Skin 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Spleen 8.4E-08 7.9E-07 2.9E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 6.7E-06 Testes 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thymus 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Thyroid 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Uterus 4.3E-09 2.2E-08 7.5E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Remainder 5.1E-08 4.7E-07 1.7E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 4.0E-06 Effective dose 1.4E-08 9.2E-08 3.2E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 7.4E-07 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 7.5E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Bladder Wall 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Bone Surface 1.3E-08 1.1E-07 4.0E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 9.4E-07 Brain 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Breast 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 GI-Tract Oesophagus 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 St Wall 4.4E-09 2.2E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 SI Wall 4.7E-09 2.2E-08 7.2E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 ULI Wall 6.6E-09 2.5E-08 7.6E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 LLI Wall 6.9E-09 3.2E-08 8.5E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Colon 6.7E-09 2.8E-08 8.0E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Kidneys 9.3E-08 8.9E-07 3.2E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 7.5E-06 Liver 4.9E-08 4.6E-07 1.7E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Muscle 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Ovaries 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Pancreas 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Red Marrow 2.1E-08 1.8E-07 6.7E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Respiratory Tract ET Airways 9.0E-09 2.8E-08 7.9E-08 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Lungs 1.9E-08 3.7E-08 8.7E-08 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Skin 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Spleen 8.1E-08 7.6E-07 2.8E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Testes 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Thymus 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Thyroid 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Uterus 4.1E-09 2.1E-08 7.2E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Remainder 4.9E-08 4.6E-07 1.7E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Effective dose 1.3E-08 8.8E-08 3.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Po-210, adult worker Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type F, f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 6.3E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bladder Wall 3.5E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Bone Surface 1.1E-08 9.5E-08 3.4E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 7.9E-07 Brain 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Breast 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 GI-Tract Oesophagus 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 St Wall 3.7E-09 1.8E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 SI Wall 4.0E-09 1.9E-08 6.1E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 ULI Wall 5.9E-09 2.1E-08 6.5E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 LLI Wall 6.1E-09 2.8E-08 7.2E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 6.0E-09 2.4E-08 6.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Kidneys 7.8E-08 7.5E-07 2.7E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 6.3E-06 Liver 4.1E-08 3.9E-07 1.4E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Muscle 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Ovaries 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Pancreas 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Red Marrow 1.8E-08 1.6E-07 5.6E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Respiratory Tract ET Airways 8.4E-09 2.5E-08 6.8E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Lungs 1.3E-08 2.8E-08 7.0E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Skin 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Spleen 6.8E-08 6.4E-07 2.3E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 5.5E-06 Testes 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thymus 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Thyroid 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Uterus 3.5E-09 1.8E-08 6.0E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Remainder 4.1E-08 3.8E-07 1.4E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Effective dose 1.0E-08 7.4E-08 2.6E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 6.0E-07 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.001 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 7.6E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bladder Wall 9.8E-10 5.7E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bone Surface 3.1E-09 3.0E-08 1.1E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Brain 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Breast 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 GI-Tract Oesophagus 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 St Wall 1.5E-09 6.2E-09 2.1E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 SI Wall 2.2E-09 6.9E-09 2.1E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 ULI Wall 6.6E-09 1.4E-08 2.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 5.8E-08 LLI Wall 7.2E-09 2.9E-08 4.5E-08 7.6E-08 7.6E-08 7.6E-08 7.6E-08 7.6E-08 7.6E-08 7.6E-08 Colon 6.9E-09 2.0E-08 3.5E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 Kidneys 2.1E-08 2.3E-07 9.0E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Liver 1.1E-08 1.2E-07 4.6E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Muscle 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Ovaries 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Pancreas 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Red Marrow 4.7E-09 4.9E-08 1.9E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Respiratory Tract ET Airways 9.4E-08 6.1E-07 2.3E-06 7.9E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 8.1E-06 Lungs 3.6E-06 1.9E-05 5.2E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 7.6E-05 Skin 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Spleen 1.8E-08 2.0E-07 7.7E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Testes 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thymus 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thyroid 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Uterus 9.8E-10 5.6E-09 2.0E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Remainder 1.3E-09 9.4E-09 3.4E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 Effective dose 4.4E-07 2.3E-06 6.4E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 9.2E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.003 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.9E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Bladder Wall 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Bone Surface 3.5E-09 3.5E-08 1.4E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 3.9E-07 Brain 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Breast 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 GI-Tract Oesophagus 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 St Wall 1.6E-09 7.2E-09 2.5E-08 6.8E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 6.9E-08 SI Wall 2.3E-09 7.9E-09 2.6E-08 6.9E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 7.0E-08 ULI Wall 6.2E-09 1.5E-08 3.4E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 7.8E-08 LLI Wall 6.6E-09 2.9E-08 5.1E-08 9.7E-08 9.8E-08 9.8E-08 9.8E-08 9.8E-08 9.8E-08 9.8E-08 Colon 6.4E-09 2.1E-08 4.1E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Kidneys 2.4E-08 2.7E-07 1.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 3.1E-06 Liver 1.3E-08 1.4E-07 5.7E-07 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 1.6E-06 Muscle 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Ovaries 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Pancreas 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Red Marrow 5.4E-09 5.7E-08 2.3E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 6.4E-07 Respiratory Tract ET Airways 7.5E-08 4.9E-07 1.8E-06 6.3E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 6.5E-06 Lungs 9.5E-06 4.7E-05 1.3E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 1.9E-04 Skin 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Spleen 2.1E-08 2.4E-07 9.6E-07 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 2.7E-06 Testes 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Thymus 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Thyroid 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Uterus 1.1E-09 6.6E-09 2.5E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Remainder 1.5E-09 1.1E-08 4.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Effective dose 1.1E-06 5.6E-06 1.6E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.010 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bladder Wall 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Bone Surface 3.9E-09 3.9E-08 1.7E-07 7.0E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 7.1E-07 Brain 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Breast 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 GI-Tract Oesophagus 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 St Wall 1.6E-09 7.9E-09 3.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 SI Wall 2.0E-09 8.4E-09 3.2E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 ULI Wall 4.3E-09 1.3E-08 3.8E-08 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 1.3E-07 LLI Wall 4.4E-09 2.4E-08 5.2E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Colon 4.3E-09 1.8E-08 4.4E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Kidneys 2.7E-08 3.1E-07 1.4E-06 5.6E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 5.7E-06 Liver 1.4E-08 1.6E-07 7.2E-07 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 2.9E-06 Muscle 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Ovaries 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Pancreas 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Red Marrow 6.1E-09 6.4E-08 2.9E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Respiratory Tract ET Airways 3.8E-08 2.5E-07 9.3E-07 3.2E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 3.3E-06 Lungs 1.2E-05 5.7E-05 1.6E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 2.3E-04 Skin 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Spleen 2.3E-08 2.7E-07 1.2E-06 4.8E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 4.9E-06 Testes 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thymus 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Thyroid 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Uterus 1.2E-09 7.5E-09 3.1E-08 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 1.2E-07 Remainder 1.6E-09 1.2E-08 5.2E-08 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 2.1E-07 Effective dose 1.4E-06 6.8E-06 1.9E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 2.8E-05 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.030 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.3E-04 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Bladder Wall 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 Bone Surface 3.6E-09 3.5E-08 1.7E-07 8.6E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 8.8E-07 Brain 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Breast 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 GI-Tract Oesophagus 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 St Wall 1.3E-09 7.0E-09 3.1E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 SI Wall 1.5E-09 7.2E-09 3.1E-08 1.5E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 ULI Wall 2.5E-09 9.7E-09 3.5E-08 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 1.6E-07 LLI Wall 2.5E-09 1.5E-08 4.3E-08 1.7E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 1.8E-07 Colon 2.5E-09 1.2E-08 3.9E-08 1.6E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 1.7E-07 Kidneys 2.5E-08 2.8E-07 1.4E-06 6.9E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 7.1E-06 Liver 1.3E-08 1.4E-07 7.0E-07 3.6E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 3.7E-06 Muscle 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Ovaries 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Pancreas 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Red Marrow 5.6E-09 5.8E-08 2.8E-07 1.4E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Respiratory Tract ET Airways 1.6E-08 1.0E-07 3.9E-07 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 1.4E-06 Lungs 6.5E-06 3.1E-05 8.7E-05 1.3E-04 1.3E-04 1.3E-04 1.3E-04 1.3E-04 1.3E-04 1.3E-04 Skin 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Spleen 2.1E-08 2.4E-07 1.2E-06 5.9E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 6.1E-06 Testes 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thymus 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Thyroid 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Uterus 1.1E-09 6.8E-09 3.1E-08 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 1.5E-07 Remainder 1.5E-09 1.1E-08 5.1E-08 2.5E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 2.6E-07 Effective dose 7.9E-07 3.8E-06 1.1E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.100 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 6.4E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Bladder Wall 6.0E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Bone Surface 1.9E-09 1.9E-08 9.1E-08 4.7E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 4.9E-07 Brain 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Breast 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 GI-Tract Oesophagus 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 St Wall 6.7E-10 3.7E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 SI Wall 7.5E-10 3.8E-09 1.7E-08 8.4E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 8.6E-08 ULI Wall 1.2E-09 4.9E-09 1.9E-08 8.7E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 8.9E-08 LLI Wall 1.2E-09 7.4E-09 2.3E-08 9.5E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 9.7E-08 Colon 1.2E-09 6.0E-09 2.0E-08 9.0E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 Kidneys 1.3E-08 1.5E-07 7.3E-07 3.8E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Liver 7.0E-09 7.6E-08 3.8E-07 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 2.0E-06 Muscle 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Ovaries 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Pancreas 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Red Marrow 3.0E-09 3.1E-08 1.5E-07 7.9E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 8.1E-07 Respiratory Tract ET Airways 7.4E-09 4.8E-08 1.8E-07 6.6E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 6.7E-07 Lungs 3.1E-06 1.5E-05 4.1E-05 6.4E-05 6.4E-05 6.4E-05 6.4E-05 6.4E-05 6.4E-05 6.4E-05 Skin 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Spleen 1.1E-08 1.3E-07 6.3E-07 3.3E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 3.4E-06 Testes 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Thymus 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Thyroid 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Uterus 5.9E-10 3.6E-09 1.6E-08 8.3E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Remainder 7.9E-10 5.8E-09 2.7E-08 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 1.4E-07 Effective dose 3.7E-07 1.8E-06 5.0E-06 7.9E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 8.0E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 0.300 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 3.2E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Bladder Wall 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Bone Surface 1.2E-09 1.2E-08 5.4E-08 2.6E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Brain 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Breast 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 GI-Tract Oesophagus 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 St Wall 4.6E-10 2.3E-09 9.8E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 SI Wall 5.7E-10 2.5E-09 1.0E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 ULI Wall 1.2E-09 3.6E-09 1.1E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 LLI Wall 1.2E-09 6.1E-09 1.5E-08 5.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Colon 1.2E-09 4.7E-09 1.3E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 Kidneys 8.3E-09 9.2E-08 4.3E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Liver 4.4E-09 4.8E-08 2.2E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Muscle 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Ovaries 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Pancreas 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Red Marrow 1.9E-09 1.9E-08 9.0E-08 4.3E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 4.4E-07 Respiratory Tract ET Airways 1.3E-08 8.2E-08 3.1E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Lungs 1.5E-06 7.2E-06 2.0E-05 3.1E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 3.2E-05 Skin 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Spleen 7.2E-09 7.9E-08 3.7E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Testes 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Thymus 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Thyroid 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Uterus 3.8E-10 2.2E-09 9.7E-09 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Remainder 5.1E-10 3.6E-09 1.6E-08 7.7E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 7.9E-08 Effective dose 1.8E-07 8.7E-07 2.4E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 1.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.3E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Bladder Wall 5.8E-10 3.4E-09 1.3E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Bone Surface 1.8E-09 1.8E-08 7.2E-08 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 2.7E-07 Brain 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Breast 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 GI-Tract Oesophagus 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 St Wall 8.4E-10 3.6E-09 1.3E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 SI Wall 1.2E-09 4.0E-09 1.4E-08 4.7E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 4.8E-08 ULI Wall 3.2E-09 7.0E-09 1.7E-08 5.1E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 5.2E-08 LLI Wall 3.5E-09 1.4E-08 2.5E-08 6.1E-08 6.1E-08 6.1E-08 6.1E-08 6.1E-08 6.1E-08 6.1E-08 Colon 3.3E-09 1.0E-08 2.0E-08 5.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 Kidneys 1.2E-08 1.4E-07 5.8E-07 2.1E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Liver 6.6E-09 7.2E-08 3.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Muscle 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Ovaries 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Pancreas 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Red Marrow 2.8E-09 2.9E-08 1.2E-07 4.4E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 4.5E-07 Respiratory Tract ET Airways 4.5E-08 2.9E-07 1.1E-06 3.8E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 3.9E-06 Lungs 1.0E-06 5.3E-06 1.5E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 2.3E-05 Skin 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Spleen 1.1E-08 1.2E-07 5.0E-07 1.8E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Testes 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Thymus 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Thyroid 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Uterus 5.8E-10 3.3E-09 1.3E-08 4.6E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 4.7E-08 Remainder 7.9E-10 5.5E-09 2.2E-08 8.0E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 8.1E-08 Effective dose 1.3E-07 6.4E-07 1.8E-06 2.9E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 3.0E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 3.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 2.2E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Bladder Wall 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Bone Surface 2.6E-09 2.5E-08 9.7E-08 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 3.0E-07 Brain 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Breast 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 GI-Tract Oesophagus 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 St Wall 1.3E-09 5.2E-09 1.8E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 SI Wall 1.8E-09 5.8E-09 1.8E-08 5.3E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 5.4E-08 ULI Wall 5.4E-09 1.1E-08 2.4E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 6.0E-08 LLI Wall 5.9E-09 2.3E-08 3.7E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 7.4E-08 Colon 5.6E-09 1.6E-08 2.9E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 6.6E-08 Kidneys 1.8E-08 2.0E-07 7.8E-07 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 2.4E-06 Liver 9.4E-09 1.0E-07 4.0E-07 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 1.2E-06 Muscle 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Ovaries 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Pancreas 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Red Marrow 4.0E-09 4.1E-08 1.6E-07 4.9E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 5.0E-07 Respiratory Tract ET Airways 7.8E-08 5.1E-07 1.9E-06 6.7E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 6.8E-06 Lungs 9.9E-07 5.0E-06 1.4E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 2.2E-05 Skin 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Spleen 1.5E-08 1.7E-07 6.7E-07 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 2.1E-06 Testes 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Thymus 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Thyroid 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Uterus 8.3E-10 4.8E-09 1.7E-08 5.2E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 5.3E-08 Remainder 1.1E-09 7.9E-09 3.0E-08 9.1E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 9.2E-08 Effective dose 1.2E-07 6.1E-07 1.7E-06 2.7E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 2.8E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD = 5.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 1.7E-05 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bladder Wall 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Bone Surface 2.6E-09 2.5E-08 9.7E-08 2.7E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 2.8E-07 Brain 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Breast 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 GI-Tract Oesophagus 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 St Wall 1.3E-09 5.3E-09 1.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 SI Wall 1.9E-09 5.9E-09 1.8E-08 4.9E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 5.0E-08 ULI Wall 5.7E-09 1.1E-08 2.4E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 LLI Wall 6.3E-09 2.4E-08 3.8E-08 7.0E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 7.1E-08 Colon 6.0E-09 1.7E-08 3.0E-08 6.2E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 6.3E-08 Kidneys 1.8E-08 2.0E-07 7.7E-07 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Liver 9.5E-09 1.0E-07 4.0E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Muscle 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Ovaries 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Pancreas 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Red Marrow 4.1E-09 4.2E-08 1.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 4.6E-07 Respiratory Tract ET Airways 8.5E-08 5.5E-07 2.1E-06 7.2E-06 7.3E-06 7.3E-06 7.3E-06 7.3E-06 7.3E-06 7.3E-06 Lungs 8.0E-07 3.9E-06 1.1E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 1.7E-05 Skin 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Spleen 1.6E-08 1.7E-07 6.6E-07 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 1.9E-06 Testes 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thymus 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Thyroid 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Uterus 8.4E-10 4.8E-09 1.7E-08 4.8E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 4.9E-08 Remainder 1.2E-09 8.0E-09 3.0E-08 8.4E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 8.5E-08 Effective dose 9.8E-08 4.8E-07 1.4E-06 2.1E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Po-210, adult worker Inhalation of particulate aerosol: AMAD =10.000 micron, absorption Type M, f1 = 0.1 Highest committed equivalent dose coefficient: Lungs, 8.5E-06 Sv/Bq Remainder formulation: default Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Bladder Wall 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Bone Surface 2.4E-09 2.3E-08 8.5E-08 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 2.2E-07 Brain 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Breast 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 GI-Tract Oesophagus 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 St Wall 1.2E-09 4.8E-09 1.5E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 SI Wall 1.8E-09 5.3E-09 1.6E-08 3.9E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 4.0E-08 ULI Wall 5.4E-09 1.1E-08 2.2E-08 4.5E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 4.6E-08 LLI Wall 5.9E-09 2.3E-08 3.4E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 5.9E-08 Colon 5.6E-09 1.6E-08 2.7E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 5.1E-08 Kidneys 1.6E-08 1.8E-07 6.8E-07 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 1.8E-06 Liver 8.5E-09 9.2E-08 3.5E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 9.1E-07 Muscle 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Ovaries 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Pancreas 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Red Marrow 3.7E-09 3.7E-08 1.4E-07 3.6E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 3.7E-07 Respiratory Tract ET Airways 8.2E-08 5.3E-07 2.0E-06 6.9E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 7.0E-06 Lungs 4.4E-07 2.0E-06 5.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 8.5E-06 Skin 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Spleen 1.4E-08 1.5E-07 5.8E-07 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 1.5E-06 Testes 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Thymus 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Thyroid 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Uterus 7.6E-10 4.3E-09 1.5E-08 3.8E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 3.9E-08 Remainder 1.0E-09 7.2E-09 2.6E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 6.8E-08 Effective dose 5.5E-08 2.6E-07 7.1E-07 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 1.1E-06 Po-210, adult worker Ingestion: f1 = 0.1 Highest committed equivalent dose coefficient: Kidneys, 2.5E-06 Sv/Bq Remainder formulation: split Time after intake 1 day 7 days 30 days 1 year 5 years 10 years 20 years 30 years 45 years 50 years Adrenals 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Bladder Wall 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Bone Surface 3.5E-09 3.6E-08 1.3E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 3.1E-07 Brain 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Breast 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 GI-Tract Oesophagus 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 St Wall 2.4E-09 8.2E-09 2.5E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 5.6E-08 SI Wall 3.9E-09 9.7E-09 2.6E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 5.7E-08 ULI Wall 1.4E-08 2.4E-08 4.1E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 7.2E-08 LLI Wall 1.5E-08 5.5E-08 7.3E-08 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 1.1E-07 Colon 1.4E-08 3.7E-08 5.5E-08 8.6E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 8.7E-08 Kidneys 2.4E-08 2.9E-07 1.1E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 2.5E-06 Liver 1.3E-08 1.5E-07 5.5E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Muscle 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Ovaries 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Pancreas 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Red Marrow 5.4E-09 6.0E-08 2.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 5.2E-07 Respiratory Tract ET Airways 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Lungs 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Skin 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Spleen 2.1E-08 2.5E-07 9.2E-07 2.1E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 2.2E-06 Testes 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Thymus 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Thyroid 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Uterus 1.2E-09 6.9E-09 2.4E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 5.5E-08 Remainder 1.3E-08 1.5E-07 5.5E-07 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 1.3E-06 Effective dose 4.6E-09 3.2E-08 1.0E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07 2.4E-07